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Abstract
This thesis characterises the B cell response of C57BL/6 mice after infection with 
Plasmodium chabaudi chabaudi (AS) with regard to plasma cell longevity, B cell memory 
and the specific response to part of the merozoite surface protein-1 (M SP-I21), an antigen 
involved in protection against malaria. Infected spleens showed massive but reversible 
disruption of the white pulp architecture around the peak of infection. Nevertheless, strong 
plasma cell and germinal centre responses were detected along with atypical plasma cell 
location and apparent involvement of marginal zone B cells. The M SP-l2rSpecific B cell 
response to primary infection did not display any obvious abnormalities at the cellular level. 
The longevity of protection was assessed in the presence and absence of parasites. P. c. 
chabaudi parasites persisted for 2-3 months after infection. A single infection mediated 
protection in form of reduced parasitaemias for up to 9 months. When mice were reinfected 
after 2.5 months but not later, the presence of parasites from the primary infection led to an 
additional reduction. This can be attributed to cooperation between effector and memory 
cells.
MSP-121-specific IgG levels were measured in primary and secondary infections and during 
the intervening period. Plasma levels of IgG against MSP-121 and crude malarial extract drop 
significantly between 1 and 2.5 months post infection and then remain constant, suggesting 
that Plasmadium-s^Qcific plasma IgG levels are maintained by long-lived plasma cells 
independent of parasite presence or absence after day 30. However, M SP -l2i-specific 
memory B cell generation, maintenance or reactivation appears to be reduced in the presence 
of parasites albeit with increased affinity maturation. Primary and secondary antibody 
responses to M SP-I21 develop more slowly than antibody responses observed in other 
infections, suggesting that despite the strong B cell response during primary infection with 
malaria, there is an impairment of the B cell response at some level.
I wish to acknowledge the following people for allowing me to include data from shared 
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1 Introduction
1.1 The relevance of malaria for immunological studies
Malaria is a major health issue in much of the developing world and because of increased 
tourism and global warming it is also becoming more important to inhabitants o f other 
countries. Insecticide- and medication-based eradication campaigns have been successful 
in some parts of the world, but frequently, these efforts have only controlled the level of 
infections temporarily. In parallel, parasite resistance to anti-malarial drugs is on the rise 
and can complicate treatment. Despite detailed knowledge of the transmission mode and 
life cycle o f the parasite, no vaccine against malaria has been developed yet. Most o f the 
effective vaccines in existence are against diseases like measles to which survivors acquire 
long-term immunity after one encounter or diseases which would naturally progress so 
rapidly that death occurs before natural immunity can develop, e.g. tetanus. By contrast, 
malaria is contracted repeatedly and parasitaemia can persist over long periods of time. 
This indicates that vaccine design is not a simple case of pre-exposure to a single parasite 
protein. Therefore, it is very important to understand precisely how the parasite interacts 
with the host’s immune system in order to create an effective vaccine.
Malaria is also an intriguing object of study from an immunological point of view. M any 
of the basic concepts in immunology have been established by studying the immune 
response to non-replicating antigens. However, important aspects o f the immune system, 
such as the link between the innate and adaptive branches of the immune system or the 
existence of long-lived antibody-producing cells, were discovered by studying the immune 
response to replicating pathogens. Infections differ from immunisations in the kinetics, 
location and immunological context of antigenic exposure with a much higher possibility 
of synergy or antagonism between different branches o f the immune system. The immune 
response to malaria is of particular interest because of the exposure of the host to very
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high doses o f antigen followed by diminished but chronic parasitaemia. In addition, the 
parasites evolved a number of immune evasion mechanisms in their adaptation to the host 
and careful analysis of these processes is likely to reveal strengths and weaknesses in 
immune responses.
1.2 Background on malaria
1.2.1 The Plasmodium parasite
Malaria is caused by protozoans of the subgenus Plasmodium, which belong to the 
family Plasmodiidae and the order Apicomplexa. The species which occur naturally in 
humans and those adapted to laboratory mice are listed in Table 1.1. Plasmodium is an 
obligatory parasite requiring two hosts. Species of Plasmodium are closely adapted to 
particular hosts with mammals, avians and reptiles serving as the vertebrate hosts. The 
invertebrate host must belong to either the Anopheles or Culex genus of mosquitos, with 
Culex restricted as a vector of avian malarias. Asexual reproduction occurs in the 
vertebrate host in two stages and sexual reproduction in the mosquito host. An overview 
of the Plasmodium life cycle is given in Fig. 1.1, with the emphasis on the stages in the 
vertebrate host. A detailed review can be found in (Gamham, 1988). The mosquito injects 
saliva containing a small number o f sporozoites into the vertebrate host. The sporozoites 
travel quickly from the injection site to the liver via the blood stream. They initiate the 
hepatocytic (also known as the pre-erythrocytic or exo-erythrocytic) stage o f the life 
cycle by invading hepatocytes where they develop into hepatic trophozoites. Nuclear 
division creates a hepatic schizont containing thousands o f merozoites which are released 
into the blood stream by hepatocyte rupture. In most Plasmodium species, the 
hepatocytic stage takes place only once in each infection, but in P. vivax, P. ovale and the 
simian parasite P. knowlesi the parasite can persist in the liver in form of hypnozoites.
Table 1.1 'DïfÏQXQnX Plasmodium species
Species Other designations Host
P. falciparum malignant tertian, subtertian, 
aesotivo-autumnal, tropical, 
pernicious
Man
P. vivax benign tertian, simple tertian, 
tertian
Man
P. ovale ovale tertian Man
P. malariae quartan Mouse
P. chabaudi Mouse
P. yoelii Mouse
P. berghei P. yoelii berghei Mouse
P. vinckei Mouse
Table 1.2 Species-specific characteristics of the life cycle of parasites with human and 
mouse hosts
Exo-erythrocytic stage Erythrocytic stage
Parasite
species
Duration of 
cycle
Number of 
merozoites / 
schizont
Duration 
of one 
cycle
Number of 
merozoites / 
schizont
Preferred type of 
invaded 
erythrocyte
P. falciparum 5.5-6 days 40 000 48 h 8-24 all
P. malariae 13 days 2 0 0 0 72 h 8 -1 2 mature
P. ovale 9 days 15 000 49-50 h 16 reticulocytes
P. vivax 8 days > 10  0 0 0 48 h 12-18 reticulocytes
P. berghei 50 h
4000-20 000
24 8-18 reticulocytes
P. chabaudi 53-58 h 24 h 4-10 mature
P. vinckei 60-68 h 24 h 6 -1 2 mature
P. yoelii 50 h 24 h 12-18 reticulocytes
This table was adapted from (Li, 1999).
Figure 1.1 The Plasmodium life cycle
Adapted from (Godson, 1985) by Dr. Jean Langhome.
 ^ Ù (D
Sporozoite
Gametocyte
Hepatocyte
Schizont
Merozoite
Points of immune attack
The merozoites from liver schizonts initiate the erythrocytic stage of the parasite life 
cycle, which then repeats itself every 24-72 h, dependent on the parasite species, and is 
responsible for all of the symptoms of malaria. Merozoites invade erythrocytes rapidly 
and are enclosed by a parasitophorous vacuole formed by the erthrocyte outer membrane. 
The parasites develop through the ring stage, trophozoite and schizont stages. Mature 
schizonts cause the erythrocytes to rupture and release between 6  and 24 merozoites, 
depending on the species of parasite, for reinvasion of new erythrocytes. This cycle of 
erythrocytic schizogony is repeated until the increasing parasitaemia is controlled by 
immune mechanisms or chemotherapy. After a minimum of two erythrocytic schizogony 
cycles (in most species), some merozoites differentiate into sexual forms, the female 
macrogamétocyte and the male microgamétocyte. Gametocytes are taken up by 
mosquitoes with the blood meal and undergo sporogony in this host: In the midgut, the 
gametocytes differentiate into macro- and microgametes which combine to zygotes. The 
zygotes transform into motile ookinetes, which penetrate the midgut epithelium and there 
form oocysts. The oocysts undergo nuclear division into as many as 10 000 sporozoites. 
The sporozoites travel to the mosquito’s salivary gland and are finally transmitted to a 
new vertebrate host.
This life cycle is common to the nearly 200 different species o f Plasmodium, Individual 
characteristics of the life cycles for the species infecting humans and mice are illustrated 
in Table 1.2. As mentioned earlier, P. vivax and P. ovale possess a unique life stage not 
shared by the other human malaria parasites, where parasites can survive in the liver as 
hypnozoites for periods of up to 5 years before initiating blood stage infections. These 
renewed manifestations of infection arising from the survival o f hypnozoites are called 
relapses whereas the reemergence of infection from low levels o f surviving erythrocytic 
parasites is called a recrudescence.
1.2.2 Malaria disease in humans
There are four Plasmodium species which cause malaria in humans: P. vivax, P. ovale, P. 
malariae and P. falciparum. Occasional episodes o f zoonosis occur with species which 
normally infect monkeys, but these are uncommon. Malaria is widespread in Africa, 
South-East Asia and South America, with about 40% of the world’s population at risk. 
The Plasmodium parasite caused an estimated 856 000 deaths in 1990 (Murray and 
Lopez, 1997) and is generally assumed to cause 100-200 million infections annually. This 
makes malaria the largest health problem caused by a single infectious agent, with the 
possible exception of tuberculosis. Most of the deaths occur in children up to 5 years of 
age, with pregnant women, immigrants to endemic areas and travellers representing 
further high risk groups. Malaria is typically accompanied by periodic fevers elicited by 
erythroctye rupture. Further symptoms include severe anaemia and cerebral malaria (the 
main causes of death), pulmonary oedema, renal complications from deposited immune 
complexes, hypoglycaemia, thrombocytopenia, splenomegaly, hepatomegaly, renal 
damage and immunodépression.
Plasmodium parasites and their hosts have adapted to each other over the long course of 
their co-existence. Selective pressure has led to high prevalence of a number o f genetic 
factors offering partial protection in malaria-endemic areas. Frequently, these are 
erythrocytic defects which are lethal or disadvantageous to the host in their homozygous 
form, whereas the heterozygous form offers a degree of protection against malaria. These 
include sickle cell anaemia, thallassaemias and glucose-6 -phosphate dehydrogenase 
deficiency. Less detrimental adaptations include resistance to P. vivax infection due to a 
lack of Duffy blood group antigen on erythrocytes and biased occurence of certain major 
histocompatibility complex (MHC) genotypes which results in a more effective immune 
response against the parasite (reviewed in (Miller, 1988; Riley, 1996)).
1.2.3 Malaria distribution patterns
The terminology describing the epidemiology of malaria is somewhat complex, as several 
different factors need to be considered. Endemic areas are defined as regions where there 
is a measurable incidence both of cases and of natural transmission over a succession of 
years. Endemicity is further divided into four categories proposed by the World Health 
Organisation (WHO): holoendemic, mesoendemic, hyperendemic and hypoendemic. 
Table 1.3 outlines two standard ways of defining these categories. In general, the level of 
endemicity decreases with increasing latitudes and malaria epidemics occur chiefly at the 
borders of the endemic distribution range. Malaria distribution is further differentiated 
into perennial and seasonal transmission and often referred to as stable or unstable, 
depending on the resistance of the situation to change. Endemicity must be established 
individually for each species. A further way of characterising the situation is to measure 
the number of infective mosquito bites experienced during a particular time period, 
usually a year (reviewed in (Molineaux et a l, 1988)).
Table 1.3 Definitions of malaria endemicity
Degree of endemicity Definition by spleen rate Definition by parasite rate
Hypoendemic 0-10% in children of 2-9 years as a rule < 10% in children of 2-9 
years; may be higher during part of 
the year
Mesoendemic 11-50% in children of 2-9 years as a rule 11-50% in children of 2-9 
years; may be higher during part of 
the year
Hyperendemic constantly over 50% in 
children of 2-9 years, adult 
spleen rate also high
constantly over 50 %
Holoendemic constantly over 75% in 
children of 2-9 years, adult 
spleen rate low, adult tolerance 
high
constantly over 75% in infants, 
spleen rate high (New Guinea type) 
or low (African type); parasite 
density declining rapidly between 
2 "^  and 5^ year o f life and then 
more slowly
a) Definitions are standard definitions as outlined in (Molineaux et a l ,  1988).
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1.2.4 Animal models for malaria
1.2.4.1 Rodent models
Four species of Plasmodium which were isolated from the African thicket rat 
Thamnomys rutilans are capable of infecting mice and rats. The well characterised 
immune system of the mouse along with the availability of different strains with defined 
genetic defects make the mouse the preferred animal model for most studies. It is 
necessary to choose the appropriate parasite species on the basis o f similarities to the life 
cycle of the human parasites. Genetic similarity is not a useful criterion, as all o f the 
Plasmodium species diverged in the range of tens of millions to hundreds of millions 
years ago, making even the human species genetically very diverse (reviewed in (Ayala et 
a l, 1998)). P. chabaudi chabaudi is considered a good model for P. falciparum, because 
these species share a preference for mature red blood cells, antigenic variation (del Portillo 
et a l,  2001; McLean et a l,  1982) and parasite sequestration (Cox et a l,  1987; Gilks et a l, 
1990). Synchronicity of the blood stage and maturation of gametocytes late in infection 
make it easier to pinpoint the parasite stage responsible for any identified phenomena. 
The typical pattern of P. chabaudi chabaudi parasitaemia, consisting o f exponential 
multiplication followed by strong reduction and a brief low recrudescence, can be 
observed in the wild-type curve shown in Fig. 1.2.
The other three species of rodent malaria are used for models with a different focus. 
Different strains of P. berghei are used to model cerebral malaria and anaemia. P. yoelii 
has adapted in vitro into clearly defined lethal and nonlethal strains and is therefore useful 
for questions centring on the virulence of the parasite. The lethal strains are also preferred 
for vaccine studies as animal survival can be defined as a measure o f protection. A number 
of the earlier studies in rats, especially chemotherapy studies, were performed with P. 
vinckei, but this species is not commonly used anymore (reviewed in (Langhome et a l, 
2002; L ie t a l , i m ) .
The mouse strain is also important for the course o f infection, with the same strain of 
Plasmodium causing different outcomes of infection in different strains of mice. For the 
long-term studies of B cell responses in this thesis, the C57BL/6 strain of mice is most 
suitable, because mice are fairly resistant to P. chabaudi infection and therefore usually 
survive for the duration o f the experiments. In addition, many genetically deficient mice 
are available on the C57BL/6 background, making it easy to test assumptions in other 
systems afterwards and a lot of data has been published with mice from this genetic 
background.
1.2.4.2 Simian models
There are 20 species o f Plasmodium which infect lemurs, monkeys and higher apes and 
the four species o f human malaria pathogens can also infect some of these animals 
(reviewed in (Collins, 1988)). Many of these species are not suitable for animal models 
due to limited availability of hosts for experiments. In addition, it is often necessary to 
perform splenectomy to increase the degree of parasitaemia or to make chimpanzees 
susceptible to the P. falciparum and P. vivax species, which make it difficult to assess 
immunological fimction in these model systems. However, simian models are sometimes 
used as a final step in vaccine and anti-malarial drug studies, for example P. cynomolgi as 
a model for P. vivax ond P. fragile for P. falciparum. The simian parasite P. knowlesi has 
been used to study antigenic variation, but does not correspond well with the species 
affecting humans because of its 24-hour life cycle. The most commonly used monkey 
genera are Macaca, Saimiri dind Aotus.
1.3 The immune system
1.3.1 Innate versus adaptive immunitv
The immune system contains an innate and an adaptive component. The innate immune 
system is the first level of defense against many common pathogens. Macrophages,
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neutrophils and dendritic cells respond to universal components found on pathogens by 
phagocytosis, release of inflammatory mediators and activation of the alternative 
complement pathway. The innate response is important as a defense mechanism in the 
first days o f infection while the adaptive immune response develops to full potency, but 
it also involved in both activation of and modulation o f the adaptive immune response.
The adaptive branch of the immune system allows the host to respond specifically to 
antigenic challenge and improve the quality of the immune response during the course of 
exposure to pathogens. The antigen-specific cells are T and B lymphocytes, which are 
generated as naive cells in the primary lymphoid organs thymus and bone marrow, 
respectively. These cells migrate into the secondary lymphoid organs via the blood and 
the lymphatic system. The secondary lymphoid organs include lymph nodes, the spleen, 
Peyer’s patches, tonsils and the appendix. They represent specialised environments 
where lymphocytes can encounter antigens and are aided in their development into 
effector and memory cells. Many of the different cells and developmental stages found in 
the immune system are identified by specifically expressed surface molecules. The 
nomenclature is to use the name of the molecule followed by the raised signs + and - to 
refer to the presence or absence of that surface molecule (e.g. CD4^CD8' cells). When the 
level at which the molecule is expressed is important, the terms high, low and int 
(intermediate) are used instead.
The specificity of the lymphocytes is determined by the T and B cell receptors. As the 
lymphocyte matures, inherited sets of gene segments are rearranged and random 
nucleotides are included at the joins of the segments to form the variable region o f the B 
or T cell receptor. The variable region, which is responsible for the receptors’ unique 
antigenic specificity, is combined with a constant region which is important for the 
receptors’ function. The protein products of all successfully rearranged genes are 
expressed at the surface o f the naive T and B cells, thus creating a very large pool o f cells
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with different receptor specificities. When the host encounters a new antigen, cells with 
appropriate receptors are activated, proliferate and differentiate, resulting in groups of 
genetically identical cells capable of responding to the antigen. This process is known as 
clonal selection.
1.3.2 T cell development
The T cell receptor recognises proteolytically processed antigenic peptides presented in 
the context of MHC molecules. T cells can bear either aP  or yô T cell receptors. yÔ T 
cells have a reduced range of genetic receptor diversity and are sometimes counted as part 
of the innate immune system (reviewed in (Hayday and Tigelaar, 2003)). A further class 
of lymphocytes with limited T cell receptor diversity and tissue-specific segregation are 
the natural killer (NK) T cells. These cells are a class of lymphocytes which express the 
N K l. 1 marker on the cell surface and recognise antigen in the context of the MHC class I- 
like CD Id molecule (reviewed in (Schmieg et a l, 2003)). However, the following 
explanations will deal only with aP  T cells. T cells with the CDS coreceptor interact with 
major histocompatibility complex (MHC) class I, which is expressed on almost all cell 
types and is the main presentation pathway for antigens located in the cytosolic 
compartment. T cells carrying the CD4 coreceptor recognise antigen in the context of 
MHC class II, which presents peptides generated in the exocytotic processing pathway 
and is found only on specialised antigen-presenting cells. These include dendritic cells, 
macrophages and activated B cells. As the T cells develop in the thymus, they are 
positively selected to ensure that they have sufficient affinity for MHC molecules and 
negatively selected and eliminated if they have high affinity for self antigens. This is one 
of the most important steps for creating tolerance of the adaptive immune system to self 
antigens.
Cytotoxic T cells, which are usually CDS^ T cells, kill cells by targeted release of 
molecules causing penetration of the cell membrane and induction of apoptosis
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(programmed cell death). This is an important mechanism for elimination of cells 
expressing tumour-specific antigens or viral proteins. The CD4^ T cells are subdivided 
into three subclasses, the inflammatory or ThI, the helper or Th2 cells (Bottomly, 1988; 
Mosmann et a l, 1986) (more recent reviews in (Murphy, 2003; O Gor et a l, 2003)) as 
well as regulatory T cells (sometimes also known as Th3 or suppressor cells) (reviewed 
in (Bluestone and Abbas, 2003; Francois Bach, 2003)). Cells from the three subclasses 
express different sets of the intercellular signalling molecules called cytokines - interleukin 
(IL)-2, interferon (IFN)-y, and lymphotoxin are characteristic o f ThI cells, IL-4, IL-5, 
IL-6  and IL-10 are typical for Th2 cells and IL-10 and TGF-P are also expressed by 
regulatory T cells which are further defined by their CD4^CD25^ phenotype (reviewed in 
(O'Garra and Barrat, 2003)). The inflammatory T cells activate macrophages to kill 
intracellular pathogens and recruit phagocytic cells to sites o f infection. Helper T cells are 
responsible for B cell activation and this interaction will be discussed in more detail in 
Section 1.3.5. Regulatory cells mediate tolerance by down-regulating other T cells which 
have escaped auto-immune screening mechanisms.
1.3.3 B cells as antibodv producers
The main role of B cells is the secretion of antibody, which is the basis of humoral 
immunity and allows the immune system to deal with pathogens in several different 
ways. Neutralisation is the simple process of coating a pathogen or toxin and thereby 
preventing adherence to host cells or blocking access to critical molecular binding sites. 
Opsonisation involves coating of the surface o f the pathogen with antibody. The constant 
or Fc portion of the antibodies binds to Fc receptors on macrophages and facilitates 
phagocytic uptake of the pathogen. Antibodies bound to a pathogen can also activate 
complement, which enhances opsonisation and can also lead to lysis of certain bacteria. 
Immunoglobulins are generated in different isotypes, as determined by the Fc portion, 
and antibody function is dependent on the immunoglobulin isotype. This is shown in
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Table 1.4 for human antibodies. The human antibody isotypes are IgAl, IgA2, IgD, IgE, 
IgGl, IgG2, IgG3, IgG4 and IgM. The mouse isotypes are called IgA, IgD, IgE, IgGl, 
IgG2a, IgG2b, IgG3 and IgM. In general, the function of the isotypes correlates between 
species, but at the IgG subclass level, this no longer holds true and Table 1.5 shows how 
the subclasses are thought to correspond between species. (The data on antibody 
structure and function is reviewed in depth in (Shakib, 1990) and (Hamilton and Mohan, 
1998)).
1.3.4 Earlv B cell development
B cells are generated in the bone marrow, where they undergo a process o f maturation 
driven by bone marrow stromal cells. Productive rearrangement of the immunoglobulin 
(Ig) heavy and light chain genes leads to the formation of immature B cells, which express 
B cell receptors o f the IgM isotype on the cell surface. If a B cell recognises self antigen 
at the immature stage, it is eliminated or inactivated. Some self-reactive B cells escape 
elimination by further immunoglobulin gene rearrangement or receptor editing. B cells 
which do not recognise any antigen found in the bone marrow environment differentiate 
into mature B cells bearing both IgM and IgD on the cell surface and circulate through the 
periphery and secondary lymphoid organs as naive B cells (reviewed in (MacLennan et 
a l,  1997; MacLennan et a l, 2000)). In parallel to the yô T cells, B cells also contain a 
subpopulation using a reduced selection of rearranged receptors. These cells are called B 1 
cells and are found mainly in the peritoneal and pleural cavities. Along with the marginal 
zone B cells (described in Section 3.1.6), B1 cells are the source o f natural antibody which 
recognises frequent pathogenic determinants. B1 cells are subdivided into the CD5^ B la  
and the CD5' B ib  cells (reviewed in (Martin and Kearney, 2001)).
14
%I
t
OX)
%
I§
I%
1
I
H
+
+
+
+
I
I
%
I
I
+
1 /3
t/3
I:I
+
t
fa
I
I
C/3
+
IA
IO
i
I
!
+
+
I
f
I
+
Ph
1
I
I
CQ
+
+
(D0
OQ
1
0
1
(L>
§
u
I
+
+
+
<
I
S0s
1
I
CQ
VOo\
oo(N
I
I
I
c3
I
CO
15
Table 1.5 Correlation between human and mouse immunoglobulin isotypes
Human isotype Mouse isotype Points of similarity
IgG2 IgG3
• respond to carbohydrate antigens (however, human 
IgG2 does not autoaggregate)
IgG4 IgGl
• elevated in association with high IgE levels
• regulation via IL-4
IgGl & IgG3 IgG2a&IgG2b
• complement fixation
• binding to FcyR
• mediate antibody-dependent cellular cytotoxicity 
(ADCC)
a) This table is based on information found in (Knight, 1996; Snapper, 1990; Snapper and 
Finkelman, 1993).
1.3.5 B cell activation
Naive B cells are activated by cross-linking of the B cell receptor in the right context. For 
thymus-dependent antigens, this requires input from T helper cells. Extensive B cell 
receptor binding through monovalent soluble antigens in the absence of T cell help leads 
to anergy (an activation refractory state) or deletion of the B cells (reviewed in 
(MacLennan, 1998; Nossal, 1996)). Immature B cells are especially sensitive to 
elimination in this manner, which represents a tolerance-inducing mechanism against self 
reactivity. As a rule, B cell tolerance to self is not as carefully controlled as T cell 
tolerance and must therefore be governed through the requirement for B cell help. 
However, B cells can also be activated in the absence of T cell help by two types of 
thymus-independent antigens. Thymus-independent type I (TI-1) antigens are 
intrinsically able to induce B cell proliferation and in high doses even cause polyclonal B 
cell activation. TI-2 antigens cause extensive B cell receptor cross-linking through highly
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repetitive structures such as bacterial cell wall polysaccharides. TI-2 but not TI-1 
responses can be augmented by T cell help (reviewed in (Garcia de Vinuesa et a l ,  1999)). 
Unless stated otherwise, the mechanisms discussed in the following sections involve 
thymus-dependent antigens.
Activation of B cells in response to thymus-dependent antigens requires help from a T 
cell recognising an antigenic determinant or epitope from the same pathogen or antigen. 
The epitopes recognised by the B and T cell do not have to be identical, which is 
important for immune responses against epitopes which are not processed very well. 
Antigens binding to the B cell receptor are internalised and degraded, following which, 
processed peptides will be presented to T cells via MHC class II. Binding o f the B cell 
receptor represents a first activating signal and a T cell responding to any of the peptide / 
MHC class II complexes supplies the second activating signal in form of secreted IL-4 
and membrane-bound CD40 ligand (CD40L). TI-1 and TI-2 antigens also transmit a 
second signal of a different type, but cells which bind to antigen in the absence of any 
second activating signal undergo apoptosis (Gray et a l,  1997; Noelle et a l,  1992; Wykes 
et a l, 1998).
The activation and ensuing development of B cells takes place in specialised 
microenvironments in the secondary lymphoid organs (described in more detail for the 
spleen in Section 3 and reviewed in (MacLennan et a l, 1997)). The B cells pass through 
areas packed with T cells such as the T cell zones in the spleen or the paracortex in the 
lymph nodes. Some B cells can then differentiate into plasma cells which secrete 
antibody. In the spleen, these cells are found in the extrafollicular foci outside of the 
white pulp. The antibody produced by these plasma cells tends to be o f lower affinity 
than that seen later in the immune response (Smith et a l, 1997; Tarlinton and Smith,
2000). Other activated B cells migrate into the primary follicles in the B cell areas. The 
primary follicles consist o f naive recirculating B cells clustered around the follicular 
dendritic cells. When activated B cells enter the primary lymphoid follicles, they begin
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dividing and thereby form germinal centres. The whole germinal centre along with the 
surrounding mantle of naive recirculating B cells is now called a secondary lymphoid 
follicle.
1.3.6 The germinal centre reaction
In general, only thymus-dependent antigens cause germinal centre formation, whereas TI 
antibody responses are not associated with functional germinal centers or memory 
formation (Jacob et a l, 1991b; MacLennan et a l, 1990; Maizels and Bothwell, 1985). 
Under exceptional conditions, T cell-independent germinal centres can form, but do not 
complete their development (Garcia de Vinuesa et a l, 2000). Several important events 
take place in the germinal centres: somatic hypermutation of the immunoglobulin genes, 
isotype switching and generation of memory B cells (reviewed in (Camacho et a l, 1998; 
Kosco-Vilbois et a l, 1997; Kosco-Vilbois et a l,  1997)). With the partial exception of 
isotype switching, these events are all dependent on the environment of the germinal 
centre. Polymerase chain reaction (PGR) analysis o f the immunoglobulin genes at the 
single cell level has shown that all o f the B cells in a germinal centre can be traced back to 
only one or a few founder cells (Jacob et a l, 1991a; Jacob et a l,  1993; Ziegner et a l, 
1994). These cells divide about once every 6  h and rapidly fill the germinal centres. These 
proliferating B cells are called centroblasts and they give rise to the non-proliferating 
centrocytes. By the 7* day, germinal centres develop two distinguishable regions - the 
dark zone which consists mainly of closely packed centroblasts and the light zone where 
the centrocytes and the majority of the follicular dendritic cells are located (reviewed in 
(Camacho et a l, 1998; Kosco-Vilbois et a l, 1997)).
During centroblast division, the rearranged immunoglobulin genes undergo somatic 
hypermutation, which can lead to changes in antibody affinity and specificity. The 
hypermutation is directed at the areas o f the immunoglobulin gene which were encoded 
by the variable regions and form the antigen-binding site (Jacob et a l,  1993). The 
centrocytes then compete for binding to antigen presented on the processes of the
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follicular dendritic cells. Cells whose B cell receptor binds antigen well receive survival 
signals resulting in the internal expression o f the bcl-2 gene (Smith et a l,  2000). The 
definitive survival signal is CD40-mediated signalling delivered by T cells which recognise 
antigen internalised during the interaction with the follicular dendritic cells (Gray et a l,
1997). B cells with poor or altered recognition of their antigen undergo apoptosis and are 
phagocytosed by the tingible body macrophages (Han et a l,  1995). The average antibody 
affinity increases slowly at the beginning of a primary immune response, because most of 
the cells start with low antibody affinities. However, the selection pressure is increased 
later in the primary and in the secondary immune responses and B cells can cycle 
between the centroblast and centrocyte compartments several times to increase antibody 
affinity (reviewed in (Neuberger et a l, 2000)). The germinal centre reaction is the source 
of two major populations of B cells, memory B cells and long-lived plasma cells.
Isotype switching is usually linked to the germinal centres but can also occur in the 
extrafollicular pathway (Toellner et a l, 1996; Toellner et a l, 1998). Irreversible genetic 
splicing allows combination of different Fc components with any given rearranged 
variable region. Isotype switching is not directly linked to affinity maturation or memory 
B cell generation, but because they usually occur around the same time in the germinal 
centres, these phenomena are often referred to as a logical unit and isotype switching to 
IgG (or affinity maturation) is often used as a surrogate marker for memory B cell 
generation.
1.3.7 Plasma cells
Plasma cells are terminally differentiated B cells whose function is the secretion of 
antibody. A large proportion of the activated B cells develops into plasmablasts, which 
proliferate and thereby increase the production potential for each selected antibody 
specificity. (Plasma cells and plasmablasts will sometimes be referred to collectively as 
antibody-containing cells within this thesis). When the plasmablasts differentiate into 
plasma cells, they develop an enlarged cytoplasm with a prominent rough endoplasmic
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reticulum required for the production of secreted immunoglobulins, allowing them to 
secrete over 5000 immuglobulin molecules per second (reviewed in (Slifka and Ahmed, 
1996)). Plasma cells can no longer alter the specificity or isotype of their 
immunoglobulins and no longer have strong expression of the B cell receptor or MHC 
class II on the cell surface. This means that they can no longer interact with helper T 
cells, making antibody production independent of T cell help or the presence of antigen. 
The majority of plasma cells are short-lived and die after 8 h to 3 days (Jacob et a l,  
1991a; Sze et a l, 2000)). These cells are located in extrafollicular foci. Single cell analysis 
o f the rearranged immunoglobulin genes has revealed that cells found in the germinal 
centres and the extrafollicular foci can be of the same clonal origin (Jacob and Kelsoe, 
1992), demonstrating that the antibody specificity and affinity do not determine whether 
an activated B cell enters the follicular (or germinal centre) or the extrafollicular pathway. 
Nevertheless, the cells in the extrafollicular foci generally produce antibody of lower 
affinity than those emerging from the germinal centres. The antibodies produced by these 
plasma cells are critical for controlling pathogens while B cells with higher affinity are 
being selected in the germinal centres. Many of the short-lived plasma cells are o f the IgM 
isotype and the higher avidity of the pentameric IgM (as compared to monomeric IgG) 
can partially compensate for the poorer affinity. Secreted antibody has a limited life span 
in serum, which in humans ranges from 2 days for IgA through 7 days for IgG3 to 21 
days for IgGl (reviewed in Shakib, 1990).Thus, the effector molecules survive their 
short-lived plasma cell source temporarily but do not remain in the serum indefinitely. 
Recently, it has been discovered that some plasma cells have a much longer life span of at 
least 2 years in the mouse (Manz et a l, 1997; Sliflca et a l, 1998; Slifka et a l,  1995). 
These cells persist in the bone marrow and to a smaller extent in the spleen and are 
thought to be responsible for the maintenance of serum antibody levels after the 
termination of infection (Slifka and Ahmed, 1996; Slifka et a l ,  1998). Chronically 
inflamed tissues seem to represent an additional survival niche for long-lived plasma cells
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(reviewed in (Manz and Radbruch, 2002)). Many open questions still remain concerning 
these cells, such as the signals and selection processes governing plasma cell survival.
1.3.8 Memorv B cells
Memory B cells are resting cells which can be reactivated rapidly to proliferate and 
differentiate into antibody-secreting cells (reviewed in (Ahmed and Gray, 1996; 
MacLennan et a l, 2000). Memory B cells have altered homing patterns leading to 
accumulation in particular locations - the epithelium of the tonsilar crypts, the sub- 
epithelial part of the dome in Peyer’s patches and the inner surface of the subcapsular 
sinus in lymph nodes (reviewed in (MacLennan et a l,  2000)). They are responsible for 
secondary antibody responses which are more rapid, generally generate antibodies of 
higher affinity and show a preponderance of the IgG, IgA and IgE isotypes. (However, 
evidence exists for a large compartment of IgM-expressing memory B cells in humans and 
mice as well (Ho et a l,  1986; Klein et a l, 1997)) The rapidity of the secondary response 
is based on the higher frequency of antigen-specific B cells, the availability of T cells with 
corresponding antigenic specificities and irreversible molecular changes of the B cell 
receptor which lead to increased proliferative burst capacity (Martin and Goodnow, 
2002). The memory B cell response is limited to T-dependent antigens. This is due to the 
requirement for CD40-mediated signalling in allowing germinal centre B cells to enter the 
memory pathway (Gray et a l, 1994; Siepmann et a l,  2001).
In humans, memory B cells can by identified by expression o f CD27 on cells in the 
periphery or o f either CD27 or CD 148 on cells in the spleen (Klein et a l,  1998; Tangye 
et a l, 1998). In mice, no unique marker for memory B cells has been identified as of yet. 
Mouse memory B cells express high levels of CD38, but this marker only serves to 
distinguish the population from their germinal centre B precursors and from antibody- 
forming cells, as CD38 is also expressed by naive B cells (Ridderstad and Tarlinton, 
1998). Therefore, studies on murine B cell memory are forced to rely on circumstantial 
detection methods. In immunisation studies, the most common method is to define any
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antigen-specific, isotype-switched B cells detected after an interval long enough for the 
elimination o f activated non-memory B cells as memory B cells. Sometimes, just the 
presence of IgG^ B cells after a given time period is taken as an indication of B cell 
memory, but that is a very simplified way of addressing the problem. Another way of 
detecting memory B cells is in a functional assay where the rapidity and affinity of a 
secondary antibody response is used as a readout for B cell memory.
There is considerable debate about the mechanisms involved in the persistence of memory 
B cells (reviewed in (Martin and Goodnow, 2000)). One theory is that the memory B 
cells must be restimulated occasionally by the appropriate antigen or a cross-reactive 
facsimile. This idea is supported by experiments where memory B cells were transferred 
into sublethally irradiated congenic rats. If the cells were transferred without the 
activating antigen, memory B cells had a half life o f 2-3 weeks and were undetectable by 
12 weeks post transfer (Gray and Skarvall, 1988). The other theory is that memory B 
cells can persist in a resting state without further stimulation. This idea is supported by 
findings that B cell memory persists in mice lacking follicular dendritic cells and in mice 
deprived of helper T cells (Karrer et a l, 2000; Vieira and Rajewsky, 1990). An elegant 
study with a mouse strain carrying two rearranged immunoglobulin alleles showed that 
memory cells which were generated after exposure to one o f the recognised antigens 
persisted after the immunoglobulin gene had been replaced by the gene whose specific 
antigen was not present in the mouse, supporting the hypothesis that B cell memory can 
persist in the absence of the activating antigen (Maruyama et a l,  2000). However, the 
evidence is not conclusive, as the mice were only studied for 15 weeks after the gene 
switch.
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Figure 1.2 Influence of the presence of various lymphocyte types on the course of 
parasitaemia.
The course of parasitaemia is shown for wild-type mice and mice deficient for various 
lymphocyte populations.
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1.3.9 Interactions of immune cells in protective humoral responses
The mechanisms involved in protective immunity against infections with live pathogens 
are similar to those which are elicited by immunisation with non-replicating antigens. 
However, repeated immunisations are usually necessary for the development of 
comparable immunity and therefore, this section will focus on infections. If  the 
reinfection occurs very soon after the first exposure, effector B and T cells will still be 
present and can counter the infection. Otherwise, the first line o f protection are serum 
antibodies produced by long-lived plasma cells. Studies of viral infections in isolated 
populations have shown that serum antibodies are produced for decades after a single 
infection (reviewed in (Ahmed and Gray, 1996; Slifka and Ahmed, 1996)). In some o f the 
classic cases (reviewed in (Ahmed and Gray, 1996; Slifka and Ahmed, 1996)), such as the 
measles outbreaks on the Faroe islands with an intervening interval of 75 years, only 
protection was shown, not presence of antibodies. However, the presence of neutralising 
antibodies 75 years after an outbreak of yellow fever was demonstrated by passive 
antibody transfer to monkeys and the maintenance of polio- and vaccinia-specific 
antibodies over 40 and 15 years, respectively, in the absence of re-exposure to antigen 
was shown by enzyme-linked immunosorbent assay (ELISA).
It seems that protection lasts longer for systemic than for mucosal infections, which may 
be due to the anatomical location of the long-lived plasma cells. If neutralisation and 
opsonisation via pre-existing antibody are not sufficient to control the spread of the 
pathogen, a secondary immune response is triggered which relies on the presence of 
memory T cells as well as memory B cells. The presence of both cell types increases the 
speed of the secondary response, as one o f the main delaying factors in the primary 
response is the necessity for two consecutive activation steps.
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1.4 Immune responses to malaria infection
1.4.1 Relevance of immune responses against different stages of Plasmodium
The different stages in the Plasmodium life cycle result in an immune response taking 
place at several non-related levels. The three areas of interest are the immune responses 
against the sporozoite and liver stage, against the blood stage and against the gametocytes. 
This introduction focuses on the immune mechanisms dealing with the blood stage o f the 
parasite; the other two stages will be mentioned only briefly. Sporozoites are only 
accessible to the immune system for a very limited time period and are injected in small 
numbers, so sporozoite-specific immunity develops slowly even in highly endemic areas 
and is o f low magnitude. Anti-sporozoite immunity can be induced in humans with 
multiple exposures to attenuated but not killed sporozoites injected intravenously or by 
irradiated malaria-infected mosquitoes. The immune response against sporozoites and 
infected hepatocytes includes CDS'*’ and CD4^ T cell-mediated release of IFN-y and 
induction o f nitric oxide synthesis, but apparently no role for direct killing of infected 
hepatocytes via the perforin or Fas pathways. Antibodies to sporozoites are probably 
important and antibodies against liver-stage antigens, NK T cells (a special group o f T 
cells expressing the N K l.l marker and a semi-invariant TCR) and yô T cells also seem to 
be involved to some extent (reviewed in (Hollingdale and Krzych, 2002; Sinnis and 
Nardin, 2002)).
Immune responses against the sexual form of the parasite are o f little benefit to the 
current host, but are important in blocking parasite transmission. This area o f research 
has concentrated on antibodies which can be effective either in the vertebrate or the 
mosquito host (reviewed in (Kaslow, 2002)). Therefore, vaccines are being designed to 
include B cell epitopes eliciting an immune response against the gametocytes. In fact, 
vaccines which contain epitopes against all stages of the Plasmodium life cycle are a 
popular idea, since a single parasite slipping through the stage controlled by the vaccine­
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generated immune response can multiply in the next stage of the parasite life cycle and 
nullify the effect of the vaccine.
1.4.2 The role of T cells in the rodent malaria model
Early experiments in naturally occurring mutant mouse strains have shown that T cells 
are essential for the development of anti-malarial immunity in rodents. T cell-deficient 
nude mice which were infected with the normally nonlethal parasite species 
P. c. chabaudi, P. c. adami or P. vinckei petteri could not control the parasitaemia and 
eventually died (Cavacini et a l, 1986). However, nude mice could be rescued from the 
lethal effects of P. c. chabaudi or P. c. adami infection by adoptive transfer o f immune T 
cells (Meding and Langhome, 1991) Adoptive transfer of parasite-specific T cell clones 
was also able to protect nude mice from lethal infection with P. yoelii (Brake et a l,  1988; 
Brinkman a/., 1985; Jayawardena , 1975).
Genetically engineered mice where a single gene has been “knocked out”, thereby 
preventing the development o f particular cell populations, have proven extremely useful 
in determining the effects of different cell types on anti-malarial immunity. P. c. chabaudi 
infection has been tracked in mice where either the a|3 and the yô TCR had been knocked 
out or yÔ T cells had been depleted by antibody administration (Langhome et a l, 1995) 
and Fig. 1.2 shows the course of parasitaemia in these and other knock-out mice. Mice 
lacking the aP  TCR are incapable of clearing infection with P. c. chabaudi or even of 
reducing the parasitaemia after the peak. The absence of T cells expressing the yô TCR 
has less pronounced effects, with only a slight delay in reduction of the peak of 
parasitaemia and a slightly increased level of parasite recmdescence as compared to wild- 
type mice.
The (%P TCR-positive T cells can be further split into CD4^ and CD8  ^ T cells, whose 
relevance has been examined in knock-out mice or mice depleted o f the appropriate T 
cells by repeated injection of anti-CD4 or anti-CD8 antibodies from birth. Mice lacking
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CD8^ T cells - either through antibody treatment or because the CD8 or p2-i^icroglobulin 
gene was knocked out - exhibit only a slight delay in the clearance of the acute 
parasitaemia (Suss et a l,  1988). However, antibody depletion o f CD4^ T cells results in a 
similar course of parasitaemia as that seen in aP  TCR knock-out mice (Kumar et a l, 
1989; Podoba and Stevenson, 1991; Simon-Haarhaus et a l, 1991; Suss et a l,  1988). This 
shows that CD4‘^ T cells are the main T cell population involved in protection against the 
erythrocytic stages o f malaria infection.
The role of NK T cell in malaria is still under debate. One study demonstrated a role for 
NK T cells both in vivo and in vitro in the humoral response against the pre-erythrocytic 
stages of malaria (Schofield et a l, 1999). However, two other groups were unable to 
confirm these results (reviewed in (Schmieg et a l, 2003)). NK T cells were able to 
enhance protective immunity induced by protective malaria vaccines if  the NK T cell 
ligand a-galactosylceramide was injected along with the vaccine, but this may not mimic a 
natural role for these cells (Gonzalez-Aseguinolaza et a l,  2002). An interesting study has 
shown that NK T cells are involved in murine cerebral malaria pathogenesis with 
differential outcome in C57BL/6 and BALB/c mice by regulation o f the Thl / Th2 switch 
via inflammatory cytokines (Hansen et a l,  2003).
1.4.3 The Thl to Th2 switch during infection
During P. c. chabaudi infection, the T cell response switches from a Thl response during 
the acute phase to a Th2 response in the chronic phase (Langhome et a l ,  1989; 
Langhome and Simon, 1989; Stevenson and Tam, 1993). The Thl cells release IFN-y with 
peak production preceding the peak of parasitaemia by 2 or 3 days (Meding et a l,  1990; 
Slade and Langhome, 1989). The IFN-y does not act directly on the parasites. Instead, it 
mediates an inflammatoiy response by activating macrophages which are responsible for 
reducing the parasitaemia in the acute phase (reviewed in (Li et a l,  2001)). As the 
infection progresses, the cytokines produced by splenic CD4'*’ cells shifts to Th2-type
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pattern and antibody help can be demonstrated (Langhome et a l,  1989; Langhome and 
Simon, 1989; Stevenson and Tam, 1993). Interestingly, this switch to a Th2 response is 
dependent on the presence of B cells (Langhome et a l,  1998).
1.4.4 The role of B cells in the rodent malaria model
Transfer of immune serum into naïve humans or mice can diminish or prevent infection in 
the recipient (Cohen et a l, 1961; Jarra et a l, 1986). At the cellular level, it has been 
shown that mice with severe combined immunodeficiency (SCID), i.e. lacking both B and 
T cells, could only control and clear parasites when B cells were transferred with the T 
cells (Meding and Langhome, 1991). The importance of B cells is also revealed by 
infections of B-cell deficient mice like the |X-MT or JhD mouse. In these mice, the 
parasitaemia is partially controlled in the acute phase but then continues as a fluctuating 
visible chronic infection which can rise as high as 50% parasitised red blood cells in male 
p-MT mice (van der Hey de et a l, 1994; von der Weid et a l, 1996). The control of 
chronic parasitaemia is effected by antibodies, as repeated passive immunisation with 
immune serum during the chronic phase of the infection enables the B cell-deficient mice 
to clear their parasites (Langhome et a l, 1998; von der Weid et a l, 1996). Mice which are 
depleted of CD4^ T cells during the chronic phase of their infection are able to control 
their parasitaemia as long as the specific antibody titres remained high (Langhome et a l,
1990). Together, these results show that B cells or parasite-specific antibody is necessary 
for the final reduction step in the rodent malaria P. c. chabaudi, although they do not 
appear to play a strong role during the acute phase of infection. B 1 cells are known to be 
involved in the immune response against other protozoan parasites such as Trypanosoma 
cruzi and it has been hypothesised that they play a role during malaria infection, but no 
conclusive evidence exists yet for this theory (Minoprio et a l,  1989).
Malaria infection with P. c. chabaudi is accompanied by changes in the antibody isotype. 
Malaria-specific IgG2a could be measured 2 weeks after infection. This was followed by
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IgG3 and IgG2b production, whereas IgGl could only be measured during late infection 
(Falanga a l, 1987; Langhome et a l, 1984). This pattem is seen for the total parasite- 
specific response, but has also been shown for separate fragments of the merozoite 
surface protein-(MSP)-l, with the exception that the IgG2b response precedes the IgG2a 
response in some cases (Quin and Langhome, 2001a). The switch to IgGl production 
could be attributed to the production of IL-4, IL-5 and IL-6  by Th2 T cells, although 
suppression of IgGl production has been seen in severe malaria infections (Falanga et a l, 
1987; Langhome et a l, 1984).
Malaria infection is accompanied by hypergammaglobulinaemia in both mice and humans 
(Greenwood, 1974; Wyler, 1974). It has been shown in mice that polyclonal B cell 
activation occurs (Langhome et a l, 1985; Rosenberg, 1978). This type of response is 
suggestive of a large thymus-independent response. There has been some debate about 
the role of a B cell mitogen in malaria, which would elicit a TI-2 response, but there has 
been no conclusive decision on the matter (Greenwood, 1974; Wyler, 1974; Wyler et a l, 
1979). Newer studies have presented evidence for thymus-independent responses to the 
repeat sequences of the 70-kDa P. falciparum  heat shock protein and the repetitive 
surface protein of sporozoites (Kumar and Zheng, 1998; Schofield and Uadia, 1990). 
Considering the high degree o f repetitive epitopes found in Plasmodium antigens, one 
would expect more TI-2 responses against malaria, but this issue has not been addressed 
thoroughly yet.
1.4.5 Theories on the antibodv mechanisms involved in malaria
The effector mechanisms by which antibodies act on the Plasmodium parasite are still not 
clear. Evidence exists for several theories and the most likely explanation is that several 
mechanisms are acting simultaneously. Antibodies directed against variant antigens on the 
surface of infected erythrocytes can cause erythrocyte agglutination and thereby target 
the erythrocytes for phagocytic destruction (Bull et a l, 1998). Neutralising antibodies
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can act at several levels, such as preventing binding of the 235-kDa rhoptry protein to 
infected red blood cells and thereby preventing erythrocyte invasion (Ogun et a l, 2000), 
preventing the pre-invasion processing of merozoite surface protein-1 (MSP-1) 
(discussed in Section 4.1.1) or interfering with the sexual development stage of the 
parasite in the mosquito midgut after ingestion of the blood meal and thereby preventing 
parasite transmission (discussed in (Gozar et a l,  1998)).
Although human studies suggest that there may be a role for the interaction o f antibodies 
and the classical complement pathway in the immune response to malaria infection 
(reviewed in (Taylor et a l, 2001)), this was not confirmed in mouse studies. Mice 
deficient in either the classical complement pathway or both the classical and alternative 
pathways showed only minor delays in the control of primary infections (Taylor et a l,
2001). However, a larger role was identified for the classical complement pathway during 
reinfection. As a further mechanism, sera from clinically immune individuals can opsonise 
P. yh/cij^arww-parasitised Saimiri red blood cells and this effect is mediated by the IgGl 
and IgG3 subclasses (Groux and Gysin, 1990). Sera taken from P, c. chabaudi (AS)- 
infected CBA/Ca mice 1-2 days after the peak of infection also bind to parasitised red 
blood cells in a strain-specific manner and mediate phagocytosis in vitro (M ota et a l,
1998) The link between opsonisation and phagocytosis can also be assumed for early 
studies showing that macrophages of the liver, bone marrow, spleen and peripheral blood 
contained infected erythrocytes (reviewed in (Arese et a l,  1991)).
A possible antibody effector mechanism termed antibody-dependent cytotoxic inhibition 
(ADCI), a variation on antibody-mediated cell cytoxicity (ADCC), has been studied in 
considerable detail for P. falciparum  (reviewed in (Druilhe and Pérignon, 1997)). In vitro 
experiments have shown that cytophilic antibodies (antibodies of the IgGl and IgG3 
isotypes in humans) crosslink surface antigens (such as MSP-3) on free merozoites with 
the FcRyll on monocytes (Bouharoun-Tayoun et a l, 1990; Bouharoun-Tayoun et a l,
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1995; Oeuvray et a l, 1994). The monocytes release soluble mediators such as TN F-a 
which cause parasites located in nearby erythrocytes to remain at the one-nucleus stage 
of schizogony. This parasitistatic effect is seen for sera taken from residents of endemic 
areas who are in a state of premunition, but not for sera from non-exposed individuals or 
sera taken after a single malaria attack (Bouharoun-Tayoun et a l ,  1995).
Support for this hypothesis is drawn from human field studies showing that the isotype 
distribution differs between protected and non-protected individuals. In clinically immune 
subjects from the Ivory Coast, IgGl and IgG3 were the predominant antibodies, whereas 
children or adults experiencing their first malaria attack tended to display different 
isotype distributions (Bouharoun-Tayoun and Druilhe, 1992). It has also been shown in 
Dielmo, an area of seasonal holoendemic malaria transmission, that increases in IgG3 
levels during the high transmission season were associated with protection from clinical 
malaria, with the strongest effects seen in children 3-6 years of age (Aribot et a l,  1996). 
A protective role for human IgGl has been suggested for an area o f unstable malaria 
transmission in Brazil (Braga et a l, 2002). In mice, a protective role has also been shown 
for the cytophilic IgG2a subclass in lethal and non-lethal P. yoelii infection (White et a l,
1991). Passive antibody transfer of different IgG subclasses showed that only IgG2a (but 
not IgG2b, which is also a cytophilic antibody) could impede the development of 
parasitaemia in a fashion similar to passively transferred hyperimmune serum. This 
difference between subclasses did not appear to be caused by different antigen 
specificities.
However, further studies in the mouse model raise the question how relevant ADCI is in 
vivo. The course of parasitaemia was not changed in mice made deficient for FcR and 
infected with P. yoelii or P. c. chabaudi while simultaneously receiving parasite-specific 
antibody, although these mice do not have the capability to perform ADCI ((Rotman et 
a l,  1998; unpublished data by Dr. J. Langhome). There are several possible explanations
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for the discrepancies between the in vitro results with P. falciparum  and the in vivo 
mouse studies. One is that the ADCI effect is unique to either P. falciparum  or humans 
and could therefore not be detected in the animal model. Another possibility is that the 
effect is supplanted by other protective antibody-mediated mechanisms at the high 
antibody concentrations used in the mouse studies. Another consideration is that the 
epidemiological studies showing temporal concurrence between the presence of cytophilic 
antibodies and clinical protection do not necessarily represent a causal link for the 
importance of ADCI. Several malarial antigens preferentially or exclusively induce 
antibodies of a particular subclass, such as a predominant IgG3 response to MSP-2 
(Taylor et a l, 1995). The antibody response to MSP-1, which plays a role in clinical 
protection (discussed in Section 4.1.2) is also limited to IgGl and IgG3,with a bias of 
IgGl for the C-terminal portion and IgG3 for the N-terminal part observed in Sudan, the 
Gambia and Kenya but not in Senegal (Cavanagh et a l, 2001; Diallo et a l, 2002; Egan et 
a l, 1995; Garraud et a l, 1999). Thus, it is possible that the link between clinical 
protection and the presence of cytophilic antibodies is based on the antibody specificity 
rather than the effector mechanism. Alternatively, the milieu in which B cells are activated 
could be the reason for the occurrence of cytophilic antibodies as locally secreted 
cytokines and the type of antigen-presenting cell can direct isotype switching.
1.4.6 Immunopatholoev
In addition to controlling parasitaemia, the immune system can also contribute to the 
aetiology of malaria. This is a large field of malarial research and shall only be outlined 
briefly here. The cytokine theory of malarial disease states that many of the disease 
symptoms of malaria can be attributed to inflammatory mediators released by the host in 
response to schizogonie erythrocyte rupture. The foremost of these inflammatory 
cytokines is TN F-a and locally high levels of this molecule are involved in cerebral 
malaria and anaemia. Further components of the inflammatory response are IL-1, IFN-y
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and lymphotoxin. Some of the effects previously attributed to T N F-a may actually be 
caused by lymphotoxin, as the two ligands share a receptor (e.g.(Engwerda et a l,  2002)). 
These cytokines lead to up-regulation of inducible nitric oxide synthase, resulting in high 
levels of nitric oxide in tissues which are normally only exposed to low levels of this 
cellular messenger (reviewed in (Clark gf" a/., 1997; Clark and Schofield, 2000; Jakobsen et 
a/., 1995).
1.4.7 Immune evasion mechanisms
The Plasmodium parasite employs several mechanisms o f immune evasion: The 
replication cycles in the liver and the blood are immunologically independent in many 
respects (discussed in (Urban and Roberts, 2003). Once merozoites enter the 
erythrocytes, they occupy an immunologically privileged site lacking antigen presenting 
or processing capability. Furthermore, many surface molecules on the parasite are 
polymorphic, making immune recognition of new strains more difficult. In addition, 
several o f the antigens expressed on the surface of the parasite or the infected red blood 
cell undergo antigenic variation. Different variant antigen families have been discovered on 
P. falciparum, P. vivax, P. knowlesi, P. chabaudi and P. yoelii (reviewed in (Snounou et 
a l, 2000)). The families can contain up to several hundred variants and it has been shown 
for the the var gene family of P. falciparum  that even without immune pressure, 2% of 
the population switch the expressed gene per generation in vitro (Roberts et a l,  1992). 
The members the var family also function as adhesion molecules, allowing the infected 
red blood cells to sequester in various tissues and avoid erythrocyte elimination by the 
splenic red pulp macrophages (Su et a l,  1995).
It has also been suggested that many malarial antigens elicit cross-reactive immune 
responses to a high degree, both at the intra- and intermolecular level (Anders, 1986). 
Another possible way of interfering with the B cell response lies in the shedding o f large 
quantities of soluble antigen which occurs during merozoite invasion. This can interfere
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with the B cell response by causing anergy of immature B cells (reviewed in (Nossal, 
1996)) or deletion of B cells leaving the germinal centres (MacLennan, 1995; Pulendran et 
a l, 1995; Shokat and Goodnow, 1995). At an even earlier stage, P. falciparum  and P. 
yoelii parasites have been shown to inhibit dendritic cell maturation and thereby affect 
both CD4^ and CDS’*' T cell responses (Ocana-Morgner et a l,  2003; Urban et a l,  1999; 
Urban and Roberts, 2003). However, no comparable effect has been observed for 
P. c. chabaudi parasites (Seixas et a l, 2001).
1.5 Protection against malarial reinfection
1.5.1 Tvpes o f protection
For many pathogens, a single infection suffices to enable the immune system to protect 
the host from disease for the rest of the host’s life span. However, malaria is contracted 
repeatedly both under endemic and epidemic conditions. Instead of developing classic 
immunity, people living in malaria-endemic areas reach a steady state level termed 
premunition, where the host is protected from disease as long as exposure to the parasite 
continues. Premunition is not a sterilising form of immunity and is maintained by the 
persistence of low-grade chronic parasitaemia. The phenomenon is peculiar to holo- or 
hyperendemic areas, mainly in Afnca and protection is lost within 1 year without 
rechallenge (reviewed in (Druilhe and Pérignon, 1994)).
One very basic problem in evaluating studies on protection against malaria is that there 
are two different levels of protection involved. Protection against the parasite and 
protection against disease are both seen in semi-immune individuals, as the hosts show 
both resistance to the infiammatory effects of the anti-parasite immune response and 
reduced levels o f parasitaemia. The two forms of protection develop at different rates 
(Gupta et a l, 1999). The studies on malaria infection often do not differentiate between 
these different types o f protection and field studies usually only measure protection 
against disease, with parasitaemias only being measured in people entering the hospital
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with symptoms of malaria. An additional problem is that it is usually not possible to 
determine how many infections someone living in an endemic area has experienced by the 
time they develop premunition. Some information on this aspect can be gleaned from 
studies in the 1930’s, when malaria infection was used to treat neurosyphilis. One such 
study summarises data from 2061 Roumanian patients who were infected several times 
with malaria for syphilis treatment (Ciuca et a l,  1934). This study showed that after one 
treatment with P. falciparum, 29% of patients did not develop measurable parasitaemia 
upon reinfection, with the number of protected patients rising gradually to 97% after nine 
infections. Protection developed more rapidly against P. malariae and P. vivax, but even 
for P. vivax infection, four mosquito incoculations were required for protection to reach 
100%. No species cross-protectivity was observed and the cross-protection between 
different strains of P. vivax was also low.
1.5.2 The cumulative exposure and age-dependent hvpotheses o f protection
The general view of resistance to malaria infection is that it takes 10-15 years of 
continuous exposure in a holo- or hyperendemic area for the host to be protected from 
morbidity and mortality. Most of the mortality occurs in children under 5 years of age 
and pregnant women. Several hypotheses exist to explain this slow development of 
immunity (reviewed in (Baird, 1998)). One theory is that immunity develops slowly 
because antigenic variation by the parasite make it necessary for the host to develop 
immune responses to each of the prevalent parasite strains and many o f the variants of 
their surface molecules (Bull et a l, 1999; Bull et a l, 1998).
In contrast to this cumulative exposure theory Baird also puts forward the hypothesis 
that the slow onset of immunity to P. falciparum  is linked to changes in immune 
functions determined by normal host development and maturation (age-dependent 
hypothesis). This is based on observations that children acquire protection from death 
rapidly if exposed to high levels o f malaria, but still suffer from a high degree of
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morbidity. The slow development of premunition in endemic areas is attributed to the 
fact that the first infections occur before the immune system o f the host is capable of an 
adequate response. This hypothesis is supported by data from Indonesia, where 
inhabitants o f Java, a low malaria transmission area, were encouraged to migrate to Irian 
Jaya which has high malaria transmission. Comparison o f malaria incidence between the 
immigrants and the natives after 19 months showed a comparable distribution o f disease 
prevalence and other linked parameters such as spleen rate and parasite density among 
the age groups, irrespective of the individual’s origin (Baird et a l, 1991). Subsequent 
studies in six further transmigration villages confirmed these results (Baird et a l,  1993). 
Both of the hypotheses discussed above deal with the development of resistance to 
malaria under continuous exposure. However, even under hyperendemic conditions, it 
took an estimated three to six infections for the morbidity rate to drop and the age- 
dependent prevalence pattern to establish itself in the Indonesion transmigrants (Baird, 
1998; Baird et a l,  1993). In addition, as stated previously, immune individuals who leave 
the endemic area lose their immunity without the continued exposure to parasite. This is 
in sharp contrast to the situation seen with many viral infections which render the host 
immune after a single exposure. Therefore, irrespective o f whether the cumulative 
exposure or the age-dependent hypothesis is a better description of the development of 
anti-malarial immunity, standard immune mechanisms are not functioning as fully in 
malaria as they do in other infections. This issue needs to be examined in greater detail 
and main candidates for disturbed immune mechanisms are faulty generation or 
maintenance of B or T cell memory or of long-lived plasma cells. T cell memory will not 
be examined here, but the next two subsections present the confusing array of data on B 
cell memory and long-lived plasma cells in malaria.
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1.5.3 B cell memory after malaria infection
The presence of activated B cells or memory B cells has been detected in both human and 
rodent malaria long after the initial infection. Spleen cells derived from mice infected with 
P. chabaudi can be stimulated in vitro by parasitised red blood cells to produce parasite- 
specific antibody 369 days after infection (Pearson et a l, 1983). However, the levels are 
fourfold lower than those produced by spleen cells taken 96 days after infection, 
indicating a decay of memory. In human infections, peripheral B cells from malaria- 
exposed donors can be activated in vitro by combinations of cytokines and co stimulatory 
signals to secrete Plasmodium-s^QQifiQ antibodies (Garraud et a l, 2002). In this, study, 
antibody production was seen for peripheral B cells from individuals living in holendemic 
or mesoendemic areas, but rarely for individuals from a hypoendemic area and not at all in 
Europeans with no history of P. falciparum  infection. Limiting dilution assays showed 
that Plasmodium-s^Qoific B cells could be activated from the blood of individuals from a 
hyperendemic area in Cameroon as well as in Madagascans who had probably last 
encountered malaria parasites 8 years previously, with the latter generally found in lower 
numbers (Migot et a l ,  1995). These different studies share the weakness that one cannot 
be sure that the reactivated cells are truly memory B cells, as there were no definite 
controls for the absence of recent infections. In addition, the use o f total parasite antigen 
increases the risk that cross-reactive B cells are restimulated in these systems. Therefore, 
it is necessary to examine memory B cell generation in malaria in a more stringent system 
with exact knowledge of the host’s infection history.
1.5.4 Plasma cell longevity after malaria infection
Information concerning the persistence of plasma cells can be derived from longitudinal 
studies of malaria-exposed human populations where exposure to the parasite is reduced 
or terminated in some fashion. Several studies have shown that in areas o f seasonal
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malaria transmission antibody levels to malarial proteins drop during the dry season: In 
an area of low intensity malaria transmission, the levels of variant-specific antibodies 
directed against the malarial antigen P. falciparum  erythrocyte membrane protein-1 
(PfEMP-1) drop within months of clinical malaria attacks (Giha et a l, 1999). Antibody 
responses to the non-polymorphic rhoptry-associated protein 1 (RAPl) measured in the 
same area showed that these were even more short-lived and closely linked to clinical 
infection (Fonjungo et a l, 1999).
A meticulous 4-year longitudinal study relating antibody levels against components o f the 
MSP-1 protein to clinical malaria infection showed that antibodies against the C-terminal 
MSP-119 fragment were found in 61%-73% of individuals with clinical malaria and only in 
11-14% of individuals without clinical malaria in any given transmission season. For the 
polymorphic Block 2 antigens of MSP-1, 39-47% of clinical malaria patients had 
antibodies against one of the nine variants tested but only 0 -6 % non-symptomatic 
individuals had detectable antibodies. Since 96% of the cohort experienced clinical malaria 
during the observation period, this speaks for a rapid decay of antibody levels. This is 
also shown explicitly for 2 0  individuals who experienced clinical malaria and were drug 
treated. Their antibody levels drop by 45% for M SP-119 and by 40% for Block 2 in the 
8-9 months o f the following transmission season (Cavanagh et a l, 1998).
This rapid drop in MSP-1-specific antibody levels was also observed in a study of P. 
vivax infections in Belem, Brazil where exposure to the parasite occurs only on visits to 
the surrounding countryside (Soares et a l, 1999). Further evidence can be found in a 
research project involving a total of about 3000 people in the Garki District o f Nigeria. A 
large-scale serological study was performed fi*om 1970-1975 before, during and after a 
period of intense insecticide- and drug-mediated malaria control. Several different 
serological tests showed that P. falciparum- and P. malariae-spQcific antibody levels 
dropped after the intervention (Brogger et a l, 1978). Taken together, these data show
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that antibodies against malarial antigens drop after parasite exposure ends, often reaching 
undetectable levels. This contrast with antibody responses to non-renewable protein 
antigens that can be sustained for years (Askonas et a l, 1970; Maple et a l, 2000). 
However, data also exist showing that only the children experienced fluctuations in 
antibody levels between the dry and rainy seasons whereas antibody levels remained 
constant in adults (over 16 years of age). This was shown in a longitudinal study in 
comparing antibody levels against MSP-1, MSP-2 and SP360 (a gametocyte antigen) in 
children and adults (Taylor et a l, 1996).
There are difficulties in evaluating these longitudinal field studies where rough trends have 
to be dissected from the background o f individual variation. It is likely that the 
parasitaemic status of the study participants exerts a strong influence in form of chronic 
infections or individual treatment regimes. One study showed that a third of the subjects 
from an area of seasonal transmission actually had detectable parasitaemia right before the 
start of the transmission season (Ferreira and Katzin, 1995). There are no comparable 
studies made in an animal model although this offers the possibility of directly linking 
antibody levels to the infection history and the presence or absence o f parasites.
However, a few studies do exist where the parasitaemic status o f the participants is 
somewhat more defined and which show that after the initial drop in antibody levels, 
antimalarial antibodies can persist in the absence of infection. In a small study group, 
antibodies against sporozoite antigens were shown to persist 6 -1 0  years after the hosts 
had left the malaria-endemic area (Druilhe et a l, 1986). Even more surprisingly, a single 
50-day outbreak of P. vivax (with very thorough controls for parasitaemia infection 
afterwards) resulted in antibodies against circumsporozoite protein and MSP-1 which 
could still be detected in some individuals 7 years later (Braga et a l,  1998).
On the island of Aneityum in the Vanuatu archipelago of Melanesia, malaria was 
mesoendemic until 1991 when a thorough eradication campaign involving multiple drug
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administration, pesticide-treated bed nets and distribution of mosquito-larvicidal fish was 
initiated (Kaneko et a l, 2000). The parasitological status of the roughly 700 islanders was 
monitored over the next 7 years. P. falciparum  infection was practically eliminated within 
the first year o f the programme and the last cases o f P. vivax (probably relapses rather 
than reinfections) were detected in 1996. When malaria-specific IgG titres were measured 
7 years after the start o f the intervention, 37% of 6-15-year-olds and 80% of 16-30-year- 
olds had titres higher than the cut-off point. However, part of this antibody is likely to be 
caused by cross-reactivity with non-malarial antigen, as 19% and 29%, respectively, of 
the inhabitants of an island without malaria had positive IgG titres too (Kaneko, 1999). 
Therefore, further studies, preferably focusing on single antigens, are required.
1.6 Aims of the thesis
In summary, the introduction has shown that despite the importance of antibody and B 
cells for protection against the erythrocytic stages of the Plasmodium parasite, relatively 
little is known about the development of the B cell response during malaria infection. 
Therefore, this thesis aims to characterise the B cell response in the P. c. chabaudi (AS) 
model system. This can be accomplished by the following means:
1. Analysis of the primary B cell response during P. c. chabaudi infection
2. Determination of the longevity of protection against reinfection in this model
3. Assessment of memory B cell generation in malaria infection
4. Evaluation of plasma cell longevity following malaria infection
The primary B cell response to malaria infection is dealt with in the first two results 
chapters. Section 3 analyses the total splenic B cell response irrespective o f antigenic 
specificity using immunohistology and flow cytometry to identify and quantify the B cell 
populations of the spleen. Section 4 focuses on the proportion of that response which is
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specific for one particular malarial antigen, the merozoite surface protein-1 (MSP-1). The 
next two results chapters focus on the development of the immune response after the 
acute phase of primary infection and during secondary infection. In Section 5, secondary 
infections with the same strain of parasite are used to elucidate the quality of protection 
and how this is influenced by parasite persistence. Section 6  deals with the long-lived 
plasma cell and memory B cell responses by using ELISA to determine changes in MSP- 
1-specific IgG levels and affinity in the period after primary infection and during 
reinfection.
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2 Materials and Methods
2.1 Buffers
This section lists all the buffers used in the Materials and Methods section. All chemicals 
whose source is not stated were purchased from Sigma (Poole, UK) or BDH (Poole, UK). 
Unless specified otherwise, dHiO refers to water from the NanoPure system.
Parasites and infections (Section 2.4)
Glycerol freezing buffer glycerol
sodium lactate
potassium chloride 
pH to 7.4
40% v/v 
0.14 M 
0.005 M
Staining of thin blood films (Section 2.5)
Giemsa lOx buffer
Giemsa stain
NaCl 0.9% w/v
KH2PO4 0.2 mM
K2HPO4 0.8 mM
pH to 7.0-7.2
improved R6 6  solution 'Gurr' 20% v/v
(#35086 5P, BDH))
Giemsa 1 Ox buffer 10% v/v
dH2 0  70% v/v
43
Whole blood transfer (Section 2.10)
Heparanised Krebs phosphate saline buffer with glucose, p H  7.2
NaCl
KCl
M gS04 X 7 H2O 
NaH2P04  
1 M H C l
make up to 1 L with dH2 0  
heparin
6.67 g 
0.341 g 
0.284 g 
3.094 g 
4.36 mL
25 U/mL
(# 9860, Léo Laboratories Ltd., Aylesbury, UK) 
add the heparin directly before use
MSP-1 / MBP fusion proteins (Section 2.12)
Rich medium tryptone 
yeast extract 
NaCl 
glucose 
ampicillin
lOg/L
5gd.
5gâ ,
2 gd.
50mg/L
Affinity purification of MBP fusion proteins (Section 2.13)
Loading buffer Tris HCl pH 7.4 10 mM
Elution buffer
NaCl 
EDTA 
sodium azide
Loading buffer 
maltose (M-5885, Sigma)
200 mM 
ImM
0.05% w/v
10 mM
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Reducing SDS-PAGE (Section 2.15)
Sample buffer, reducing 1 M Tris/HCl pH 6 .8  8 mL
10 % (w/v) SDS 20 mL
20 mM dithiotreitol (DTT) 154.2 mg
glycerol 10 mL
0.2% w/v bromphenol in ethanol 0.6 mL 
fill up to 50 mL with d H2O
Running buffer (5x) Tris base 25 mM
glycine 250 mM.
SDS 0.1% w/v
fill up to 2 L with dH20 
Coomassie staining of SDS-PAGE gels (Section 2.16)
Coomassie stain Coomassie Brilliant Blue R250 0.25 % w/v
(# B-0149, Sigma)
ethanol 45 % v/v
acetic acid 1 0 % v/v
(AnalR, # lOOOlCU, Merck, internal order) 
dH2 0  45 % v/v
Coomassie destain ethanol 
acetic acid
dH20
Silver staining of SDS-PAGE gels (Section 2.17)
Fixative formaldehyde
( # F 1635, Sigma) 
methanol 
deionised H2O
45 % v/v 
10 % v/v 
45 % v/v
0.05% v/v
50% v/v 
49.95% v/v
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DTT stock
Silver nitrate solution
Developer
dithiothreitol (DTT) 
(D-9779, Sigma)
deionised H2O
store at -20°C
AgNOs (AnalR quality) 
deionised H2O
Na2C0 3  (GPR quality) 
formaldehyde 
deionised H?0
5 mg/mL
0 .1% w/v
3% w/v
0.05% w/v
Immunohistology (Section 2.21)
Tris stock (0.2 M)
Saline stock
Trizma base
fill up to 5 L with deionised water
NaCl
fill up to 5 L with deionised water
121.14 g
42.5 g
Tris-buffered saline p H  7.6 Tris stock
saline stock 
concentrated HCl 
deionised H2O
Tris-buffered saline p H  9.2 Tris stock
(0.1 M) pH to 9.2 with 1 N HCl
fill up to 1 L with saline stock
1 L 
1.6 L 
14 mL 
1.386 L
500 mL
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Nonspecific esterase staining (Section 2.24)
Bufferedformol sucrose NaH2P0 4 .H2 0
solution, p H  6.8 Na2HP0 4
sucrose
formaldehyde (40%) 
dH20
store at 4°C
Gum sucrose
Fixative
2g
3.25 g 
37.5 g
50 mL 
450 mL
gum arabicum (gum acacia)
sucrose
dHoO
1% w/v 
30% w/v
filter through thick paper and store at 4°C
citrate solution (kit) 
acetone
formaldehyde (37%)
12.5 mL
32.5 mL 
4 mL
a-NE staining solution (all ingredients from Sigma kit 91 -A)
Fast Blue BB base 1 mL
sodium nitrite solution 1 mL
mix Fast Blue and sodium nitrite and wait 2 min
Trizmal concentrate 
a-naphthyl acetate 
deionised water, 37°C 
Flow cytometry (Section 2.26)
Erylysis buffer 0.16 M NH4C1-Tris buffer, pH 7.2
1 part 0.16 M NH4CI 
50 parts 0.17 M Tris base
5 mL
1 mL
40 mL
47
FACS buffer BSA 
EDTA 
sodium azide 
PBS
1% w/v 
5 mM 
0 .0 1 % w/v
Supplemented HBSS Hepes 12 mM
(#15630-056, Gibcco BRL, Paisley, Scotland)
PCS 5% v/v
(#S-0001a, batch 6010826, Harlan Sera-Lab Ltd, 
Crowley Dovm, UK)
Hank’s balanced salt solution(HBSS, #24020-291- 
091,Gibco BRL)
Annexin V staining in flow cytometry (Section 2.28)
Binding buffer Hepes / NaOH, pH 7.4 10 mM
sodium chloride 140 mM
CaCl2 2.5 mM
sterile filter and store at 4°C 
Enzyme-linked immunosorbent assay (ELISA) for MSP-1-specifîc IgG (Section 
2.29)
Carbonate buffer (pH 9.5) NaH2C0 3
NaHC03 
pH to 9.5
15 mM 
35 mM
Blocking buffer
Wash buffer
BSA
Tween 20 
sodium azide 
PBS
store at 4°C
sodium chloride 
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1% w/v 
0.3% v/v 
0.05% w/v
0.9% w/v
Diluent buffer
K2HPO4 
KH2PO4 
Tween 20 
pH to 7.0-7.2
BSA
Tween 20 
sodium azide 
PBS
5 mM 
5 mM 
0.025% v/v
0 .1% w/v 
0.3% v/v 
0.05% w/v
Diethanolamine buffer diethanolamine 48.5 mL
MgCl2 • 6  H2O 400 mg
sodium azide 450 mL
dH2 0  (autoclaved) 450 mL
stir overnight at 4°C in dark to dissolve diethanolamine 
adjust pH to 9.8
fill up to 1 L with autoclaved dH2 0  
Enzyme-linked immunosorbent assay (ELISA) with crude malarial extract 
(Section 2.30)
Parasite lysis buffer Tris HCl, pH 7.5 50 mM
EDTA 1 mM
SDS, pH 8.0 0.5% w/v
2.2 Antibodies
Primary antibodies used for immunhistology are listed in Table 2.1, secondary antibodies 
for immunohistology in Table 2.2, antibodies for flow cytometry in Table 2.3 and 
isotype controls for flow cytometry in Table 2.4. For ELISA, the only commercial 
antibody was AP-labelled goat anti-mouse IgG H +L (# 1031-04, lot G770-W990E, 
Serotec).
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Table 2.4 Isotype controls for flow cytometry
Isotype Label Source O rder no. Batch
rat IgG2b,K FITC Pharmingen 11184C M 040705
rat IgG2a, k PE Pharmingen 553930 MO73097
rat IgM, K FITC Pharmingen 11054C 7
rat IgM, K biotin Pharmingen 11052C M 027261
rat IgG2a, k FITC Pharmingen 110224C MO34036
rat IgG 1, K biotin Pharmingen 11012C M 028793
a) All antibodies were diluted to the same concentration as the antibody whose control 
they represented.
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2.3 Animals
Female C57BL/6 mice bred in the SPF unit at the National Institute for Medical Research 
(London) were used at 6-12 weeks of age. Recombination activation gene (RAG)-2- 
deficient mice on a BALB/c background were used at 2-5.5 months of age and were kindly 
provided by Anton Rolink (Basel Institute for Immunology, Basel, Switzerland) (Young 
et a l, 1994). All mice were conventionally housed on sterile bedding, food and water. The 
food was autoclaved 41B rodent diet (Harlan) until May 2001 and was then changed to 
autoclaved CRM rodent diet (Harlan). For short-term experiments, animals were 
identified by tail marking with a waterproof Edding pen. In long-term experiments, 12- 
mm microchips (Avid, Uckfield, UK) were implanted for identification. The light cycle in 
the animal unit consisted of 12 h light and 12 h dark to mimic conditions in malaria- 
endemic regions. Mice were checked daily to identify gross health problems and cages 
were cleaned once a week.
Mice were usually killed by cervical dislocation. When large quantities of blood were 
required, mice were lethally anaesthetised by i.p. injection o f 0.1-0.15 mL Sagatal 
Pentobarbitone sodium BP (#7SA005, Rhône-Mérieux). After 2-3 min, the effectivity of 
the anaesthesia was confirmed by absence o f reaction to placing a finger on the mouse’s 
eye or pinching between the toes. All injections were performed with sterile 1 mL 
syringes and 27G x _  " needles.
2.4 Parasites and infections
P. c. chabaudi clone (AS) was originally isolated from an African thicket rat {Thamnomys 
rutilans) by Dr. D. Walliker and cloned in vivo by passaging in mice (Carter and 
Walliker, 1975; Ladel et a l, 1995). The orginal frozen stabilate obtained from Dr. K.N. 
Brown (National Institute for Medical Research, London) had only been passaged five or 
six times in mice. In order to keep mutation and genetic drift to a minimum, frozen stocks 
were passaged once and then amplified by infection of large numbers of mice (e.g. 16 mice
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for the present stock). Mice were lethally anaesthetised mice and bled out when the 
parasitaemia had reached 10-15%. The blood was centrifuged 10 min at 4°C and 500 x g 
and plasma removed without disturbing the erythrocyte pellet. Two pellet volumes of 
glycerol freezing medium (Section 2.1) were added dropwise. The solution was aliquoted 
into cryotubes, frozen rapidly at -80°C and then stored in liquid nitrogen until use. One 
batch of frozen stock was sufficient to initiate all infection series for 3-5 years before it 
became necessary to amplify another vial from the previous stock. This ensures genetic 
comparability between experiments performed at different times and makes the parasites 
as similar to the original stock as possible. Frozen stocks were negative for mycoplasma 
contamination and for common mouse pathogens such as hepatitis, pasteurella and lactate 
dehydrogenase virus.
Infections were initiated from frozen stocks by thawing the stock rapidly at room 
temperature by addition of 200pL of 0.9% sodium chloride (#88776, Sigma) and injecting 
this i.p. into two to three mice. The erythrocytic stages of the parasites were passaged up 
to four times by i.p. injection of 100 pL of 0.9% sodium chloride containing 10  ^ or 10  ^
parasitised red blood cells obtained from infected mice before the peak o f parasitaemia. 
Inoculum sizes were calculated by determining the percentage of parasitaemia in the 
infected mice and assuming an erythrocyte density of 6 x 10  ^/ mL blood.
Taking blood before the peak of parasitaemia ensures that parasites are healthier and less 
likely to undergo antigenic variation in response to immune pressure. Keeping the number 
o f passages low also reduces the amount of time in which antigenic variation can occur 
and prevents the increase of virulence seen when the erythrocytic stage of parasites is 
passaged for long periods (e.g. (Stevenson and Kraal, 1989)). An inoculum size of 10  ^
P. c. chabaudi (AS) pRBC was chosen for all infections.
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For drug-mediated elimination of parasites, mice were treated with three i.p. injections of 
25 mg chloroquine / kg body weight in 0.9% saline solution at 48-h intervals, starting 
between days 30 and 35 of infection (Taylor et a l ,  2001).
2.5 Staining of thin blood films
Thin blood films were made from tail blood and fixed with 100% methanol. For fast 
results, the blood films were stained with the LAMB/034-K (Raymond A. Lamb) by 
dipping six times each in first the acid dye and then the basic dye. For better quality 
staining the Giemsa stain was used (Section 2.1). Giemsa stain was made up fresh each 
day and could only be reused (for a maximum of three lots of slides) if the Coplin jar was 
wrapped in aluminium foil and covered with a lid to prevent oxidisation. Slides were 
immersed in the stain for 2 0  min and then rinsed thoroughly under running tap water. 
Slides were left to air dry and could then be stored indefinitely.
2.6 Counting parasitaemias
The parasitaemia was counted under oil immersion on the Zeiss Axioskop with a lOOx 
objective (1200x final magnification). The grid in the eye piece was used to define fields 
for counting and the percentage of pRBC was calculated according to this formula:
Total number of infected erythrocytes in n fields
Parasitaemia [%] = ---------------------------------------------------------------------------  x 100%
(Total number of erythrocytes in a representative field) x n
The number of fields counted varied, depending on the density of pRBC. Ten fields were 
counted for high parasitaemia (>1%) and 50-100 fields for low parasitaemias (0.01%- 
0.1%), with twenty to thirty fields for intermediate levels o f pRBC.
To calculate average parasitaemias, it is necessary to use geometric means, because 
variation in parasitaemias from the same day o f infection does not follow a Gaussian
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distribution in non-transformed mode due to the exponential expansion o f parasites. The 
positive and negative standard error of a geometric mean differ when shown on a linear 
scale and the error is only shown in one direction in figures for clarity. The geometric 
mean is calculated by taking the average of the decadic logarithm o f the parasitaemias and 
unlogging that result. The positive error is calculated by taking the SEM of the logged 
parasitaemias, unlogging the result and then multiplying that with the geometric mean.
2.7 Crude malarial extract
Crude malarial extract (preparation #38) was taken from laboratory stock. It was 
prepared in the following manner: Synchronously infected mice kept in reverse light cycle 
were bled out under lethal anasthaesia (Section 2.2) when the parasitaemia had exceeded 
15%. Blood was taken at the late trophozoite stage and collected in heparinised syringes. 
CPU columns were prepared for leukocyte removal by layering dry C F l l  powder 
(Whatman International Ltd., Maidstone, UK) onto a thin bed of nylon wool (NEN 
Products) in a 5-mL syringe. The column was pre-washed with cold PBS and then loaded 
with the blood. The eluted erythrocytes were centrifuged 10 min at 500 x g and 4°C. The 
supernatant was removed carefully with a sterile glass pipette and the erythrocyte pellet 
washed twice in PBS. The erythrocyte membranes were lysed by addition of one to two 
drops of 10% saponin (BDH). Lysis took about 5 min and was complete when the 
solution had turned dark brown. The parastite pellet was washed three times in PBS and 
centrifuged 10 min at 750 x g and 4°C. The protease inhibitor aprotinin (Sigma) was 
added and the pellet was aliquoted and stored at -20°C until use.
2.8 Preparation of plasma
Syringes were filled with approximately 0.1 mL heparin (500 U) and used to take blood 
from the chest cavity after cutting the artery leading from the heart. For smaller 
quantities, a drop of heparin (about 3 |iL or 15 U) was put in an Eppendorf tube and the 
pipette tip left coated with heparin. The mouse’s tail was nicked with a scalpel blade and
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blood flow encouraged by massaging gently from the base to the tip of the tail until 50 or 
100 |xL had been collected. The blood was centrifuged twice at 8500 x g and 4°C and the 
plasma removed. Samples were stored at -20°C.
2.9 Normal mouse plasma and hvperimmune plasm
Normal mouse plasma was prepared from uninfected mice as described in Section 2.8. 
Hyperimmune plasma was prepared from mice who had been infected six to eight times 
in 2-4-week intervals. Starting with the the fourth infection, titres of antibodies specific 
for crude malarial extract (see Section 2.7) were tested by ELISA (Section 2.29) 1 week 
after reinfection. If the levels of IgM, IgG I, IgG2a, IgG2b and IgG3 were sufficiently 
high, plasma was taken as described in Section 2.8.
2.10 Whole blood transfer
Blood donor mice which had been infected the stated number of months previously were 
lethally anaesthetised (Section 2.3) and after opening up the chest cavity, the artery under 
the heart was cut. A glass Pasteur pipette was used to transfer 200-250 pL heparinised 
Krebs saline buffer into the body cavity and then the blood buffer mixture was 
transferred to a sterile Eppendorf tube. The blood was taken up in a syringe, avoiding air 
bubbles and clots and two RAG-2-deficient mice injected i.p.with 300 pL, using two 
injection sites.
2.11 Immunisation with chicken gamma globulin fCGG)
Chicken gamma globulin (#003-000-002; Jackson Immunoresearch Inc., Bar Harbor, ME, 
USA) was diluted to a concentration of 1 mg/mL and then mixed with an equal volume of 
9% potassium aluminium sulphate. Sodium hydroxide (1 M) was added dropwise until 
the maximum precipitate had formed. The precipitate was washed twice in 5 mL PBS by 
centriftiging 5 min at 300x g and then resuspended in 0.9% saline solution. Mice were 
injected i.p. with the precipitated equivalent of 25 pg CGG in a volume of 100 pL.
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2.12 MSP-1 / MBP fusion proteins
The approximate equivalent of the C-terminal portion of MSP-1 is expressed in E. coli as 
a fusion protein with maltose binding protein (MBP) in the pMCK129 protein (amino 
acids 1640-1729; see Fig. 4.1). by a modified pMAL-CRI plasmid (McKean et a l,  1993a; 
M cK eane/a/., 1993b).
Plasmid-containing E. coli were grown overnight from glycerol stocks in 20 mL of rich 
medium (Section 2.1). This volume was then expanded to 1600 mL with rich medium. 
The bacteria were incubated at 37°C, shaking at 120 rpm until the ODôoo reached 0.5. 
IPTG was added at 0.3 mM to induce protein expression and the culture incubated 
another 2 h. Bacteria were centrifuged 20 min at 4500 x g and 4°C. The pellet was 
resuspended in 120 mL amylose resin loading buffer (Section 2.1) with CompleteTM 
proteinase inhibitor (#1697498, Roche Diagnostics Ltd., Lewes, UK). The bacteria were 
lysed at 10 000 pounds per square inch with the cell disruption device in the large scale 
cell culture lab at the NIMR and the debris cleared by centrifuging 30 min at 4°C and 
17 400 X g, followed by a 2-h centrifugation in an ultracentrifuge at 40 000 rpm and 4°C. 
The supernatant was snap-frozen and stored at -70°C or passed directly over an amylose 
resin column for affinity purification.
2.13 Affmitv purification of MBP fusion protein
An Amersham Pharmacia XK 16 column (Amersham Pharmacia, Little Chalfont, UK) 
was packed with the MBP-binding amylose resin (# 800-2IL, New England Biolabs, 
Hitchin, UK) according to the instructions supplied by New England Biolabs. The 
ultracentrifuged bacterial supernatant from the previous section was filtered through a 
0.22-pm filter (GV type filter, # GVWP04700, Millipore, Watford, UK) in a Reusable 
Bottle Top Filter (# 0320-5033, Nalgene, Milton Keynes, UK) and diluted fourfold in 
loading buffer. The sample was run over the prepared amylose resin column at 1 mL/min 
or less at 4°C and the OD280 of the effluent monitored to detect the presence o f protein.
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For large quantities of protein, the amylose resin was loaded by batch binding, in which 
the resin was transferred into 50-mL tubes containing the supernatant. These were placed 
for 2 h on an end-over-end roller at 4°C and after that time the column was repacked.
The column was washed with at least three to five column volumes of loading buffer until 
the OD280 had returned to the baseline. Bound protein was eluted with elution buffer 
(Section 2.1). The eluted protein was detected by the change in the OD28o- The column 
was regenerated by washing with three column volumes dH2 0 , three column volumes 0.1 
% w/v SDS (at room temperature), three column volumes dH20 and three column 
volumes loading buffer.
Samples were taken before loading, from the effluent during loading and during elution to 
determine the efficacy o f the affinity binding. This was done by measurement o f the 
protein concentration (Section 2.14) and SDS-PAGE followed by Coomassie Brilliant 
Blue or silver staining (Sections 2.15-2.17). The gels also showed whether the protein had 
been contaminated or degraded. The eluted protein was concentrated in an Amicon 
concentrator with a lOkDa cutoff ultrafiltration membrane (#13622, Millipore) and 
stored at -70°C.
2.14 Measuring protein concentrations
Protein concentrations were measured with the BCA protein assay (#23223, Pierce, 
Rockford, IL) according to the manufacturer’s instructions. Components A and B were 
mixed in a ratio of 50 parts to 1 part. The reaction was carried out in flat-bottom 96-well 
plates and each well contained 200 pL of the pre-mixed BCA reagents and 25 pL of the 
protein. Concentrations o f BSA (diluted in the same buffer as the protein samples) 
ranging from 0-2 mg / mL were included as a standard. The plate was covered with an 
acetate plate sealer (#76-401-05, ICN Biomedicals, Aurora, OH, USA) and incubated at 
37°C for 30 min. The optical density at 565 nm was measured on the ELISA reader and 
the protein concentration calculated by comparison with BSA the standard curve.
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2.15 Reducing SDS-PAGE
Denaturing, discontinuous SDS-PAGE under reducing conditions was performed
according to the Laemmli method as described in Current Protocols in Immunology (John
Wiley and Sons Inc., 1995). SDS-PAGE gels were cast and run in the BIO-RAD Mini
Protean II system. The gels were made up according to the following recipes:
Separating gel (for 2 gels)
Stock solutions Final acrylamide concentration
7.5% 10% 12.5%
Ultra pure protogel 2.5 mL 3.3 mL 4.16 mL
1 M Tris pH8 .8 3.75 mL 3.75 mL 3.75 mL
10% w/v SDS 0.1 mL 0.1 mL 0.1 mL
dHzO (ml) 3.6 mL 2.8 mL 1.94 mL
10% w/v APS 50 pL 50 pL 50 pL
TEMED 5 pL 5 pL 5 pL
Stacking gel (for 2 gels)
Stock solutions Final acrylamide concentration 4%
Ultra pure protogel 1.3 mL
IM Tris pH 6.8 1.25 mL
10% w/v SDS 0.1 mL
dHiO (ml) 7.3 mL:
10% w/v APS 100 pL
TEMED 30 pL
The reagents were procured from the following suppliers: Ultra pure Protogel (30 % 
acrylamide, 0.8 % bisacrylamide, premixed solution; # EC-890 (1 L), National 
Diagnostics ), TEMED (N, N, N', N'-Tetramethylethylenediamine, #15524-010, 
GibcoBRL), APS (ammonium persulphate, #15523-012, GibcoBRL) and Trizma Base 
(#T-8524, Sigma).
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The gel constituents were mixed immediately before use, with APS and TEMED being 
added before casting. The separating gel was poured first, overlayed with dH2 0  and left 
to polymerise. Then the separating gel was poured with a plastic comb creating pockets. 
Once this layer had polymerised as well, the gel was transferred to the electrophoresis 
chamber which was filled with running buffer (diluted down to Ix concentration from the 
buffer in Section 2.1).
Samples were diluted with an equal volume of reducing loading buffer (Section 2.1) and 
heated for 5 min at 95°C to denature the proteins. Protein samples were loaded into the 
pockets o f the stacking gel and a prestained protein medium molecular weight standard 
with a range of approximately 14-200 kDa (#26041-020, GIBCO/BRL) was included. A 
constant voltage of 120 V was applied to the gel and progress of the proteins was 
monitored by the location of the bromphenol blue band. (For better resolution, the 
voltage could be kept at 80-100 V until the blue band had exited the stacking gel.) Proteins 
were revealed by Coomassie or silver staining (described below).
2.16 Coomassie staining of SDS-PAGE gels
Coomassie staining was used as the standard method for protein visualisation in SDS- 
PAGE gels (detection limitiabout 1 pg protein). Buffers were prepared as described in 
Section 2.1. The gel was covered with Coomassie staining solution and placed on shaker 
for 1 h at room temperature or until the gel had absorbed the blue colour. After this, the 
staining solution was poured off and the gel rinsed in deionised water followed by 
incubation with destain solution. A piece of tissue paper was included in the staining tray 
to aborb the blue colour and speed up the destaining process. The gel was placed on a 
shaker until the protein bands became visible in blue and the background was clear or only 
moderately stained. The destaining solution was replaced by deionised water. Gels were 
stored that way for photography or dried onto Whatman filter paper with a Scie-Plas gel 
drier (model GD4534). The Coomassie staining solution was reused up to ten times by
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pouring the used solution through Whatman filter paper (e.g. No. 1, 15 cm diameter, 
internal orders).
2.17 Silver staining of SDS-PAGE gels
For greater sensitivity, SDS-PAGE gels were silver stained (detection limit 2-5 ng of 
protein). All buffers except for DTT stock were made up fresh (Section 2.1). Gels were 
washed in fixative for 15 min and washed thoroughly at least twice in deionised H2O. 
Then they were incubated for 15 min in 25 mL DTT at 5 pg/mL (diluted 1:1000 from 
stock in Section 2.1) and the solution was poured off without rinsing. The next 
incuabation was for 15 min in 25 mL silver nitrate solution, which had to be removed in a 
swirling fashion to ensure even staining. Gels were rinsed once in a small volume of 
deionised H2O and twice in 25 mL developer. Finally the gel was incubated 25 mL 
developer until brown- or silver-coloured bands became visible and the reaction was 
stopped by several washes in deionised H2O.
2.18 Expression of MSP-1 in Pichia pastor is
Dr. Meike Hensmann, Dr. Ching Li and Dr. Robin Stephens (Division of Parasitology, 
NIMR) kindly supplied the purified recombinant M SP-121 fragment expressed by Pichia 
pastoris. The methods basically followed those outlined in the Invitrogen manuals. In 
brief, the Hxa vector was produced by Dr. Bill Morgan (NIMR) by addition o f an N- 
terminal six-histidine (His) tag to the Invitrogen pIC9K vector (Morgan et a l,  1999). The 
M SP-121 fragment was inserted into a blunt-ended P m ll site and the vector cloned into 
competent Escherichia coli (E. coli) cells, which were selected on kanamycin. The vector 
was then transfected into competent SDl 168 Pichia pastoris cells by electroporation and 
clones with multiple inserts selected by high concentrations of G418. The yeast cells 
were expanded with glycerol as a carbon source and protein expression via the AOX 
promoters was induced by switching to methanol, which was added in 24-h intervals over
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3-4 days. The protein was purified via the His tag with the aid of a nickel column and 
then passed over a gel filtration column to remove further contaminants.
2.19 Tissue preparation for immunohistologv
The methods in sections 2.19-2.22 were performed according to standard protocols from 
the laboratory o f Prof. Ian MacLennan (Division o f Infection and Immunity, University 
o f Birmingham, Birmingham, UK) and are partially described in (Luther et a l, 1997). 
Spleens were removed after cervical dislocation. The ends were cut off and the spleen was 
placed on a rectangle of aluminium foil. The enlarged spleens from later stages of infection 
were halved before freezing. The spleens were snap frozen by repeated dipping in liquid 
nitrogen, which prevents tissue cracking. They were placed in gripseal plastic bags and 
stored at -70°C
2.20 Crvosectioning
Cold OCT compound (# 4583, Sakura, Zoeterwede, The Netherlands) was placed on a 
cryostat chuck and the frozen spleen gently pressed into the embedding compound with 
the widest flat plan facing upwards. The freezing process was started with Quickfreeze 
spray (#1950, Histological Equipment Ltd., Nottingham, UK) and spleens were left 20 
min to freeze. Sections were cut either in a Bright cryostat at the Medical School in 
Birmingham or a Jung 2000 cryostat at the National Institute for Medical Research in 
London. In the latter, the chamber temperature was set at -23°C and the object 
temperature at -19°C. The top layers o f the spleen were trimmed off and the cutting 
surface shaped with a scalpel so that the hardened OCT compound formed a supporting 
structure without being cut itself and the splenic capsule was trimmed off to prevent 
jerky cutting on account of different hardnesses. Serial 5-|im cryosections were mounted 
on four-spot glass slides (#PH-005, Hendley Essex, Loughton, UK). Slides were allowed 
to air diy at room temperature with a fan for at least 1 h. They were fixed in 90% acetone 
at 4°C for 20 min, air dried and stored in gripseal bags at -20°C until use.
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2.21 Immunohistologv
Slides were allowed to adjust completely to room temperature before opening the gripseal 
bags and then washed for 5 min in 0.05 M TBS pH 7.6 (see Section 2.1). All antibodies 
were diluted in 0.05 M TBS pH 7.6 (dilutions see Tables 2.1 and 2.2) and mixtures of 
antibodies applied at 75 pL per section. The sections were incubated with the primary 
antibodies for 1 h at room temperature in a moist chamber. Sections were washed twice in 
0.05 M TBS pH 7.6, followed by a 45 min incubation with secondary HRP- or AP- 
labelled antibodies. All secondary antibodies had been preincubated for 30 min with 10% 
normal mouse plasma (see Section 2.9) in a volume of 50-100 pL to minimise binding to 
mouse tissues. AP- or HRP-labelled StreptABC complex (#K0391 and #K0377, DAKO, 
Cambridgeshire, UK) was prepared by mixing 45 pL each of components A and B in 5 
mL 0.05 M TBS pH 7.6 and waiting at least 30 min before use. After two 5-min washes, 
StreptABC complex was added to the sections for 30 min to bind to biotin-labelled 
antibodies. This was followed by two more washes.
Sections were developed first for HRP activity with freshly prepared diaminobenzidine 
tetrahydrochloride (DAB;#D-5905, Sigma) solution. One tablet (10 mg) was dissolved in 
15 mL 0.05 M TBS pH 7.6 buffer and the solution filtered through Whatman No. 1 filter 
paper. One drop of H2O2 was added to 10 mL of the filtrate to inhibit endogenous 
peroxidases. Sections were incubated with the solution until the brown stain was 
sufficiently developed and then washed twice in 0.05 M TBS pH 7.6. AP activity was 
detected using the substrate Naphthol AS-MX phosphate (0.4 mg/mL, #N-4875, Sigma) 
and the chromogen Fast Blue BB salt (1 mg/mL, #F-3378, Sigma) in 0.1 M TBS pH 9.2, 
containing .0.8 mg/mL levamisole (#L-9756, Sigma), which inhibits endogenous 
phosphatases, and 3.8% v/v N,N-dimethylformamide (#D-4254, Sigma). The solution 
was filtered through Whatman paper and applied to the sections. Sections were 
developed until the blue stain was sufficiently strong and then washed twice in 0.05 M
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TBS pH 7.6 and once in distilled water for 5 min each. The slides were then mounted in 
Immuno-Mount (#999 0402, Shandon, Pittsburgh, PA) with 23x65 mm^ coverslips 
(BDH).
2.22 Size measurements in histological sections
The size o f the germinal centers (PNA^ areas in the follicular mantle) and of total spleen 
sections was determined by systematic perusal o f the entire section through the grid of 
the microscope ocular while counting the number of grid intersections that fell within the 
area of interest. This measurement was converted into mm^ by comparison with the grid 
of a Neubauer counting chamber at the same magnification. Where spleens had to be 
halved for cryosectioning, germinal center numbers were extrapolated for whole spleens.
2.23 Haematoxvlin and eosin staining of splenic sections
Spleens were fixed 24 h in 10% neutral buffered formalin. They were then given to the 
Histology Division at the NIMR, where they were embedded in fibrowax (BDH) and 
sectioned. The sections were stained with Ehrlich’s haematoxylin and eosin, dehydrated 
in graded alcohols, cleared with Histoclear (National Diagnostics, Hull, UK) and mounted 
in DPX (BDH).
2.24 Nonspecific esterase staining
Spleens were placed in buffered formol sucrose for 24 h and then in gum sucrose for 24 h 
(Section 2.1) and then frozen by repeated dipping in liquid nitrogen. Cryosections o f 5- 
8 pm thickness were made as described in Section 2.20, except that the slides were dried 
for 30 min at 37°C and then processed immediately. Nonspecific esterase staining was 
performed with an a-naphthyl acetate esterase kit (#91-A, Sigma). Slides were placed in 
the fixative for 30 s and agitated for the last 5 s. They were rinsed in running deionised 
water for 45-60 s and then immediately placed in foil-wrapped Coplin jars containing the 
a-NE staining solution. The slides were stained for 30 min and then rinsed under running
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deionised water for 2 min. The hematoxilyn supplied with the kit was used to 
counterstain the slides for 2 min and rinsed off with tap water. After air drying, the slides 
were mounted in Immunomount.
2.25 Detection of antigen-specific B cells specific bv immunohistologv
CGG-specific B cells were detected by binding of biotinylated CGG (kindly supplied by 
Prof. Ian MacLennan) to immunoglobulin. The biotinylated antigen was used at a dilution 
of 1:150 and detected as described above.
MSP-121-specific B cells were detected by binding of the M SP-121 / MBP fusion protein 
pMCK 129 to immunoglobulin. The fusion protein was then detected with rabbit anti- 
MBP followed by biotin-labelled swine anti-rabbit immunoglobulins (see Tables 2.1 and 
2.2). As the MBP binds to a number of sugar residues including starch, all antibodies and 
the StreptABC were diluted in 0.05 M TBS pH 7.6 supplemented with 10 mM maltose 
to inhibit binding by MBP. All further steps were performed as described in Section 
2 .21.
2.26 Flow cvtometrv
Spleens were collected into 10 mL supplemented HBSS. Single cell suspensions were 
made by pressing spleens through a fine-meshed sieve into 5 mL supplemented HBSS 
(Section 2.1). The volume was made up to 30 mL and the splenocytes were washed by 
centrifuging for 10 min at 4°C and 240 x g. Erythrocytes were lysed by 10 min incubation 
with 0.16 M NH4Cl2-Tris buffer, pH 7.2. The cells were washed again in supplemented 
HBSS and resuspended in 10 mL FACS buffer (see Section 2.1). Cells were filtered 
through cell strainer caps to remove clumps and stained with a Trypan blue (#T-8154, 
Sigma, diluted 1:4) to distinguish dead cells. Cells were counted in a Neubauer chamber 
and the cells aliquoted into 5-mL FACS tubes (#35202, Falcon) or round-bottom 96-well
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PS microplates (#650101, Greiner), depending on the number o f samples. Each sample 
contained 5x10^ live cells. Cells were kept in the dark and on ice from now on. 
Fluorochrome-labelled antibodies were diluted in FACS buffer (dilutions in Table 2.3), 
centrifuged 5 min at 8500 x g and 4°C to remove aggregates and added at 25 pL per 
sample. Anti-Fc receptor antibody (Unkeless, 1979) was added to all samples to prevent 
non-antigen-specific antibody binding via the Fc component. This was followed 
immediately by the first antibody. All antibody incubation steps were 15-25 min long. 
They were followed by two washes in 150 pL or 2 mL FACS buffer, for plates or tubes 
respectively, for 5 min at 240 x g and 4°C. After the final wash, cells were resuspended in 
250-300 pL FACS buffer. If  the staining was performed in plates, they were now 
transferred to 1-2 mL Cluster tubes (#4401, Costar, Coming, NY, USA). Samples were 
acquired on a FACScalibur® at a maximum speed of 2000 events per second. Cells 
stained with a single fluorochrome were used to calibrate the flow cytometer so that the 
emission from each fluorochrome was registered in separate fluorescence channels. The 
results were analysed with CellQuest Pro 4.0.1 software (BD Biosciences, San José, CA). 
Gates defining cell populations were set by comparisons with isotype control staining. 
Staining plasma cells with the anti-syndecan-1 antibody can be complicated (personal 
communications by Anja Hauser, Deutsches Rheumaforschungszentmm, Berlin, 
Germany and Kai Toellner, Division of Infection and Immunity, University of 
Birmingham, Birmingham, UK). After trying numerous methods, the best results (i.e low 
background and identifiable populations) were achieved by using FACS buffer without 
sodium azide and otherwise adhering to the method described above. The results are clear 
for high numbers of plasma cells, but it is difficult to identify small populations 
accurately and therefore, the results with low numbers of antibody-containing cells are 
prone to error.
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2.27 Cell death in flow cvtometrv
The nuclear binding marker 7-aminoactinomycin D (7-AAD; #A-9400, Sigma) was used 
to detect apoptotic cells, with the necrotic cell marker propidium iodide used in parallel 
to ascertain that the majority of the 7-AAD^ cells were actually apoptotic. Unfixed, 
nonpermeabilised splenocytes were stained as described in the previous section. In the 
final step, either 7-AAD (1 pg/2.5 x 10  ^ cells) or propidium iodide (1 pg/2.5 x 10  ^ cells; 
#P-4864, Sigma) was added for 20 or 5 min, respectively. Cells were then analysed on the 
FACScalibur® without any further washes.
2.28 Annexin V staining
Annexin V binds to the membrane phospholipid phosphatidylserine which is translocated 
from the inner to the outer leaflet of the plasma membrane in apoptotic cells. Annexin V 
is therefore used as an early apoptosis marker. Cells (2.5 x 10  ^ per well) were prepared 
and stained as described in Section 2.26, with all steps reduced to the minimal possible 
times. At the end, the cells were washed twice in cold PBS to remove all EDTA and 
resuspended in 200 pL binding buffer. The samples were transferred to the final tubes 
and 2 pL of allophycocyanin (APC)-labelled annexin V (#209-252-T100, lot L08625, 
Alexis Biochemicals, Lausen, Switzerland) added per tube. The samples were incubate 10 
min at room temperature in the dark and the acquisition performed within the next hour.
2.29 Enzyme-linked immunosorbent assav ŒLISAI for MSP-1 specific IgG
The P/c/z/a-produced MSP-121 was diluted to a concentration o f 5 pg/mL in carbonate 
buffer pH 9.5 (Section 2.1). Flat-bottom 96-well polysorb plates (Nunc,) were coated 
overnight at 37°C with 50 pL/well of the antigen. All incubation steps were performed in 
a moist chamber in the dark. Plates were flicked out and incubated for 2 h at 37°C with 
200 pL blocking buffer (Section 2.1) per well to prevent nonspecific binding to the 
plastic. Plates were washed by hand with a 12-channel washer (Nunc). The test sera and 
hyperimmune serum (Section 2.9) and normal serum (Section 2.9) - all from C57BL/6 
mice - were diluted in blocking buffer in a two-fold titration starting with a 1:50 dilution
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and applied at 50 pL per well. Each ELISA plate also contained two controls: C57BL/6 
normal mouse plasma to assess background reactivity and C57BL/6 hyperrimmune 
plasma as a standard (preparation described in Section 2.9). The controls were titrated in 
the same fashion as the samples, except that there was only one row of each control per 
plate since the inclusion on all plates provided replicates. Background staining by normal 
mouse plasma was consistently low for all plates. The plates were incubated 1 h at 37°C 
and then washed. AP-labelled goat anti-mouse IgG (Section 2.2) was diluted 1:1000 in 
PBS, added at 50 pL per well and incubated for 1 h at 37°C.
The substrate for the alkaline phosphatase was made up by diluting PNPP capsules 
(nitrophenylphospate-sodium salt, #N-9389, Sigma) at 1 mg/mL in diethanolamine buffer 
(Section 2.1). Another particularly thorough wash followed and then 50 pL of PNPP 
substrate were added per well. The plates were kept in the dark at room temperature 
while monitoring the change in optical density. Once the optical density at 405 nm 
reached the range of 0.5-1.0 for the 1:50 dilutions of the test sera, measurements were 
taken with the ELISA reader (Vmax Kinetic Microplate Reader, Molecular Device 
Corporation, Sunnyvale, CA, USA). Data was analysed with the Revelation 3.0 
program.
The CD values were converted into arbitrary units by designating the binding of 
hyperimmune plasma as 1 Unit. Plasma IgG titres were calculated from all measurements 
where the titration resulted in a linear decrease in CD and these values were averaged 
arithmetically. IgG titres from different mice were averaged geometrically.
2.30 Enzvme-linked immunosorbent assav (ELISAI with crude malarial extract
Crude malarial extract was prepared as described in Section 2.7. A 50-pL aliquot was 
thawed and diluted in 200 pi parasite lysis buffer (Section 2.1). A portion o f this sample 
was then diluted 1:100 in PBS so that the OD280 was between 0.1 and 0.2. Plates were 
coated with 50 pL per well and after that, the ELISA was carried out as described in 
Section 2.29.
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2.31 Chaotropic ion dissociation in ELISA
In this assay, the concentrations of plasma, coating antigen and detecting antibody are 
kept constant and the variant factor is the concentration of sodium thiocyanate (S-7757, 
Sigma) (Kang et a l,  1998). The coating and blocking steps were performed as descibed in 
Section 2.29. For the next step, two different serum concentrations were chosen, which 
were from the linear portions of the respective IgG titration curves. For sera taken during 
secondary infections and hyperimmune serum, which would have high MSP-121-specific 
IgG titres, a dilution of 1:800 was chosen. All other sera were diluted in 1:100. Dilutions 
were in ELISA diluent buffer. This incubation step was again 1 h at 37°C. Sodium 
thiocyanate titrations ranging from 0-3 M salt concentrations were made in PBS and were 
applied to the plates for exactly 15 min, after which the reaction was stopped by flicking 
out the plates and covering the wells with wash buffer. For sera diluted 1:800, there were 
11 salt concentrations for sera diluted 1:100 only 7 salt concentrations due to limited 
amounts of serum. Hyperimmune serum was applied in a single row per plate, all other 
sera were in duplicate rows. All further steps were performed as described in Section 
2.29.
2.32 Statistics
Data were analysed with a two-tailed Mann-Whitney test with a 95% confidence 
interval, because this does not assume a Gaussian distribution of values. Probabilities of 
less than 0.05 were considered statistically significant. All statistical analyses were 
performed with Prism Graphpad, version 3.0c (Graphpad Software, Inc., San Diego, 
CA).
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3. Splenic responses to primary infection with malaria
3.1 Introduction
3.1.1 The spleen as the main lymphoid organ for malaria infection
This section deals with the analysis of the microstructure o f the spleen and the 
population dynamics o f the splenic lymphocyte subsets during primary infection with 
P. c. chabaudi, Immunohistology and flow cytometry are used to analyse the splenic B 
cell populations and thereby assess the potential for long-lived malaria-specific B cell 
responses.
The spleen is separated into the red and white pulp. Macrophages filter the blood and 
phagocytose defective erythrocytes in filtration beds in the red pulp whereas the white 
pulp is a major site o f immune effector cell development. This combination makes the 
spleen the main lymphoid organ dealing with blood-borne infections (reviewed in (Kraal, 
1992)). This holds true for malaria, as numerous studies have shown that the spleen 
improves the ability of human, monkey and rodent hosts to control parasitaemia (e.g. 
(Butcher a/., 1978; Favila-Castillo et a l, 1996; Israeli et a l, 1987; Petersen et a l,  1992; 
Spitalny et a l, 1976; Wyler et a l, 1977)). It has also been shown that an intact splenic 
microarchitecture is required for effective immune responses against malaria infections, 
including P. c. chabaudi infection (Yap and Stevenson, 1994).
3.1.2 Blood flow within the spleen
The current model of blood flow in the rodent spleen is as follows (reviewed in (Kraal, 
1992; Steiniger and Barth, 2000)): Several branches of the splenic artery enter the main 
body of the spleen and give rise to the central arterioles. Capillaries leave the central 
arterioles at right angles to empty into the marginal sinus, which is formed by a series of 
vascular spaces but is not classed as a true blood vessel because it lacks high endothelial 
venules. Larger branches of the central arterioles traverse the red pulp as «marginal zone 
bridging channels" or «terminal arterioles" ending in the splenic cords (also knovm as
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cords of Billroth). The splenic cords contain large number of mature macrophages, as well 
as B and T lymphocytes, erythrocytes, thrombocytes, granulocytes, some plasma cells 
and haematopoietic cells in a network of fibroblasts. Blood passes from the splenic cords 
into the splenic sinuses (or sinusoids) of the red pulp, which are vessels lined by 
endothelia with intercellular slits. These vessels carry the blood out of the spleen. The 
splenic cords and the marginal sinus constitute the open component o f splenic circulation 
and the closed component is formed by the arteries and capillaries. Most of the work 
elucidating these connections has been done on rat spleens and there is still debate about 
the relative extents of open and closed circulation.
3.1.3 White pulp architecture
The structure of the splenic white pulp is schematically depicted in Fig. 3.1 and is 
reviewed in (Steiniger and Barth, 2000). In rodents, the white pulp is organised 
concentrically around the central arterioles and consists of three compartments: the T 
zone or periarteriolar lymphatic sheath (PALS), the follicular mantle and the marginal 
zone. The T zone surrounds the central arteriole and is in turn enveloped by the follicular 
mantle, which consists of individual follicles. Primary follicles contain a uniform 
population of naive recirculating B cells (also known as follicular B cells), which are 
characterised by surface IgD and IgM and have a short life span unless they become 
activated by antigen encounter. Secondary follicles contain a germinal centre and the 
recirculating cells are displaced to the outer edge of the follicle. The T zone and B cell 
follicles are girdled by the marginal zone, whose border is demarcated by the marginal 
sinus.
3.1.4 Differences between human and mouse spleens
Human spleens differ from rodent spleens in a number of aspects (reviewed in (Steiniger 
and Barth, 2000)). In the white pulp, T cell areas are more dispersed, with many sections 
of the central arterioles surrounded only by B cell follicles, which consist o f four rather
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Figure. 3.1 Overview of white pulp structure and cell populations.
(a) Schematic representation of the separation of the spleen into red and white pulp areas.
(b) Division of the white pulp into different fiinctional areas. An extrafollicular focus of 
antibody-containing cells is also shown as an element of the red pulp, which lies at the 
edge of marginal zone bridging channels.
(c) Detailed structure of the marginal zone which also shows central arteriole branches 
terminating in the marginal sinus and red pulp. This panel is a colored reproduction of a 
figure in (Kraal, 1992).
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than three distinct areas - the germinal centre, the corona (which corresponds to the 
follicular mantle of rodent spleens), the marginal zone and the perifollicular zone, which is 
sometimes viewed as part o f the red pulp. The overall shape o f these follicles tends to be 
globular rather than hemispheric. Marginal sinuses and marginal zone metallophilic 
macrophages (described below) are absent, but a unique form of macrophage-sheathed 
blood vessel, the sheathed capillary, can be found in the perifollicular zone. Despite the 
differences in structure and possibly in blood circulation, the spleen appears to function 
similarly to its rodent counterparts, with one exception. Human spleens do not become 
additional sites of haematopoiesis in times of haematological stress, a phenomenon 
common in rodent spleens (e.g. (Nikcevich et a l,  1986)).
3.1.5 B cell populations of the spleen
This chapter studies the cells generated in the spleen in the follicular and extra-follicular B 
cell responses. This differentiation is performed by studying the four major B cell 
populations of the spleen: naïve recirculating B cells, germinal centre B cells as the source 
of memory B cells and long-lived plasma cells, plasma cells and their plasmablast 
precursors (grouped as antibody-containing cells) and the marginal zone B cells. Naïve 
recirculating B cells have already been discussed in Sections 1.3.4 and 3.1.3 and germinal 
centres and antibody-containing cells in Sections 1.3.6 and 1.3.7.
3.1.6 The marginal zone
The marginal zone contains three unique cell populations: metallophilic macrophages, 
marginal zone macrophages and marginal zone B cells (Fig. 3.1c). The marginal zone 
metallophilic macrophages have a characteristic appearance, especially in small rodents, 
with slender cell processes extending into the white pulp. Located on the white pulp side 
of the marginal sinus, they are well situated for degradation o f foreign material and 
interaction with both stationary and migrating lymphocytes, but their actual functions are
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still unknown. Marginal zone macrophages are distributed between the marginal sinus and 
the red pulp and appear to be in close contact with marginal zone B cells. They are highly 
phagocytic and specialise in the uptake of neutral polysaccharides, which are classed as 
thymus-independent type 2 (TI-2) antigens (reviewed in (Kraal, 1992)).
The marginal zone is also enriched in a population of B cells differing from the adjacent 
follicular B cells. They are IgM^'^^ IgD^°^ CD21^'^^ CD23'°^ as opposed to the mainly 
IgM*°'  ^ CD2T"^CD23* '^®  ^phenotype in the follicles (Oliver et a l,  1997). They are
also larger than the follicular B cells and do not recirculate but display high motility in 
response to stimuli such as heat-killed E. coli (Gray et a l, 1984; Gray et a l, 1982). 
Marginal zone B cells can be generated in a thymus-independent manner (Kumararatne 
and MacLennan, 1981; Kumararatne and MacLennan, 1982) and are preferentially 
selected into this pathway by weak signals through the B cell receptor (Cariappa et a l, 
2001), leading to a clonally restricted repertoire. This cell type is only found in the 
spleen, although attempts have been made to define equivalents in the lymph nodes.
The function of these cells has been studied in mice lacking the tyrosine kinase Pyk-2 
which do not produce marginal zone B cells. They are deficient in thymus-independent 
type II responses and to a lesser extent in thymus-independent type I responses 
(Guinamard et a l, 2000) suggesting a role for MZ B cells in these responses. There is also 
a smaller group of marginal zone B cells which responds to thymus-dependent antigens. 
Marginal zone B cells are particularly responsive to blood-borne particulate antigens 
(Martin et a l,  2001) and polysaccharide antigens are specifically targeted to marginal 
zone B cells via complement, creating a link between the innate and adaptive immune 
systems (Guinamard et a l, 2000). Therefore, along with B1 cells, marginal zone B cells 
are often described as the source of «natural memory" and «natural antibody" and are 
very important in the early immune response.
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In VH81X_Ig heavy chain transgenic mice, which have a higher proportion of marginal 
zone B cells, it was shown that marginal zone cells are not activated per se, because they 
do not express increased levels of the activation markers CD69, CD25, MHC class I, 
MHC class II and CD95 as compared to follicular B cells (Oliver et a l, 1999). However, 
their surface antigens indicate a memory phenotype characteristic of previous antigen 
encounter, i.e. decreased levels of CD62L and IgD and increased levels of CD44, B7.1 and 
B7.2. In addition, they have lower thresholds for activation, proliferation and 
differentiation into antibody-secreting cells and are more sensitive to apoptosis than the 
recirculating follicular B cells (Kumararatne et a l, 1980; Martin et a l,  2001; Oliver et a l, 
1997; Oliver et a l,  1999). Therefore, these cells are sometimes classed as a particular 
subtype of memory B cells (first suggested by (Liu et a l, 1988)) or as a mixture of 
memory and virgin cells.
3.1.7 Aims and strategv
In this chapter, immunohistology was used to analyse the four splenic B cell populations 
during a primary infection with P. c. chabaudi in comparison with a classic immunisation 
model. The following aspects were studied:
(i) the respective distribution of T cells and recirculating naive B cells by staining for CD3 
and IgD,
(ii) the extrafollicular antibody response by staining cells committed to plasma cell 
differentiation with syndecan-1 (CD 13 8),
(iii) the development and persistence of germinal centres by staining for PNA binding,
(iv) the involvement of marginal zone B cells by IgM staining in the marginal zones. 
Flow-cytometric analysis was used to validate these data with quantitative evaluations 
and to assess the extent of apoptosis in the different B cell populations.
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3.2 Results
3.2.1 Experimental design
C57BL/6 mice were infected with 10  ^ P. c. chabaudi (AS) parasitised red blood cells 
(pRBC) and spleens were taken at various time points afterwards for analysis. Days 3-8 
represent the stage of ascending parasitaemia, days 9-12 the peak, days 16-30 the late 
stages and recrudescence and days 40 and 60 the phase when parasitaemia is no longer 
detectable by thin blood smear.
The main methods of analysis in this section are immunohistology and flow cytometry 
(Fig. 3.2). Two series o f infected spleens with three mice per time point were frozen for 
cryosectioning and immunohistology. The first series encompassed days 0, 4, 8 , 10, 16, 
20, and 40 of infection and the second supplied additional information for the peak and 
late stages of infection with days 7-12, 20, 30 and 60. Cryosections of 5 pm thickness 
were made so that approximately one layer of cells would appear in the sections. The aim 
was to have four consecutive sections on each microscope slide so that four different 
stain combinations could be applied to spatially close areas in the spleens. Often, anti- 
IgD was used in several consecutive stain combinations to allow orientation in the spleen 
and make comparison between sections easier. However, most o f the malarial spleens 
were difficult to cut because of their increased size and fragility. Therefore, some sections 
had to be discarded and a slide did not always contain absolutely consecutive sections.
All o f the primary and secondary antibodies used for immunohistology in these 
experiments have been carefully tested for cross-reactivity and have been used 
extensively in the laboratory of Prof. Ian MacLennan (University of Birmingham, UK). 
In addition, most of the primary antibodies share the same labelled secondary reagent and 
can thus act as controls for each other. Each of the antibodies causes a unique staining 
pattern, demonstrating that there is no nonspecific binding by the secondary antibody.
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Figure 3.2 Experimental design for Section 3.
The left-hand side depicts the use of immunohistology to determine the relative location 
of splenic cell populations. The right-hand side shows the use of flow cytometry to 
quantify splenic B cell populations. It also shows how the live cell gate is defined in a 
profile graphing the side scatter (which is a marker of cell granularity) against the forward 
scatter (which is a marker of cell size) of unstained cell populations. Only cells from the 
live cell gate were then used for the further analyses. The examples are from a naive and a 
day-2 0  infected mouse and are representative of the live cell gates on which the flow 
cytometry plots in Figs. 3.4, 3.5, 3.8, 3.9, 3.10, 3.12 and 3.13 are based.
pRBC (P. c. chabaudi): erythrocytes infected with P. c. chabaudi (AS)
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Immunohistology is the ideal method for studying relative locations of cell populations 
and can normally be used for rough quantification as well. In the malaria infection, this is 
not possible, because there is marked splenomegaly with spleen weights increasing more 
than tenfold (e.g. (Sanchez-Torres et a l,  2001)) in P. chabaudi infection. Fig. 3.3a shows 
the increase of spleen size with cryosections from different stages of infection, with the 
increased gaps between the stained areas showing that most of the increase is due to red 
pulp expansion. In Fig. 3.3b, the number of nucleated splenocytes (after erythrocyte 
lysis of a single cell spleen suspension) is compared with the level of parasitaemia in Fig. 
3.3c. Peak numbers of nucleated splenocytes on day 16 of infection are eightfold higher 
than in uninfected mice.
A two-dimensional section will give a skewed picture of how cell population sizes are 
changing, because the cells are also spread out in the third dimension. Therefore, it was 
essential to perform quantification of cell populations by flow cytometry which takes the 
whole spleen into account and allows population definition with up to four 
fluorochromes exciting and emitting at different wavelengths. Spleens were analysed from 
days 0, 3-8 ,10 ,12 ,16 , 20, 30 and 40 of infection. After making single cell suspensions of 
the spleens, a sample was counted and the number of live cells per spleen calculated. 
During acquisition on the FACScalibur®, all population definitions were based on a gate 
which represented the live cells of the spleen (Fig. 3.2). Relative percentages were then 
transformed into absolute numbers with the aid of the original live cell count. A spleen 
from a naive mouse was included in every experiment as a control for normal staining. 
The splenic B cell response to an antigen frequently used in immunisation studies was 
examined by immunohistology and flow cytometry for comparison. Spleens were 
analysed 10 days after immunisation with 25pg alum-precipitated chicken gamma 
globulin (CGG), when the humoral response against the antigen is fully developed.
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Figure 3.3 Splenic size increase during P. c. chabaudi infection.
(a) Sections of spleens from days 0, 16 and 40 of infection were stained with antibodies 
against CD3 (blue), IgD (brown) and BrdU (pink). All sections were photographed at the 
same magnification (25x). At day 16, the section was larger than the microscope’s field of 
view. The increased gaps between the areas of white pulp show that most of the size 
increase is due to red pulp expansion. Each image is representative of 3-6 mice.
(b) Numbers o f nucleated splenocytes were counted after generation of a single cell 
suspension and erythrocyte lysis (as described in Sect. 2.26). Each data point represents 
3-6 mice for all times except for day 10 (9 mice) and day 0 (15 mice). Error bars represent 
theSEM .
(c) A course of parasitaemia from 5 mice is shown on the same time scale for 
comparison. The geometric mean is shown and error bars represent the SEM.
83
(a) Spleen overviews 
CDS/IgD (3rd- )
die
dSO
(b) Nucleated splenocyte numbers
L
i JI
1.0x10°® '
5.0x10°°
2 0  3 0  4 0  5 0  6 0
D a y s  p a s t  in fection
(c) Course of infection
100n
10-
i 0 .1-
0 .01-
< 0.001
D a y s  p a s t  infection
3.2.2 Total B cell numbers
Splenic B cells are identified by the markers B220 (CD45R) and CD 19. Antibodies 
against both markers were compared for quantifying B cell numbers after P. c. chabaudi 
infection (Fig. 3.4). Two clones of anti-B220 were tested: The commercially produced 
RA36B2 clone (Fig. 3.4 b) produced greater resolution between positive and negative 
populations than the RA33A1 antibody purified from hybridoma supernatant (data not 
shown). The numbers of CD 19'*' and B220^ cells were comparable (Fig. 3.4f), but the 
anti-CD 19 antibody was used in further experiments, as B220 expression is reported to 
be more variable, undergoing down-regulation on plasma cells and mature germinal centre 
B cells (Calame, 2001; Han et a l,  1997). CD 19^ B cell numbers are greatest at day 8 of 
infection when there are roughly twice as many B cells as in uninfected mice (Fig. 3.4e). 
After that, numbers drop slightly and fluctuate around a value that is still higher than that 
in uninfected or day-10 CGG-immunised mice.
3.2.3 Basic changes in the white pulp structure and the naive recirculating B cell 
population
The basic structure of the white pulp is defined by the location of T cells (CD3^) in the T 
zone and naive recirculating B cells (IgD'*') in the follicular mantle. Marked changes occur 
in the distribution of splenic lymphocytes during the rise of parasitaemia. By day 7 to 8 
of infection, the outlines of the T zone and the follicular mantle lose definition with 
concomitant blurring o f the boundary between the two areas (d8 in Fig. 3.5a) and an 
apparent loss of cells. At the peak of parasitaemia, the white pulp structure is so 
strongly disorganised that it can be impossible to identify these regions. By 10 days of 
infection, only few T cells are detected in the T zone and the indistinct follicular mantle 
consists mainly of some IgD^ recirculating small B cells at the outer surface of the newly 
formed germinal centres (Fig. 3.5a, dlO). The extraordinary white pulp disorganisation 
reverses with the waning of the parasitaemia. Between days 10 and 40, the cuff of T cells
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Figure 3.4 Total B cell numbers during P. c. chabaudi infection.
Total numbers o f splenic B cells were determined by flow-cytometric analysis. 
Representative time points are shown for staining with hiotin-labelled anti-CD 19 (a) and 
anti-B220 (clone RA36B2). Isotype controls (rat IgG2a, k )  were always negative and 
examples from day 20 are shown in (c). CD 19 staining is shown 10 days after 
immunisation with CGG as a positive eontrol (d). Forward scatter is plotted on a linear 
scale and antibody staining on a logarithmic scale. The absolute numbers of CD 19^ B cells 
calculated from the live cell gate are shown in panel (e) with a comparison between CD 19 
and B220 staining shown for selected time points in (f). Each bar represents the 
arithmetic mean and SEM from 3-9 mice for the infected groups and 15 mice for day 0.
86
d20
d40
CD19
(a) CD19 staining
< .*v
(b) B220 staining
FSC
■
B220
(c) isotype 
controis
CD19 .
con.
B220 .
con.
(d) CGG control
CD19
(e) CD19+ cells
8  5.0X10°'.
0 3 4 5 6 7 8 10 16 20 30 40 |CGQ
Days after infection
(f) Comparison between 
CD19 and B220 staining
2.0x1008-
1.0x1008-
■1 CD19 
I—I B220
8 10 16 20 30 40 | CGG
Days after infectfon
Figure 3.5 Basic white pulp structure and naive recirculating B cells during P. c.
chabaudi infection.
(a) The basie division of the white pulp into the T zone and the follicular mantle basic 
structure o f the white pulp is defined by antibodies against T cells (CD3, blue) and naïve 
recirculating B cells (IgD, brown). Dark spots at late time points are caused by the 
malarial pigment hemozoin. Spleens from days 0 , 8 , 1 0 , 2 0  and 60 of infection were 
chosen to portray the different stages during infection. Each image is representative of 
three to six mice. The size bar corresponds to 100 pm.
GC: germinal centre, FM: follicular mantle, T: T zone.
(b) Flow-cytometric profiles of the live nucleated splenocyte fraction are shown for 
representative time points The naive recirculating B cell population which corresponds to 
the IgD^ cells in panel a is defined as CD21'”^ CD23’^ . All plots are based on a logarithmic 
scale. Gates were set by comparison with the isotype control staining and in relation to 
the marginal zone B cell gate shown in Fig. 4.12b. The same gate was used for all samples 
in each experiment.
(c) Isotype controls for the anti-CD21 (FITC-lahelled rat IgG2b,K) and anti-CD23 (PE- 
labelled rat IgG2a, k )  antibodies were used as negative controls. A representative example 
from day 2 0  o f infection is shown.
(d) Flow-cytometric and immunohistological analysis 10 days after immunisation with 
alum-precipitated CGG was used as a positive control.
(e) The percentages o f the CD2F"^CD23^ live cells shown in panel h were used to 
calculate total number of naive recirculating B cell numbers after subtraction of percentage 
o f cells which was positive for the CD21 isotype control. Each bars represents the 
arithmetic mean from 3 to 6 spleens, with up to 15 spleens for time point 0, as an 
uninfected control was included in eaeh experiment. Error hars show the SEM.
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in the periarteriolar region reforms and the follicular mantle extends fully around the white 
pulp again (Fig. 3.5, d20-60). By day 40-60 of infection, the white pulp has regained 
fairly normal appearance albeit with somewhat less sharp outlines and the addition of 
germinal centres and red pulp granules o f haemozoin, a degradation product of 
haemoglobin produced by the parasite (Fig. 3.5a, d60).
In flow-cytometric analysis, the naive recirculating B cell population is best defined as 
CD2F"^CD23^ ((Oliver e /a /., 1997)) (Fig. 3.5b). The use of this marker combination has 
the added advantage that marginal zone B cells can be identified at the same time as 
CD21^CD23' (Fig. 3.12b). There was no major size difference between the 
CD 19^CD21 '"^CD23^ and the CD21‘"^CD23^ populations (data not shown), so the 
marginal zone B cells were defined without the antibody against CD 19. Representative 
flow-cytometric dot plots were chosen to represent different stages of infection. (Fig. 
3.5b) and results for isotype controls and a 10-day CGG immunisation time point are 
included as negative and positive controls, respectively. Flow-cytometric analyses are 
shown only up to day 40 of infection after several experiments showed that results 
looked very similar on days 40 and 60 of infection.
Between days 10 and 20 of infection, the red pulp appears almost devoid of IgD^ and 
CD3^ lymphocytes in immunohistological staining (Fig. 3.5a, dlO and d20). Along with 
the marked transient reduction of these cells in the follicular mantles and T zones 
observed between days 8 and 12 , one might assume that the population sizes o f follicular 
B cells and T cells would be reduced in the malarial spleens around and after the peak of 
infection. On the contrary, flow-cytometric analyses show that IgD^ B cell (Fig. 3.5b) 
and T cell (Helmby et a l , 2000) numbers are only minimally lower than in naïve mice at 
the peak (Fig. 3.5e) and even increase in the early and late stages of infection. This 
suggests that the effect observed in immunohistology is a dilution effect, where the 
lymphocytes are just spread out further in the vastly enlarged spleens.
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3.2.4 Cellularitv of the red pulp
The previous section has shown how the increase in spleen size can influence distribution 
of splenocytes. This wider spacing might influence their interactions with other cells. 
Therefore, it is necessary to identify which types o f cells occupy the expanded red pulp. 
For a basic overview, hematoxylin and eosin staining was performed on paraffin sections 
of spleens from days 0, 8 , 10, 12 and 14 of infection (Fig. 3.6a), when the spleen is 
increasing rapidly in size. This shows that the red pulp becomes the site of extensive but 
transient haematopoiesis involving large islands of erythroid precursors and abundant 
megakaryocytes. On day 10 of infection, the erythroid precursors are so numerous that 
they compress splenic cords and red pulp sinuses (Fig. 3.6a, dlO). However, by day 12 
of infection, the red pulp sinuses and cords of Billroth are seen to open up again (Fig. 
3.6a, d l2  and dl4), indicating that the strong haematopoietic burst is a response to the 
high loss of erythrocytes at the peak of parasitaemia.
Macrophages are one of the main cell groups in the red pulp and their numbers could be 
expected to increase to cope with the mass of defective erythrocytes. Nonspecific 
esterase activity and the MHC class II and F4/80 markers were used to identify 
macrophage populations of the red pulp. Activated macrophages show increased 
nonspecific esterase activity. The density o f these cells in the red pulp decreased as the 
infection progressed (Fig. 3.6b). The MHC class II stain was concentrated in the white 
pulp with particular emphasis on the follicular mantle (data not shown), suggesting that it 
was also detecting B cells and therefore not specific enough for statements about the 
changes in macrophage populations. The F4/80^ macrophages remained confined to the 
red pulp throughout infection, with their numbers but not their density increasing 
steadily as the red pulp distended (Fig,. 3.7b). Together these stains show that there may 
be more macrophages in the enlarged red pulp, but that they do not exclude other cells 
from this area.
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Figure 3.6 Cellularity of the red pulp
(a) Paraffin-embedded spleens from days 0 ,10,12 and 14 were stained with H& E.
(b) Nonspecific esterase activity was revealed with a-naphthyl esterase activity (in 
black) with a haematoxylin counterstain (green).
(c) In more detailed images of H & E stained spleens, examples of erythroid precursors 
islands are circled and some megakaryocytes are pointed out. In the righthand panel, the 
splenic capsule can be seen at the bottom of the picture.
Spleens were cut in half and one half each used for H & E and nonspecific esterase 
staining. Each panel is representative of three spleens.
RP: red pulp, WP: white pulp, ep: erythroid precursors, Meg: megakaryocyte
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Figure 3.7 Dendritic cells and macrophages during P. c. chabaudi infection.
(a) CDl Ic^ dendritic cells were stained in blue and the metallophilic macrophage 
population was identified by staining for CD 169 (brown). On day 0, the metallophilic 
macrophages were not stained. Days 8 , 16 and 40 also show traces of an irrelevant red 
stain for BrdU.
MZ: marginal zone, T: T zone
(b) F4/80^ macrophages were stained in brown.
All panels are representative of three spleens.
RP: red pulp, WP: white pulp
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More dramatic changes can be seen in a group of macrophages which are confined to the 
marginal zones, the metallophilic macrophages, which are CD16W and have a typical 
appearance that makes the marginal zone look like a crown of thorns. By day 8 of 
infection, the ring formed by these cells becomes slightly discontinuous (Fig. 3.7a, d8) 
and between days 10 and 16, it is reduced to individual cells usually located at the edge of 
secondary follicles (Fig. 3.7a, dlO and d l6 ). By day 40, some of the marginal zones 
contain metallophilic macrophages again (Fig. 3.7a, d40), but there are still no continuous 
rings.
The same figure shows the CDl Ic^ dendritic cells, which first become more numerous in 
the red pulp and the T zone (Fig. 3.7a, dlO). By day 16 they are concentrated in the T 
zone and at the edges of the follicular mantle (Fig. 3.7a, d l 6  ). By day 40, the number and 
distribution of CDllc^  cells is approaching that of naïve spleens again (Fig. 10, d40). 
Together, the increase in macrophages and dendritic cells at the peak of infection shows 
that there is a large antigen presenting potential at this time point.
3.2.5 Germinal centre B cells
Germinal centres are detected specifically in immunohistology by binding of the lectin 
PNA (Fig. 3.8a) and they are also recognisable as typical round unstained structures in 
the follicular mantle when using the IgD / CD3 stain combination (Fig. 3.5a). Small 
numbers of PNA-positive germinal centres are present in the spleens of uninfected 
control mice, which is consistent with housing in a non-sterile environment (Table 3.1). 
Slightly increased numbers of small germinal centres are seen on days 7-9 of infection and 
by day 10, the germinal centre response is firmly established (Figs. 3.5 and 3.8, Table 
3.1). The germinal centres continue to increase in size and number up to day 20. Normal 
germinal centres are present up to day 40 and still visible on day 60, in a more weakly 
stained form.
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Figure 3.8 Germinal centre B cells during P. c. chabaudi infection.
(a) Germinal centres are revealed with the lectin PNA (blue) along with naïve reciculating 
B cells (IgD, brown) for orientation. Dark spots at late time points are caused by the 
malarial pigment hemozoin. Random isolated cells in the red pulp and some epithelial 
cells are also stained by PNA, but can easily be distinguished from germinal centre B cells 
by form or location. Spleens from days 0, 8 , 10, 20 and 60 of infection were chosen to 
portray the different stages during infection. Each image is representative of three to six 
mice. The size bar corresponds to 100 pm.
GC: germinal centre
(b) Flow-cytometric profiles of the live nucleated splenocyte fraction are shown for 
representative time points. The germinal centre B cell population which corresponds to 
the PNA’*' cells in panel a is defined as GL7^CD19^. All plots are shown on a logarithmic 
scale. Gates were set by comparison with the anti-GL7 isotype control and by choosing 
obviously distinct cell populations. Therefore, gates often needed to be chosen 
individually for different samples in the same experiment.
(c) The isotype controls for the anti-GL7 antibody (FITC-labelled rat IgG2a,K) was used 
as a negative control. A representative example from day 20 of infection is shown.
(d) Flow-cytometric and immunohistological analysis 10 days after immunisation with 
alum-precipitated CGG was used as a positive control.
(e) The percentages of the GL7^CD19'^ live cells shown in panel b were used to calculate 
total number of germinal centre B cell numbers after subtraction of the percentage of cells 
which were positive for the GL7 isotype control. Each bar represents the arithmetic mean 
from 3 to 6  spleens, with up to 15 spleens for time point 0, as an uninfected control was 
included in each experiment. Error bars show the SEM.
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Table 3.1. Germinal centre growth after Plasmodium chabaudi chabaudi infection
Day No. b) Average size'^ 
[mm^]
A rea of spleen 
[%]
0 1.5 0 .0 0 2 0.01
8 2 1 .2 0.004 0.28
9 47.0 0.009 0.57
10 70.0 0.016 1.29
11 77.7 0 .0 1 0 0.91
12 78.0 0 .021 1.93
2 0 152.0 0.040 9.20
30 110 .0 0.028 4.6
60 35.2 0.013 2 .0
CGG 51.7 0.013 2.5
a) Ail values are arithmetic means of germinal centres in single cryosections from two to 
three spleens.
b) Germinal centres were counted as described in Section 2.22.
c) Areas were determined as described in Section 2.22.
d) The percentage of the spleen covered by germinal centers was calculated by measuring 
the area of the combined germinal centres and dividing this by the total area of the 
cryosection.
e) Spleens were taken 10 days after immunisation with alum-precipitated CGG.
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The germinal centres in splenic sections from day 10 of malaria infection are slightly 
larger and more frequent than those seen 10 days after immunisation with a conventional 
antigen, chicken gamma globulin (Table 3.1). At the peak o f the malaria-induced germinal 
centre response, day 2 0  o f infection the germinal centres and sizes are about threefold 
higher than those seen on day 10 of CGG immunisation and this difference is statistically 
significant (p<0.05) Germinal centre appearance is normal in that a light and dark zone 
can be distinguished by H& E staining (data not shown) and by the outer ring of T cells 
(Fig. 3.5a, d20) in the older germinal centres. There is not much variation in the staining 
intensity of germinal centres on day 60, suggesting that they are of a similar age.
In flow cytometry, germinal centre B cells were identified by positive staining with 
antibodies against GL7 and CD 19 (Fig. 3.8b), as PNA bound quite unspecifically (Fig. 
3.9) GL7 is a protein found on germinal centre B cells in the spleen and on activated 
thymocytes (but not splenic T cells) (Laszlo et a l, 1993). The relative location of the 
different populations in the dot plot shifts slightly during infection, but the germinal 
centre population is always readily recognisable.
The kinetics of germinal centre B cell development revealed by flow cytometry agree well 
with the immunohistological observations. Total numbers of germinal centre B cells rise 
gradually in the early days of infection, with greater increases on days 6  and 8 (Fig. 3.8e) 
and the peak at day 20. The GL7^CD19^ cells are still present in large numbers by day 
40 of infection and even at this late stage, levels are five times higher than at day 10 of 
chicken gamma globulin immunisation.
3.2.6 Antibodv-containing cells
Antibody-containing cells, which comprise the differentiating plasmablasts and the 
immunoglobulin-secreting plasma cells, can be recognised in both immunohistology and 
flow cytrometry by antibodies against the proteoglycan syndecan-1. Immunohistology 
shows that on both days 0 (Fig. 3.10a, dO) and 4 o f infection (data not shown), small foci
100
Figure 3.9 Comparison of germinal centre staining by PNA and anti-GL7 in FACS 
analysis.
The panels on the left show attempts to identify the germinal centre population with the 
lectin PNA in three spleens from different time points of infection. On the right, cells 
from the same spleens are stained with anti-CD 19 and anti-GL7. Comparison with the 
GL7 isotype control (shown in Fig. 4.8c) allows populations to be identified clearly.
All analyses were performed on the live nucleated splenocyte fraction. Forward scatter is 
on a linear scale. All antibody and reagent stains are on a logarithmic scale.
101
do
d8
die
PNA CD19
FSC GL7
of antibody-containing are present in the typical red pulp location. The numbers of 
antibody-containing cells increase rapidly, reaching peak density at day 9 or 10 of 
infection (Fig. 3.10a, d8 and dlO) followed by an equally rapid decline (Fig. 3.10a, d20 
and d60). In the rapid expansion period between days 7 and 10, many IgD^ antibody- 
containing cells are seen among the syndecan-1^ cells in the red pulp (Fig. 3.11a). 
Between days 8 and 10 of infection, the location of the majority of the syndecan-1^ cells 
shifts from the extrafollicular foci to the T zone of the white pulp (Fig. 3.10a, d8 and 
dlO). Antibody-containing cells are found in this location up to day 20 of infection (Fig. 
3.10a, d20) and from day 30 are again located in the red pulp (data not shown) with 
numerous foci still visible at day 60 (Fig. 3.10a, d60).
Between days 12 and 20 of infection (Fig. 3.5; dlO and d20. Fig. 3.10, dlO and d20), as 
the number of syndecan-1^ cells begins to decrease and more T cells are again seen in the 
T zone, it becomes possible to compare the relative locations of these two populations. 
The sections used for anti-CD3 and anti-syndecan-1 staining were part of a consecutive 
series with at least two other 5-|Lim sections in between. Nonetheless, the distances 
between the relevant sections are very small, making it possible to match up 
corresponding areas of the spleen accurately. This shows that between days 12 and 20 of 
the infection, T cells and antibody-containing cells occupy non-overlapping areas of the T 
zone (Fig. 3.11b and c).
The syndecan-1 staining was difficult to use in flow cytometry: With the protocol used 
for the other marker combinations, populations of syndecan- 1 ^ CD19^ cells could not be 
defined by comparison with the syndecan-1 isotype control or the uninfected mice. 
Intracellular staining resulted in clearly identifiable populations, but the background of the 
isotype control was unacceptably high (up to 50%, data not shown). Finally, an 
extracellular staining protocol using FACS buffer without sodium azide proved 
successful.
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Figure 3.10 Antibody-containing cells during P. c. chabaudi infection.
(a) The location of antibody-containing cells (syndecan-1, blue), i.e. plasma cells and 
plasmablasts, is shown along with naïve recirculating B cells (IgD, brown) for orientation. 
Dark spots at the late time points are caused by the malarial pigment hemozoin. Spleens 
from days 0 , 8 , 10 , 2 0  and 60 of infection were chosen to portray the different stages 
during infection. Each image is representative o f three to six mice. The size bar 
corresponds to 100  pm.
T: T zone, ex foe: extrafollicular focus.
(b) Flow-cytometric profiles of the live nucleated splenocyte fraction are shown for 
representative time points The antibody-containing B cell is defined as syndecan- 
1^CD19\ All plots are based on a logarithmic scale. Gates were set by comparison with 
the negative controls from part c and by choosing obviously distinct cell populations. 
Therefore, gates often needed to be chosen individually for different samples in the same 
experiment.
(c) The isotype control for the anti-syndecan-1 (PE-labelled rat Ig02a,K) is shown on 
top. The bottom panel shows that syndecan-1 staining could be blocked by prior 
incubation with unlabelled antibody in fivefold excess. As explained in Section 4.2.6 this 
proves that the syndecan-1 staining was specific. These examples are from day 20 of 
infection.
(d) Flow-cytometric and immunohistological analysis 10 days after immunisation with 
alum-precipitated CGG was used as a positive control.
(e) The percentages of the syndecan^CDlO"^ live cells shown in panel b were used to 
calculate total number of antibody-containing B cell numbers after subtraction of the 
percentage o f cells which were positive for the syndecan-1 isotype control. Each bars 
represents the arithmetic mean from 3 to 6  spleens, with up to 15 spleens for time point 
0, as an uninfected control was included in each experiment. Error bars show the SEM.
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Figure 3.11 Details of antibody-containing cells in infection.
(a) Numerous large IgD^ cells (brown) are visible in the red pulp on day 7 of infection. 
Arrowheads point out some of the cells were the grey-black colour indicates that there is 
double staining with anti-syndecan-1 (blue), demonstrating that these are plasmablasts.
(b and c) T cells (CD3^) or antibody-containing cells (syndecan-1^) were stained in blue 
with recirculating naive B cells (IgD^) in brown in nearly consecutive sections from the 
same spleens. Arrows point out the areas o f the T zone occupied by T cells but not by 
antibody-containing cells. Examples are shown for days 12 (a) and 16 (b) of infection. 
The red stain in panel c is from anti-BrdU and is irrelevant in this context.
Each panel is representative of three mice.
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An additional control was included because of the difficulties with this stain. Samples 
were incubated for 30 min with a fivefold excess of unlabelled anti-syndecan-1 before 
addition of the labelled antibody (Fig. 3.10c, lower panel). The assumption is that if the 
antibody binds nonspecifically, even a tenfold excess of the unlabelled antibody would 
not be sufficient to competitively block all potential binding sites. The controls were 
convincingly negative and for high numbers o f antibody-containing cells, the borders of 
the syndecan-1 ^ CD19^ population were very clear (e.g. Fig. 3.10b, dlO). At lower cell 
numbers, the population outlines are harder to define. This may explain why only 2.5- 
fold higher levels o f antibody-containing cells 10 days after CGG immunisation than in 
naive mice (Fig. 3.10e), less of a difference than the extrafollicular foci in the immunised 
mice observed by immunohistology would lead one to expect (Fig. 3.10d).
The flow-cytometric analysis can be used to confirm the kinetics observed by 
immunohistology: Antibody-containing cell (syndecan-1 ^ CD19"^ ) numbers increase 
sharply (Fig. 3.10b) with the peak levels at day 10 of infection about 300-fold higher than 
uninfected levels (p<0.01 comparing day 0 with day 8-12 of infection). After that, levels 
drop quite rapidly, but are still significantly higher than uninfected levels 40 days after 
infection (fourfold higher,/?<0.01). Although the numeric values may be inaccurate in the 
low range, as discussed above, the kinetics o f the plasma cell response determined by 
flow cytometry agree well with the histological results.
3.2.7 Marginal zone B cells
Marginal zone B cells are identified in immunohistology as IgM^IgD' cells at the edge of 
the white pulp, as can be seen in the spleens from uninfected mice (Fig. 3.12a, dO). After 
infection, the marginal zones become depleted of B cells and by day 10, no IgM^ IgD’ 
cells can be detected in the marginal zones (Fig. 3.12a, dlO). The cells may have migrated 
to other parts of the spleen or to other organs or have undergone apoptosis. 
Immunohistology cannot distinguish between IgM^ plasma cells and migrated IgM^
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marginal zone B cells without the additional locational indicator, so it is impossible to 
determine by this method whether the marginal zone B cells are still present in the spleen. 
By day 40, the marginal zones contain IgM^ B cells again (data not shown), but even at 
day 60 they form a less continuous structure than before the infection (Fig. 3.12a, d60). 
The marginal zone B cell population is defined in flow cytometry as CD21^CD23^ (Fig. 
3.12b), which allows it to be identified at the same time as the CD2F"^CD23' naive 
recirculating B cells (Fig. 3.5b). It is easy to obscure the typical CD21 staining pattern 
during compensation in flow cytometry, so special care was taken to ensure that the 
naive control was comparable between experiments. The gate defined for the marginal 
zone B cells of the naive mouse was then used on the plots from the infected mice, as this 
population is so small that it is otherwise not possible to locate the population in the 
enlarged spleens. The marginal zone B cell population exhibits a strong peak at days 5 
and 6 of infection (p<0.01), followed by a gradual decline up to day 16. After that, the 
population regains and maintains a level somewhat higher than the uninfected level up to 
day 40 (p<0.05, 0.01 and 0.05 for days 16, 30 and 40 of infection) (Fig. 3.12e). 
Therefore, marginal zone B cells are still present in the spleen when they are not 
detectable by immunohistology, implying that the cells have migrated to other parts of 
the spleen.
Marginal zone B cells are known to be involved in early immune responses and produce 
plasma cells more quickly than the naïve follicular B cells (Oliver et a l, 1999). As early as 
24 h after LPS stimulation, the differentiation into plasmablasts can be observed by up- 
regulation of syndecan-1 and increase in cell size (Martin et a l, 2001). The doubling in 
marginal zone B cells on days 5 and 6  and the rapid development o f plasma cells in the 
spleen following P. c. chabaudi infection suggest that marginal zone B cells may be 
differentiating into plasmablasts. Therefore, the cell size of the marginal zone B cells was 
analysed by forward scatter in spleens from days 0 and 3-7 of infection (representative 
examples in Fig. 3.13 and Table 3.2). Attempts to determine the syndecan-1^ proportion
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Figure 3.12 .Marginal zone B cells during P. c. chabaudi infection.
(a) Marginal zone B cells are defined immunohistologically by their presence in the 
marginal zones along with being positive for IgM (blue) and negative for IgD ( brown) 
Arrows point to the marginal zone B cells, arrowheads point out the location of the 
marginal zone when no marginal zone B cells are visible there. On day 10, the white pulp 
structure is so poorly defined that it was not possible to say exactly where the marginal 
zone lies.
Dark spots at the late time points are caused by the malarial pigment hemozoin. Spleens 
from days 0 , 8 , 10 , 2 0  and 60 of infection were chosen to portray the different stages 
during infection. Each image is representative of three to six mice. The size bar 
corresponds to 100  pm.
MZ: marginal zone B cells.
(b) Flow-cytometric profiles of the live nucleated splenocyte fraction are shown for 
representative time points The marginal zone B cell population which corresponds to the 
IgM'^IgD' cells in part a is defined as CD21‘"^CD23'. All plots are based on a logarithmic 
scale. Gates were set by comparison with the isotype control staining and in relation to 
the naive recirculating B cell gate shown in Fig. 4.5b. The same gate was used for all 
samples in each experiment.
(c) Isotype controls for the anti-CD21 (FITC-labelled rat IgG2b,K) and anti-CD23 (PE- 
labelled rat IgG2a, k )  were used as negative controls.Representative examples from day 
2 0  o f infection are shown.
(d) Flow-cytometric and immunohistological analysis 10 days after immunisation with 
alum-precipitated CGG was used as a positive control.
(e) The percentages of the CD2T^CD23' live cells shown in panel b were used to calculate 
total number of marginal zone B cell numbers after subtraction of the percentage of cells 
which were positive for the CD21 isotype control. Each bar represents the arithmetic 
mean from 3 to 6  spleens, with up to 15 spleens for time point 0, as an uninfected control 
was included in each experiment. Error bars show the SEM.
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Figure 3.13 Examples of plasmablasts in the marginal zone B cell population during P. c.
chabaudi infection.
The live marginal zone B cell population is depicted in representative dot plots on the left 
for days 0 and 3-7 of infection. The cells in the marginal zone B cell gates were then 
further analysed for cell size by forward scatter in the histograms on the right. The 
marked region contains marginal zone B cells of plasmablast size and its percentage is 
given in the comer. The results for all mice are summarised in Table 3.2.
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Table 3.2 Numbers o f plasmablast-sized cells in the marginal zone population
Day of infection Percentage of large cells in the 
marginal zone region* )^
0 3.19 ±0.40
3 3.54 ±0.23
4 14.00 ±0.96
5 12.17 ±0.34
6 17.28 ±1.59
7 15.41 ±3.59
a) The marginal zone region and the region defining plasmablast-sized cells are shown in 
Fig. 3.13.
b) The geometric mean and SEM from three mice are shown for each time point, except 
for day 6  where six mice were used.
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of the marginal zone B cells were unsuccessful, but the size measurements give clear 
results with the percentage of large cells in the marginal zone B cell population increasing 
from day 4 to a peak at day 6/7, where the percentages are more than fivefold higher than 
in uninfected mice. This indicates that a part of the marginal zone B cell population is 
differentiating into plasmablasts early in infection.
3.2.8 Cell death
Previous studies have shown that malarial infection causes large numbers of splenic host 
cells to undergo apoptosis (Helmby et a l, 2000; Sanchez-Torres et a l, 2001). To 
determine whether apoptosis preferentially affects any particular population of B cells, 
CD 19  ^B cells, germinal centre B cells and marginal zone B cells from days 8 , 9 and 10 of 
infection were studied. These time points were thought most likely to exhibit apoptosis, 
as the parasitaemia and splenic disruption are highest during this period. At first, staining 
with annexin V, an early indicator of apoptosis which binds to phosphatidylcholine in 
apoptotic membranes, was attempted. The levels of annexin cells in naive spleens 
were too high, perhaps because the complex marker combinations in staining made the 
staining protocol somewhat lengthy, causing many cells to begin the process of apoptosis 
in vitro. Therefore, a later indicator apoptosis was chosen, 7-aminoactinomycin D (7- 
AAD), a dye which passes through the leaky membranes of apoptotic cells to bind to 
DNA and whose fluorescence can be detected with the FL3 detector on the 
FACScalibur® (Fig. 3.14). It is customary to use propidium iodide as an indicator of 
necrosis in parallel with 7-AAD to show that cells are truly apoptotic and have not just 
been killed by the staining procedure (Fig. 3.14). Inconveniently, propidium iodide is 
registered by two of the four fluorescence detectors on the FACScalibur®, thereby 
limiting the number of fluorochromes that can be used to define the B cell populations. 
These channel limitations meant that the marginal zone B cells could not be tested for 
propidium iodide staining and neither apoptosis nor necrosis o f antibody-containing cells 
could be measured.
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Figure 3.14 Examples of cell death around the peak of P, c. chabaudi infection.
(a) The total B cell population (CD 19'*') is shown in the top row. The bottom row shows 
the 7-AAD^ and propidium iodide^ cells in the gate defined in the top row.
(b) On the top, the germinal centre B cell population is defined as either GL7^CD19^ (for 
7-AAD staining) or GL7'*’ (for propidium iodide staining). The bottom row shows the 
7-AAD'*' and propidium iodide'*' cells in the gate defined in the top row.
(c) The marginal zone B cells (CD21^CD23‘) were identified in the top row. This 
population was then analysed for 7-AAD staining in the bottom row. The marginal zone 
B cell markers could not be used in combination with propidium iodide, as the latter 
prevents use of either the second or third laser channels on the FACScalibur.
The complete nucleated splenocyte fraction was used for these analyses, as the apoptotic 
cells might otherwise be excluded with the dead cells. Forward scatter is on a linear scale. 
All fluorescence intensities are on a logarithmic scale.
116
7-AAD
(a) Total B cells
Propidium iodide
i i
CD19
FSC ►
7-AAD
►CD19
(b) Germinal centre B cells
CD19
GL7
7-AAD d8
r z 7
do
GL7
(c) Marginal zone B cells
CD21
CD23
7-AAD
►CD21
PI +
7
d8
CD19
FSC
\
GL7
PI
\
GL7
NOT POSSIBLE
Although the total number of apoptotic C D 19\ germinal centre and marginal zone B cells 
increases up to 5-fold, 23.5-fold and 2.3-fold, respectively, by day 8 or 9 of infection (Table 
3.3), the apoptotic percentage of each population remains roughly similar for the CD 19^ cells 
and drops for the germinal centre and marginal zone B cells (5.5-fold and 2.7-fold, 
respectively). This suggests that the increase in absolute apoptotic B cell numbers is entirely 
explained by the size increase in these populations during infection (see Fig. 3.3).
Examination of the hematoxylin and eosin-stained sections from days 0. 8 , 10, 12 and 14 of 
infection supports this idea. Apoptotic nuclei can be recognised by their condensed chromatin, 
but increased clusters of such cells were only observed in the germinal centres, where 
apoptosis is an integral part o f affinity-based B cell selection (Fig. 3.15).
Table 3.3. Levels of cell death in splenic B cells at the peak of P. c. chabaudi infection
Day CD19^
%
B cells
Total no. 
of cells
X 10^
Germinal c
%
entre B cells
Total no. 
of cells 
xlO^
Marginal z
%
one B cells
Total no. 
of cells 
xlO^
0 10.2 ±1.5 0.4 ± 0.09 24.4 ± 6 .4 0 .2  ± 0.08 10.7 ± 1.8 8.0 ±3 .5
8 7.7 ± 0.06 1.4 ±0.36 3.1 ±0 .9 3.3 ±0.86 4.0 ± 0.3 18±  1.3
9 8.7 ± 5 .0 2.0 ±0.35 4.4 ± 2.5 4.7 ±0.61 5.4 ±3.1 4.5 ± 0.5
10 14.1 ± 0 .9 1.7 ±0.29 5.6 ± 1.5 3.5 ± 0.24 6 .6  ± 0.8 2.6 ± 0.4
a) Each data set represents the arithmetic mean and standard error from a group of three mice.
b) % refers to the percentage of each B cell population which is apoptotic, as determined by 
the nuclear binding reagent 7-AAD.
c) Total numbers of apoptotic cells of this type in the spleen.
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Figure 3.15 Clusters of apoptotic cells in a germinal centre after P. c. chabaudi infection.
A germinal centre is shown in a haematoxylin and eosin (H & E)-stained spleen from day 
10 o f infection. Clusters o f apoptotic cells, identifiable by the condensed chromatin of 
their nuclei, are circled in white. Panel b shows a magnified section from panel a.
RP: red pulp, GC: germinal centre
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Figure 3.16 Summary of the changes in the white pulp during P. c. chabaudi infection.
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3.3 Discussion
Infection of C57BL/6 mice with P. c. chabaudi leads to severe but reversible disruption of 
the splenic white pulp architecture, with transient loss o f the follicular mantle and T zone 
integrity, atypical location o f plasma cells and migration o f marginal zone B cells 
(summarised in Fig. 3.16). These observations extend previous studies on P. chabaudi 
and P. yoelii infections where less specific histological analysis indicated splenic 
disruption and partial lymphocyte depletion.
Kumararatne et a l observed that in P. c. chabaudi (AS) infection of C57BL/6 mice, the 
white pulp was reduced in size and depleted of lymphocytes between days 10 and 11 o f 
infection (Kumararatne et a l,  1987), regaining its normal appearance after day 14 of 
infection. A partial depletion of T cells at the peak of parasitaemia occurred after 
infection of outbred CD-I mice with a more virulent strain o f P. c. chabaudi (AS) 
(Stevenson and Kraal, 1989). Stevenson et a l also noted an enlargement o f the white pulp 
which was also seen for the parasite P. yoelii (reviewed in (Weiss, 1990)). This 
enlargement can probably be accounted for by the presence of the germinal centres. These 
studies did not observe the transient depletion of the follicular mantles, the severity of 
splenic disruption or the completeness of reconstitution. This does not contradict my 
results, as these other groups were not able to assess the hill extent of the changes with 
the less specific histological methods employed and only examined a few early time 
points in infection.
The splenic disruption observed in mouse malaria infection is not just a normal 
consequence of a disease with splenic involvement. There is no parallel in severity in any 
of the varied clinical samples studied by Prof. Ian MacLennan at the University of 
Birminingham (personal communication), which include diseases such as hairy cell 
leukaemia. The one known exception, which is discussed below, is the murine model o f 
visceral leishmaniasis. There is only one published study showing immunohistology in a
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human p. yâ/c/)?arww-infected spleen (Bordessoule a/., 1990) and that only shows that 
the white pulp T cells are present and are mainly of the aP  TCR type. As there is no 
information on the stage of infection and only one spleen was examined, no general 
conclusions for splenic architecture in human malaria can be made from these data.
An unpublished study by Dr. Britta Urban (John Radcliffe Hospital, Oxford, UK) on 13 
spleens from Vietnamese patients with P. falciparum  malaria allows better comparisons. 
Similarities with the mouse model include loss of T cells from the white pulp and 
marginal zone depletion of B cells. The coronas (which correspond to the murine 
follicular mantle) however remained intact, and surprisingly, there were fewer germinal 
centres than in a normal adult. The ratio between the red and white pulp remained 
constant although the spleens almost doubled in weight. It is possible that the rapid red 
pulp expansion due to extramedullary hematopoesis in mice is responsible for some of 
the differences. On the other hand, there was also a lot of variation among the human 
samples, and B cell populations were not analysed in detail (partially because the fixation 
method made it impossible to use some antibodies). In addition, patients may have died 
before the full range of disruption seen in the mouse had a chance to occur. More 
complete analysis of human spleens should be forthcoming from a series o f specimens 
collected in Malawi by Dr. Terri Taylor which includes spleens from patients who died 
of malaria or other causes.
The disturbance of the B and T cell areas does not appear to inhibit either generation of 
germinal centres or the production of antibody-containing cells (plasma cells and 
plasmablasts) in the spleen. This suggests that uninterrupted organisation o f naive 
recirculating cells and T cells into primary B cell follicles and T cell areas is not necessary 
for the generation of germinal centres. This idea is supported by findings that B cells 
could co-localise with the follicular dendritic cell network and develop fully functional 
germinal centres in mice incapable of forming primary splenic B cell follicles (Voigt et a l,  
2000). Spleens from mice which lack organised follicular dendritic cell networks in
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addition to primary B cell follicles do not form germinal centres (Pasparakis et a l, 1996). 
Along with the complete and rapid reconstitution of white pulp structure after 
disappearance of the original insult, this implies that the follicular dendritic cell network 
remains intact during malaria infection. In visceral leishmaniasis on the other hand, which 
resembles malaria in parasite persistence and extent of splenomegaly, germinal centres 
diminished after 4 weeks o f infection in parallel with the destruction of follicular dendritic 
cells (Smelt et a l, 1997). It would be easy to verify the continued presence of these cells 
during malaria infection by immunohistological staining with antibodies specific for 
follicular dendritic cells.
The kinetics of germinal centre appearance after infection are similar to those observed 
after immunisation with classical hapten antigens such as (4-hydroxy-3- 
nitrophenyl)acetyl (NP), where PNA"^ germinal centres are visible within 8 days of 
immunisation (Jacob et a l, 1991a). The lifespan of germinal centres depends on the 
duration of antigen exposure and NP-speciflc germinal centres are present in the spleen 
for about 3 weeks after immunisation (e.g. Liu et a l, 1991). However, germinal centres in 
the spleens of P .c .chabaudi-infQctQd mice can persist for at least 60 days, which is 
reminiscent of the persistence of germinal centres at least 4 months after murine 
mammary tumour virus infection (Luther et a l,  1997). The germinal centres appear to be 
functional, as can be inferred from the large amount of isotype switching during malaria 
infection mentioned in Section 1.4.4 and the clear division of the germinal centres into a 
dark and light zone. Their persistence also speaks for their functionality, as germinal 
centres formed without the possibility of productive T and B cell interactions disintegrate 
about 5 days after formation (Garcia de Vinuesa et a l,  2000).
These results indicate that if B cell memory is impaired in malaria infections, this is not 
due to a deficiency in germinal centre formation or maintenance. It has been shown 
previously that large amounts of soluble antigen can induce apoptosis o f specific B cells 
in germinal centres and thus affect affinity maturation and B cell memory (Pulendran et
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a l, 1995; Shokat and Goodnow, 1995). Since malaria infections generate circulating 
soluble antigen (O'Dea et a l, 1995), this would be an attractive mechanism o f impairing 
the development of B cell memory in malaria. However, there was no evidence o f unduly 
enhanced apoptosis taking place in germinal centres around the peak of infection when 
maximal amounts of circulating antigen would be present.
The lack of increased apoptosis in the whole B cell population during P. c. chabaudi 
infection is supported by previous results in (BALB/cXC57BL/6)F% hybrids or BALB/c 
mice (Favila-Castillo et a l, 1999). Another study using BALB/c mice states that there is 
an increase in apoptotic B cells P. c. chabaudi infection, but they do not take into account 
that the B cell population has also increased in size (Helmby et a l, 2000). Nevertheless, 
they see a larger percentage of apoptotic B cells, which could be accounted for by 
different methodology or the different mouse strain. Sanchez-Torres et a l state that 
increased numbers of apoptotic B cells can be detected in sections by hematoxylin 
staining and TUNEL, but do not report where they saw the cells, which is likely to be the 
germinal centre location observed here (Sanchez-Torres et a l ,  2001). In fact, they only 
show one picture of apoptotic cells taken on day 38 of infection and the encapsulated 
apoptotic cells seen in that image have the typical appearance of the tingible body 
macrophages which are found phagocytosing apoptotic cells in the germinal centres. It 
would be useful to do more detailed analyses with the TUNEL method in both flow 
cytometry and histology.
Plasmablast and plasma cell numbers expand greatly up to the peak of the infection and 
then rapidly disappear. This fits in with a study showing that the spleen has a limited 
capacity to support plasma cells and always reduces their number to the same level, 
irrespective of the size of the original response (Sze et a l, 2000). Most plasma cells 
generated during an immune response are short lived, with only a small proportion of 
long-lived cells remaining in the spleen or migrating to the bone marrow (Slifka et a l, 
1998; Smith et a l, 1996). Apoptotic plasma cells probably account for a large part o f the
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increase in 7-AAD'*’ B cells around the peak of infection and may well cause further 
increases in the period between 10 and 14 days. This could perhaps be analysed with the 
TUNEL method of detecting apoptosis in immunohistology. Further experiments are 
essential to determine the balance between the acute short-lived plasma cells in the spleen 
and the long-lived plasma cells in the bone marrow, as this could provide important 
information on the longevity of the antibody response in malaria.
Normally, plasma cells move from the edges of the T zone through the marginal zone 
bridging channels into the extrafollicular foci of the red pulp (Jacob et a l,  1991a). In the 
P. c, chabaudi infection, large numbers of antibody-containing cells were detected within 
the T zone for 10 days after the peak of infection. In nonspecific histology, this atypical 
location of plasma cells has previously been noted for isolated time points after infection 
with P. berghei, P. yoelii (Turk, 1973) and P. chabaudi adami (Alves et a l,  1996). The T 
zone location of plasma cells in malaria is similar to very early observations in neonatally 
thymectomised mice, where the splenic white pulp develops an area corresponding to the 
T zone, but in place of T cells, most of the cells within are immature plasma cells (Parrott 
e ta l,\9 6 6 ) .
This suggests that plasma cells do not migrate into the red pulp if T cells are absent or 
diminished in number in the periarteriolar region. Stromally produced CCL-13 is thought 
to play a role in plasma cell migration (Hargreaves et a l, 2001), but it is not known 
whether T cells supply further migration signals via other chemokines or direct cellular 
interaction. Studies on migration of activated B cells have shown that the relative levels of 
two chemokines and their receptors can determine cell location (Reif et a l ,  2002). In 
TNFRT^" (p55'^’) mice, antibody-containing cells stained by syndecan-1 also localise to 
the T cell area around the arterioles, rather than the usual location in the outer T zone, 
bridging channels and the red pulp (Tkachuk et a l,  1998). As the TNF signalling 
pathways are quite active in malaria infection and are also linked to chemokine signalling 
(reviewed by (Müller and Lipp, 2003)), members of the TNF family could also play a
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role in the unusual behaviour of the antibody-containing cells in this infection. With the 
many drastic changes in the splenic cell populations, a detailed analysis o f chemokine 
production during malaria infection could lead to very interesting discoveries. There could 
also be important downstream effects, as the signals which cause plasma cells to remain 
in the periarteriolar region could also affect subsequent migration to the bone marrow.
The marginal zone cell populations seem to be strongly affected by P. c. chabaudi 
infection. The disappearance of marginal zone B cells and a decrease o f metallophilic 
macrophages as well as a complete disappearance of the marginal zone macrophages from 
their typical location has been noted before (Stevenson and Kraal, 1989). This partially 
matches the observations in visceral leishmaniasis, where marginal zone macrophages 
disappear and metallophilic macrophages are unaffected (Engwerda et a l, 2002). 
Unfortunately, B cells were not studied in this article. Transient loss of B cells from 
marginal zones is thought to be a normal response to antigen and EPS injection stimulates 
IgD^ blast formation, which was also observed around the peak of malaria infection (Gray 
et a l, 1984; Groeneveld et a l, 1985). A high dose of EPS also causes a decrease of 
metallophilic macrophages in the marginal zone (reviewed in (Kraal, 1992)). However, 
malaria-infected spleens do not exhibit the rapid repopulation of the marginal zone seen 
after injection of non-replicating antigens (Gray et a l, 1984) and this might be due to 
persistent antigen stimulation. The similarity of this response of marginal zone 
populations to that induced by EPS is reminiscent of the elusive „malaria toxin“. There 
have been several attempts to assign an endotoxin-like role to malarial products, most 
recently to the glycophosphatidylinositol-anchoured proteins (e.g. (Schofield et a l, 
2002)).
The GPI-anchoured proteins from the parasite could be stimulating the capability o f 
marginal zone B cells to develop quickly into plasma cells secreting low affinity antibody 
in response to particulate T-independent antigens (Martin et a l,  2001; Oliver et a l, 
1999). This is supported by the increase in marginal zone B cell numbers on days 5 and 6
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of infection with a sizable fraction of the population of plasmablast size. Due to the fact 
that B cell-deficient mice show impaired clearance of parasites after the peak of infection, 
it has been assumed that the role of B cells in malaria infection is limited to the later 
chronic stage (von der Weid et a l, 1996). Therefore, it would be interesting to see 
whether early phases of malaria infection are altered in a mouse lacking marginal zone B 
cells, such as the Pyk-2-deficient mouse (Guinamard et a l,  2000). This could also be 
important in human malaria infections, as the heightened susceptibility o f young children 
is in part blamed on an immature immune system and the marginal zone takes 1-2  years 
to develop in infants (reviewed in (Martin and Kearney, 2000)).
Obviously, the earliest stages o f the splenic immune response require more detailed 
study. In light of the visceral leishmaniasis study mentioned above (Engwerda et a l, 
2 0 0 2 ), the metallophilic macrophages and marginal zone macrophages should be studied 
in more detail. In addition, the antigen-presenting potential in the spleen seems very 
strong with the increase in CD 11c'*' dendritic cell and F4/80 macrophage numbers. 
Especially the dendritic cells in their role as the most specialised antigen-presenting cell 
need to be studied with more attention to very early events and involvement o f different 
subsets.
In summary, my findings suggest that if  there is a poor memory B cell response in malaria 
infections it is not due to any obvious deficiencies in the follicular or extrafollicular B cell 
pathways. On the contrary, the B cell response is much stronger than that seen in 
classical immunisation experiments. Malaria is known to generate a large polyclonal B cell 
response (Anders, 1986; Langhome et a l, 1985; Rosenberg, 1978) and this could mean 
that most of the B cell response seen during infection may be due to activation o f innate 
immune mechanisms by pattern receptors. Therefore, the next essential step is to study 
how the specific response to a malarial antigen with known protectivity is distributed 
between the splenic B cell compartments and in other organs such as the bone marrow.
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4 MSP-l2i"Specific B cells in a primary infection
4.1 Introduction
This section analyses the primary B cell response to a single malarial antigen, the C- 
terminal portion of the merozoite surface protein-1 (MSP-1).The main question is how 
this specific response compares with the large general B cell response described in the 
previous section and with the specific response observed after immunisation with a non­
replicating antigen. The magnitude and development of the response during primary 
infection with P. c. chabaudi are studied. Merozoite surface protein-1 was chosen for 
study because this protein is expressed during the erythrocytic life cycle o f the parasite 
and is known to elicit protective immune responses. The C-terminal fi*agment of MSP-1 
is very well characterised and was available in the laboratory as a recombinant antigen. In 
addition, it is one o f the main candidates for a malaria vaccine and so a more detailed 
understanding of the immune response against this molecule is important for clinical 
applications.
4.1.1 Structure and processing of the MSP-1 molecule
MSP-1 was first characterised in 1982 (Holder and Freeman, 1982) and has also been 
called the precursor to the major merozoite surface antigen (PMMSA), gpl90, gpl95 or 
merozoite surface antigen-1 (MSA-1). It is a polymorphic glycoprotein which is 
expressed as a precursor protein of 185-250 kDa apparent weight and has been found on 
all investigated species o f Plasmodium (Holder et a l, 1992). Most studies have used the 
P. falciparum  MSP-1 and unless otherwise stated, all sizes refer to this protein. The 
protein is attached to the parasite membrane via a GPI anchor (Heidrich et a l ,  1983). 
Before reaching the parasite membrane, the protein undergoes primary proteolytic 
processing into firagments o f 83, 30, 38 and 42 kDa (referred to as MSP-lgs, M SP-I30 , 
MSP-128 and MSP-142, see Fig. 4.1), which remain associated in a non-covalently bound
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complex (Blackman and Holder, 1992; Blackman a l, 1991). The complex also contains 
the proteins MSP-6  and one MSP-7, which are encoded by separate genes (Pachebat et 
a l,  2001; Trucco et a l,  2001), and remains attached to the parasite membrane via the GPI 
anchor of the MSP-142 fragment.
Expression o f MSP-1 begins at the trophozoite stage and the molecule is found on all 
subsequent stages up to the merozoite. The exact function o f the MSP-1 molecule is still 
unknown, but indirect evidence exists for an involvement in erythrocyte invasion. Shortly 
before reinvasion of erythrocytes, the 42-kDa fragment undergoes essential secondary 
processing by a subtilisin-like protease into the C-terminal, membrane-bound 19-kDa 
fragment (MSP-119) and a non-covalently associated 3 3-kDa fragment (MSP-133) 
(Blackman et a l, 1998). During invasion, all of the MSP-1 fragments except for M SP-119 
are shed as a soluble complex (Blackman et a l, 1994), leaving the 19-kDa fragment as the 
only part o f MSP-1 detected on the ring stages in newly parasitised erythrocytes 
(Blackman et a l, 1990). The C-terminal fragment is functionally conserved between 
distantly related Plasmodium species, indicating that strong evolutionary selection is 
preventing changes in this part of the MSP-1 (O'Donnell et a l,  2000). Structurally, the 
MSP-119 fragment is one of the most conserved portions of the molecule with only two 
sites of polymorphism in P. falciparum  (Jongwutiwes et a l, 1993). It contains 10-12 
conserved cysteine residues which form five or six cysteine bonds (depending on the 
species of Plasmodium) which are responsible for the formation of two contiguous 
epidermal growth factor (EGF)-like domains (Blackman et a l, 1991).
In vitro assays have demonstrated the existence of so-called inhibitory antibodies which 
prevent the secondary processing step and are directed against epitopes in the 19-kDa 
fragment of P. falciparum  MSP-1 (Blackman et a l, 1994). Another group o f antibodies 
called blocking antibodies competitively interferes with the inhibitory antibodies such 
that secondary processing progresses without hindrance if  both antibody types are
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present. Frequently, the epitopes recognised by inhibitory and blocking antibodies are 
similar or spatially close (Blackman et a l,  1994), but some blocking antibodies bind to 
epitopes in the 83-kDa fragment (Guevara Patino et a l,  1997). Due to the tertiary 
structure of MSP-1 protein, the blocking antibodies probably act by steric hindrance at 
both locations. A third class of MSP-1-specific antibodies, the neutral antibodies, exhibit 
neither inhibitory nor blocking function (Holder et a l, 1999). Several monoclonal 
antibodies have been described which inhibit both the cleavage of the 42-kDa fragment 
and erythrocyte invasion in vitro (Blackman et a l, 1994), demonstrating a possible 
causative link between secondary processing of MSP-1 and erythrocyte invasion. 
Antibodies o f all three types have been shown to occur in natural P. falciparum  infections 
(Guevara Patifio et a l, 1997; Nwuba et a l, 2002). Considering the degree of conservation 
in the C-terminal fragment of MSP-1, it as assumed that blocking and inhibitory 
antibodies occur in rodent infection, but this remains to be demonstrated.
In P. c chabaudi, the MSP-1 precursor protein has an apparent mass of 250 kDa in SDS- 
PAGE and a predicted mass of 197 kDa, with the difference being attributed to aberrant 
migation in SDS-PAGE rather than extensive post-translational modification (McKean et 
a l,  1993a). Primary processing results in fragments with apparent masses of 95 kDa, 52 
kDa, 63 or 66  kDa and 45 kDa, with the 95-kDa fragment sometimes splitting further 
into 35 and 52 kDa (O'Dea et a l, 1995). Secondary processing of the 45-kDa fragment 
results in the C-terminal 21-kDa fragment, which corresponds to M SP-119 o f P. 
falciparum, and a 32-kDa fragment. (In this thesis, the term MSP-121 will refer to the P. 
c. chabaudi protein in particular and the term MSP-119 will be used both as a generic term 
when the Plasmodium species is irrelevant and specifically for the P. falciparum  protein.) 
The fragments resulting from proteolytic cleavage of the P. falciparum  and P. c. chabaudi 
MSP-1 molecules are compared in Fig. 4.1 along with the recombinant MSP-1 fragments 
used in this study.
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Figure 4.1 Comparison of the results of MSP-1 processing.
This is a schematic representation of the fragments resulting from primary and secondary 
proteolytic processing of MSP-1 from P. falciparum  (a) and P. chabaudi (b). The 
products of primary processing are shown in white and the products of secondary 
processing in light grey. Molecular weights observed by SDS-PAGE are given for each 
fragment.
(c) The recombinant constructs of P. c. chabaudi MSP-121 used in this thesis are shown 
in dark grey for comparison. (The MBP fusion protein attached to pMCK129 is not 
shown.)
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(a) P. falciparum  MSP-1 (195 kDa)
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(b) P. c. chabaudi (AS) MSP-1 (250 kDa)
35 kDa 52 kDa 6 6  / 63 kDa 39 kDa 45 kDa
32 kDa 21 kDa
(c) Recombinant constructs for P.cxhabaudi MSP-l^^
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4.1.2 Correlation between M SP-lm-specific antibodies and protection
Field studies give contradictory results on the role of MSP-119-specifîc antibodies in 
protection. Protection against infection per se cannot be measured, because it cannot be 
determined whether aparasitaemic individuals were exposed to infection. Therefore, 
protection against morbidity is measured for example by differentiating between 
asymptomatic cases and symptomatic cases with parasitaemias > 5000 / pL. A study in 
an area of seasonal, stable malaria transmission in The Gambia showed that high 
concentrations of MSP-142-specific IgG correlated with reduced malaria morbidity (Riley 
et a l, 1992). Corresponding results were seen for a site in Sierra Leone with perennial 
malaria transmission but not in a seasonally endemic area of The Gambia (Egan et a l, 
1996). The prevalence of MSP-119-specific IgG was higher in children with 
asymptomatic malaria than in children with clinical malaria and was associated with an up 
to 40% reduced risk of clinical malaria. A further study encompassing sera from different 
regions of Africa and Southeast Asia indicates that antibody positivity for MSP-119 alone 
was not associated with protection whereas the antibody levels were, but this data was 
not shown (Conway et a l,  2000).
On the other hand, a study of natural infections in an area of Ghana with perennial 
transmission did not find a link between prevalence or levels of MSP-119-specific 
antibodies and protection (Dodoo et a l, 1999). The contradiction with the previously 
detailed set of studies could have several causes: The studies demonstrating protection 
looked at children of 3-8 years of age, when immunity to malaria is developing, whereas 
Dodoo et a l chose an age group of 3-15 years. It is possible that MSP-119-linked 
protection in the older children is masked by other protective immune responses which 
take longer to develop, such as the variant antigen-specific immune responses. In 
addition, geographically determined host genetic factors may influence which malarial 
antigens are targets of protective immune responses. This could also be a factor 
controlling the ratio between inhibitory and blocking antibodies, which is another issue 
that can obscure the presence of protective MSP-119-specifîc antibodies.
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4.1.3 Effectivitv of immunisation with M SP-l_m
The results from MSP-1 immunisation studies in monkeys present an equally divided 
picture. Aotus monkeys were completely protected from P. falciparum  infection after 
immunisation with antibody-purified MSP-1 (Siddiqui et a l,  1987) and partial to 
complete protection could be induced by immunisation with Baculovirus-Qx^xQSSQà 
MSP-142 (Chang et a l,  1996). In contrast, an &co/f-expressed MSP-119 fusion protein did 
not induce protection in Aotus monkeys (Burghaus et a l, 1996). The most likely 
explanation for these differences is that the first two studies immunised with complete 
Freund’s adjuvant and boosted with incomplete Freund’s adjuvant whereas the third 
study used a milder adjuvant, alum-adsorbed liposomes.
Numerous immunisation studies have been performed in the mouse model with P. yoelii 
MSP-119 and MSP-142.Complete protection from lethal infection or only low levels of 
parasitaemia were seen when the recombinant antigen was administered in complete 
Freund’s adjuvant and then boosted with incomplete Freund’s adjuvant (Daly and Long, 
1995; Hirunpetcharat et a l, 1997; Ling et a l,  1995). Protection of a lesser degree was 
seen with the AF adjuvant formulation, which is acceptable for use in humans (De Souza 
et a l, 1996). The RAS, alum and Titermax adjuvants were as successful as Freund’s 
adjuvant if additional T cell epitopes were supplied by the fusion partner GST 
(glutathione-S-transferase from Schistosoma japonicum) (Daly and Long, 1996). Linkage 
of T cell-activating elements in form of cholera toxin subunit B also improved the 
effectivity o f intranasally administered M SP-119, but the protection was still inferior to 
parenteral administration of antigen in Freund’s adjuvant (Hirunpetcharat et a l,  1998). 
Thus it appears that MSP-119 requires a strong adjuvant and a potent avenue of 
administration to induce protection.
4.1.4 Contribution of different components of the immune svstem to M S P -Im-specific 
protection
It has been suggested that the C-terminal fragment o f MSP-1 has lower immunogenicity 
than the other portions o f the molecule. In blood from residents of a holoendemic area of
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Kenya, peptides from the C-terminal portion of MSP-1 induced proliferative T cell 
responses in only 13.6-36.9% of the samples and the magnitude of these responses was 
low (Udhayakumar et a l, 1995). In the mouse model, it has been shown that the 
structural complexity of MSP-121 causes it to be processed more slowly than the less 
complex N-terminal fragments of MSP-1, leading to lower MSP-121-specific CD4"  ^ T cell 
responses and a strongly reduced capability to supply T cell help to B cells (Quin and 
Langhome, 2001a; Quin et a l,  2001b). A role for T cells is also indicated by the influence 
of the MHC haplotype in mice on the degree of protection, although this has not been 
confirmed in humans (Taylor et a l,  1996; Tian et a l,  1996).
Transfer of MSP-119-specifîc T cells from infected mice into nude mice does not protect 
against challenge infection (Wipasa et a l,  2002a), indicating that T cells do not exert a 
protective effect in the absence of antibody. Passive transfer of MSP-119-specific 
antibodies from immunised mice or of monoclonal antibodies results in partial protection 
against P. yoelii and P. chabaudi infection (Daly and Long, 1995; Spencer Valero et a l, 
1998; Tian et a l, 1996; Hirunpetcharat et a l, 1999; Wipasa et a l, 2002b; Dr. Ching Li 
unpublished data).The level of protection is lower than in the originally immunised mice 
and parasitaemias progress to the lethal stage if the host is B cell deficient or unable to 
supply T cell help for continued antibody production as the original antibody inoculum is 
depleted by binding to the parasites (Hirunpetcharat et a l,  1999; Wipasa et a l,  2002b). 
Antibody transfer experiments have shown that no other antibody specificities other than 
MSP-119 are required for protection as long as the host is immunocompetent and thus 
able to contribute to that response (Wipasa et a l, 2002b). On the other hand, 
immunisation with the 33-kDa product of secondary processing has no protective effect 
(Ahlborg et a l, 2002). Immunisation with the EGFl or EGF2 domains of M SP-119 on 
their own as well as a mixture of the single domains produces inferior results to 
immunisation with the linked EGF domains (Calvo et a l, 1996; Ling et a l,  1995). This 
shows the importance of conformational epitopes which may be a product of both EGF
137
domains or are only correctly folded if the domains are stabilising each other. The 
immunity to MSP-121 does not transfer between the species o f P. yoelii, P. berghei 
ANKA and P. chabaudi adami (Rotman et a l, 1999), which in light of the strong 
conservation of MSP-119 (McKean et a l, 1993a) suggests that only a limited number of B 
cell epitopes are involved in protection.
The poor quality of T cell help and the dependence on strong adjuvants as well as the 
lack of MSP-119-specifîc antibodies in large percentages o f malaria-exposed humans 
suggest that MSP-119 is not very immunogenic. Strong adjuvants such as Freund’s and 
the more protective parenteral administration methods are not acceptable for use in 
humans. The immunisation protocols leading to protection in mice involve up to four 
boosts after the initial immunisation, which would also be impractical for human 
vaccination. A better idea of the type of B cell response elicited by MSP-119 would be 
helpful for understanding the poor immunogenicity of the antigen and could assist in 
improving immunisation protocols.
4.1.5 Aims
The aims of this section are to characterise the splenic B cell response to the 
P. c. chabaudi M SP-I21 fragment for the following aspects:
(i) size of the specific B cell response as compared to a classic immunisation with a non­
replicating antigen,
(ii) distribution of the specific response between the extrafollicular and follicular 
compartments,
(iii) degree of isotype switching in MSP-121-specific B cells.
Together, the results should give an idea of the volume of the MSP-121-specific B cell 
response and its potential to generate long-lived cells.
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4.2 Results
4.2.1 Experimental design
Cryosections from the second series of spleens described in Section 3.2.1 were examined, 
i.e. spleens from days 0 , 7-12, 2 0 , 30 and 60 of infection. B cells specific for MSP-121 
were detected as outlined in Fig. 4.2 by binding of the MSP-121 / MBP fusion protein 
followed by a polyclonal rabbit anti-MBP antibody, a biotin-labelled swine anti-rabbit 
antibody and HRP-labelled streptavidin complex. In order to determine the location of the 
specific B cells, one section on each slide was also stained with anti-IgD antibody. Two 
sections were stained with anti-IgG or anti-IgM to observe the degree of isotype 
switching in MSP-121-specific B cells. The secondary antibodies were AP-labelled 
donkey anti-sheep antibody (for IgD) or sheep anti-rat antibody (for IgG and IgM).
To control for non-MSP-121-specific binding by the MBP fusion partner, the fourth 
section on half o f the slides received MBP as the first reagent rather than the MSP-121 / 
MBP fusion protein. On the other half of the slides, the fourth section was stained with 
MSP-121 / MBP and its revealing agents but not with the isotype-specific reagents to 
ensure that the isotype-specific brown stain was not obscuring any MSP-121-specific 
binding. A panel of additional controls was performed on spleens from day 9 of infection, 
when M SP-l2i-specific binding was strong, and is detailed in Table 4.1.
4.2.2 Identification o f MSP-121-specific B cells
The detection of M SP-l2i-specific B cells with the M SP-I21 / MBP fusion protein was a 
novel approach. The technique was adapted from antibody-based immunohistology. First 
attempts were unsuccessful, with the entire sections staining blue. This background 
staining was attributed to binding of the MBP component to sugar residues and was 
eliminated by adding 10 mM maltose to the TBS buffer (Section 2.25). This 
concentration o f maltose was chosen because it is capable o f eluting MBP-containing 
proteins from amylose resin (Section 2.13).
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Figure 4.2 Experimental design for Section 4.
This figure shows how MSP-121-specific B cells were detected by binding of the MSP- 
I21 / MBP fusion protein to the B cell receptor.
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In addition to the streptavidin and substrate layers common to all o f the 
immunohistological experiments (Section 2.21), this protocol consists of three staining 
layers in the MSP-121 / blue branch and two in the isotype / brown branch. This creates 
many potential sources of false positive and negative results and Table 4.1 shows which 
controls were performed to test these possibilities. Controls 1-6 show that the isotype 
branch neither inhibits nor exaggerates staining in the MSP-121 branch. Cell counts for 
control 6 showed that the numbers of MSP-121-positive B cells detected in the presence 
and absence of the isotype-specific antibodies were comparable (data not shown). 
Controls 1-3 and 7 show that all layers of the MSP-121 branch must be present for B cells 
to be detected in the blue pathway. B cells are also labelled when MBP rather than the 
fusion protein is used as the first step reagent and this is discussed below.
It is necessary to define carefully what represents specific B cell staining. Examples of 
positive cells are marked by squares in the first panel of Fig. 4.3a. Some of the positive 
cells display a blue halo of secreted MSP-121-specific immunoglobulin, which can 
partially cover other cells. Therefore, only cells where both an unstained nucleus and a 
stained ring of cytoplasm were visible were counted. This also prevented inclusion of 
nonspecific substrate clumps. It was also necessary to exclude macrophages which exhibit 
a narrow blue ring caused by specific immunoglobulin bound to the Fc receptor (Fig. 4.3, 
panel a). These cells can be distinguished by the narrowness of the ring and the fact that 
they usually contain dark brown granules inside the blue ring. These granules represent 
either phagocytosed haemozoin or a reaction of incompletely inhibited endegenous 
peroxidases. This precise definition of what constitutes an MSP-121-specific B cell 
probably results in exclusion of some positive cells and is likely to favour plasma cells 
rather than undifferentiated or memory B cells because of the size of the cytoplasm in the 
former.
Two examples of MSP-121 / MBP staining are shown in Fig. 4.3b and c with differing 
magnifications to allow an overview of the location of the specific B cells (Fig. 4.3b) or a
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Figure 4.3 Examples of M SP-I21 / MBP staining.
(a) The squares in the left panel are placed around cells that were counted as positive for 
the blue M SP-l2i-specific stain. Only cells with a clear nucleus and a fully stained 
cytoplasmic ring were counted to avoid confusion with FcR-bound antibody or secreted 
immunoglobulins. The circle in the right panel show macrophages (MO) with a light blue 
stain which were not counted. These were recognised by the dark brown staining in the 
centre o f the blue ring, which is caused by incompletely inhibited endogenous 
peroxidases.
(b) The panels show four consecutive sections of a spleen with an arteriole marked with 
X for orientation. The first three panels were stained with MSP-121 (blue) and IgD, IgG 
or IgM (brown) and the fourth with MBP alone (blue). This overview shows how MSP- 
I21 / MBP^ cells are located in similar locations in consecutive sections.
(c) The panels show four consecutive sections of a spleen. The first three panels were 
stained in blue for MSP-I21 and in brown for IgD, IgG or IgM. Double positive cells are 
brown-black in the second panel. The fourth panel was stained with blue for MBP and 
brown for IgM. This series shows the positive cells at larger magnification and shows an 
example o f the brown / black double-positive cells (second panel) compared with single­
positive cells (first and third panels).
Size bars correspond to 50 pm in panel a and 100 pm in panels b and c.
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more detailed view of the cells (Fig. 4.3c). The four panels represent MSP-121 / MBP 
staining in combination with antibodies against IgD, IgG or IgM and staining with M BP 
as a control. As can be seen in Fig. 4.3b, intensity of blue staining varies and blue-stained 
cells are still seen when one of the four consecutive sections on a slide was stained with 
MBP rather than MSP-121 / MBP. The MBP^ cells were often more weakly stained than 
those stained with the fusion protein in the other three sections (Fig. 4.3b), so faint blue 
stains were not counted in any of the sections. However, no clear cut-off level can be 
defined and there are MBP^ cells which are stained as strongly as the most intensely 
stained MSP-121 / MBP'*’ cells. Therefore, some of the cells detected by MSP-121 / M BP 
will be MBP^ rather than MSP-121  ^ and will inflate the count with false positives. 
Positive cells are often seen in loose foci, which show up in several consecutive sections 
(Fig. 4.3b and c). The MBP'*’ cells showed up in the same areas as the MSP-121 / MBP'*' 
part o f the time (Fig. 4.3b), but there were also many instances where the locations of the 
MBP'*' and M SP-I21 / MBP'*' cells did not correspond (Fig. 4.3c).
Sections were stained simultaneously with the MSP-121 / MBP fusion protein and an 
antibody against IgD, IgG or IgM to determine the isotype specificity o f the MSP-121- 
specific B cells The two colours combine to produce a brown / black stain on cells which 
are double-positive for MSP-121 and the respective isotype. An example can be seen in 
the second panel (MSP-I21 / IgG) of panel 4.3c).
4.2.3 Quantification of antigen-specific B cells
The number of antigen-specific cells is given as the total number counted per section 
(absolute number per section), the number of cells per 100  ocular squares (relative 
number per section) or the extrapolated relative number per spleen. The absolute number 
and the extrapolated relative number per spleen describe the size of the response. The 
relative number per section was calculated to describe densities of antigen-specific cells 
and to allow comparisons with sections with missing portions. The relative number per
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spleen was also extrapolated to allow comparison between the absolute size o f the 
specific B cell response to MSP-121 and CGG.
The calculations for determining the relative number of antigen-specific B cells per spleen 
are described in Fig. 4.4 and this shows how the values in the final column of Table 4.2 
were determined. It is not possible to compute absolute numbers o f antigen-specific cells 
in the spleen, but a rough estimate of relative numbers could be made. This is based on 
the fact that proportion of the spleen occupied by a given compartment is the same in 
both area and volume measurements (Weibel, 1963). By using the splenocyte numbers 
measured in the FACS experiments in Section 4 as a measure of spleen volume, it was 
possible to calculate the proportional number of antigen-specific B cells per spleen. The 
unit cannot be translated into absolute numbers, but the numbers are comparable between 
spleens. Therefore, the proportional numbers of MSP-121-specific B cells were converted 
into a percentage of the proportional number of antigen-specific cells found in a CGG- 
immunised spleen and the results were summarised in the final column of Table 4.2.
4.2.4 Antigen-specific B cell after malaria infection and CGG immunisation 
The relative numbers per section of M SP-I21 / MBP^ cells are shown in Fig. 4.5 and are 
compared with relative numbers of MBP^ cells. The relative numbers o f MSP-121 / 
MBP'*' B cells are highest at day 8 to 9, just before or around the peak of infection, with a 
second peak around day 30. The absolute numbers have matching peaks at the same time 
points (Fig. 4.7b, Table 4.2). As explained in Section 4.2.1, the control staining for M BP 
was only performed on half of the spleens. For the available time points (Fig. 4.5), it can 
be seen that the difference between the MSP-121 / MBP and the MBP stain is largest 
around the two peaks, whereas MBP^ staining was higher than M SP-I21 / MBP"*" staining 
for days 12 and 60 of infection- albeit with large error bars making it possible that the 
numbers are actually equal. Error bars are generally quite large, which is due to the large 
variations in positive cells between spleens from the same day of infection. Therefore,
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Figure 4.4 Calculation of the size of the MSP-121-specific B cell response as a 
proportion of the CGG-specific B cell response.
The proportional number of antigen (Ag)-specific cells per spleen was calculated in the 
same fashion for P. c. chabaudi-infQctQd and CGG-immunised spleens. The number of 
splenocytes per spleen is the average derived from all appropriate spleens used in the 
flow-cytometric experiments in Section 3. By relating numbers of splenocytes from 
treated animals to those from untreated animals via the size factor, the proportion of 
antigen-specific B cells in the whole spleen is extrapolated. The proportional number of 
antigen-specific cells is based on arbitrary units, but allows comparisons between spleens 
o f different sizes. The final result is the percentage of M SP-l2i-specific B cells in infected 
spleens when compared to the number o f CGG-specific B cells after CGG immunisation 
(100%). These values are listed in the final column o f Table 4.2.
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count section area 
(as ocular squares)
Ag-specific B cells /100 squares
X
size factor
Number of 
splenocytes / spleen 
(treated animal)
•  ,
Number of 
splenocytes / spleen 
(untreated animal)
Size factor
Proportional number of 
Ag-specific B cells / spleen
Proportional number of 
MSP-1-specific B cells / spleen
Proportional number of 
CGG-specific B cells / spleen
— % of CGG response in whole spleen
Table 4.2. Antigen-specific B cells after P. c. chabaudi infection or immunisation with 
CGG
Days after 
infection
Ag-specific 
B cells / 
section
Ag-specific B cells / 
100 squares
% of CGG response 
in whole spleen
0 2.4 2.4 1.1
7 39.1 14.5 17.0
8 100.4 3 6 J 50.0
9 73.8 24.6 46.6
10 31.8 8.1 26.2
12 14.7 3.7 13.6
2 0 33.8 10.5 16.3
30 92.2 20.3 31.0
60 2 0 .0 17.5 12.3
CGG 311.1 238.5 1 0 0 .0
a) MSP-1-specific B cells were measured at the stated time points after infection with 10  ^
P. c. chabaudi pRBC. CGG-specific B cell numbers were measured 10 days after 
immunisation with 25 pg alum-precipitated CGG. MSP-1-specific values represent the 
arithmetic means of one to three sections each in three spleens. CGG-specific values 
represent the arithmetic means of one section each from three spleens.
b) These numbers include the false positives demonstrated by MBP-specific staining and 
are adjusted to represent sections of the whole spleen.
c) The size of the section was counted in numbers o f grid squares in the ocular with a 20x 
objective and a 12x ocular magnification and the number of cells related to this area 
measurement.
d) The percentage of MSP-1-specific B cells in a whole infected spleen as compared to 
those in a whole CGG-immunised spleen was calculated as described in Fig. 4.4.
150
Figure 4.5 Comparison of B cells detected with M SP-I21 or MBP.
The number of antigen-specific cells per 100 ocular squares detected by immunohistology 
is shown for different days of infection. The values for MSP-121 / MBP-specific B cells 
represent the arithmetic means from one to three consecutive sections from two to three 
different spleens. The values for MBP-specific B cells represent the arithmetic means 
from single sections from two to three spleens. Error bars show the SEM.
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the most reliable results on MSP-12rspecific B cell numbers were obtained at time points 
corresponding to peaks o f parasitaemia.
The number of MSP-121-specific B cells generated in P. c. chabaudi infection was 
compared with the number o f CGG-specific B cells found 10 days after immunisation 
with CGG with the aid of the calculations described in the previous section (Fig. 4.4). 
The results are shown in Table 4.2. Even at the peak of infection and at the time of 
parasitic recrudescence (day 30), there are at most half as many M SP-l2i-specific B cells 
per section in the infected spleens as CGG-specific B cells in immunised spleens. The 
true percentage is probably even smaller, as the fact that some of the M SP-I21 / MBP'*’ 
cells are actually binding to the MBP fragment was disregarded in these estimates. When 
comparing the number of antigen-specific cells per 100 squares, the MSP-121 / MBP"*” 
cells are more widely spaced than the CGG-specific B cells. This is not surprising, 
considering the increase in size of the spleen during malaria infection.
4.2.6 Extrafollicular versus follicular MSP-121-specific B cell responses
An important aspect of the antigen-specific response is whether any portion of the 
malaria-specific response is found in the germinal centres and can therefore give rise to 
long-lived B cells. The majority of the MSP-121-specific B cell response was found in the 
extrafollicular spaces. In sections from 27 spleens from different stages of infection, only 
a single MSP-121-specific germinal centre was detected in one o f the day 20 spleens (Fig. 
4.6a). However, only three consecutive sections from each spleen were examined, 
meaning that further M SP-l2i-specific germinal centres may be located outside o f this 
plane o f sectioning. The germinal centre is strongly stained with clear cytoplasmic 
staining, which shows that actual cells are stained rather than just immune complexes on 
follicular dendritic cells. The cells are all o f the IgM isotype.
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Figure 4.6 MSP-121- and CGG-specific germinal centres.
(a) Consecutive sections o f a spleen from day 20 of infection with 10  ^ P. c. chabaudi 
pRBC are shown. Spleens were stained with MSP-121 / MBP fusion protein (blue) and 
either IgD, IgG or IgM (brown). In the third panel, cells are positive for both MSP-121 
and IgM, resulting in a brown-black stain. The panels show a large germinal centre and 
some antibody-containing cells located in the surrounding red pulp.
(b) Two different germinal centres are shown from a spleen taken 10 days after CGG 
immunisation with CGG stained in blue and IgG in brown. The top panel shows the 
clearest germinal centre seen in five immunised spleens and the bottom panel shows a less 
clearly defined example.
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In sections from five spleens fi*om CGG-immunised mice, about five CGG-positive 
germinal centres could be detected (examples in Fig. 4.6b), but the staining was much 
weaker than in the MSP-121-specific germinal centre. Of the CGG-positive germinal 
centres, the one with the strongest stain is shown in the upper panel of Fig. 4.5b, whereas 
the others looked more like the bottom panel o f Fig. 4.6b, where it is difficult to judge 
whether the staining represents B cells or or immune complexes. The detection protocol 
for CGG-specific cells does not stain more weakly per se, as plasma cells o f both 
specificities were stained with equal intensity.
4.2.7 Isotvpe distribution of MSP-121-specific B cells
The isotype specificity of MSP-121-specific B cells was determined by double staining 
with the MSP-121 / MBP fusion protein and antibodies against IgD, IgG and IgM. An 
example of cells double positive for MSP-121 and IgG is shown in Fig. 4.3c and for MSP- 
I21 and IgM in Fig. 4.6a. In the later stages of infection, the dark haemozoin granules look 
similar to the brown-black double-positive cells, but the presence of a visible nucleus 
makes it possible to distinguish the B cells. The percentage of MSP-121-specific B cells 
which was positive for each isotype is shown in Fig. 4.7a with the average absolute 
number of MSP-121-specific B cells per section for those days plotted in Fig. 4.7b. 
Percentages on days 0 ,1 1  and 12 could be skewed, as the total mean number of MSP-121 
/ MBP"*” cells on those days was very low (Table 4.2 and data not shown). As can be seen 
by the length of the error bars, there is considerable variation between spleens from the 
same day of infection, but nonetheless, certain trends can be identified.
On day 8 of infection, 33% of the MSP-1-specific B cells are IgD-positive. Double 
positive cells were mainly located outside of the follicular mantles. As the criteria for 
MSP-121-positivity lead to preferential detection of antibody-containing cells (see Section 
4.2.2), it seems likely that these cells form part of the extrafollicular IgD^ plasmablast 
population seen around the peak o f infection (Section 3.2.6). However, the predominant
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Figure 4.7 Isotype distribution among MSP-121-specifîc B cells.
(a) The graph shows the percentage of MSP-121 / MBP^ B cells which were also positive 
for IgD, IgG or IgM at different time points after infection with P. c. chabaudi, as 
detected by immunohistology. Each point represents the arithmetic mean from one to 
three consecutive sections from two to three different spleens. Error bars show the SEM.
(b) The absolute number of MSP-121 / MBP"*" B cells in single splenic sections is shown 
for different days of infection. This panel is important for interpretation of panel a, as it 
gives the percentages a numerical basis. The values represent the arithmetic means from 
single sections from one to three consecutive sections from two to three different spleens. 
Error bars show the SEM.
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isotype of the MSP-121-specific B cells is IgM, with the percentage o f  double-positive 
cells peaking on day 7 and total numbers on day 8 (Fig. 4.7a and data not shown). IgG 
double positive cells are present at the earliest measured time point, day 7, showing that 
isotype switching occurs at an early stage of infection, and represent the dominant 
isotype on d30 (Fig. 4.6a). Their absolute numbers peak on days 8 and 30 of infection, 
coinciding with the peaks in MSP-121-specific cell numbers (data not shown and Fig. 
4.7b).
The percentages for the three measured isotypes add up to close to 100% for days 7, 8 
and 10 of infection, but the sums are lower on days 20 and 30. (All isotypes were not 
measured at other time points). IgA and IgE double positive B cells are unlikely to make 
up the burden of the discrepancies on later days of infection, since they are far less 
common isotypes. A more plausible candidate is Ig02a. The anti-IgG antibody is made 
up of a mixture of four monoclonal antibodies directed against the four IgG subclasses, 
including one against the/g/i-7a allele of IgG2a. However, the C57BL/6 mice possess the 
Ighl-b  allele o f IgG2a also known as IgG2c (Martin et a l, 1998) which is only poorly 
stained by this antibody (data not shown), so that this subclass could well be under­
represented in immunohistology. Another explanation for the discrepancy could be that 
the high proportion of cells which are positive in MBP staining are not actually B cells, 
but perhaps macrophages with a phenotype of different appearance from those in Fig. 2a. 
These cells would obviously not bind to immunoglobulin-specific antibodies. The results 
of this section are summarised in Fig. 4.8.
159
Figure 4.8 Summary of the results from Section 4.
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4.3 Discussion
The MSP-121-specific B cell response forms only a small fraction o f the malaria-induced 
extrafollicular and follicular B cell response described in Section 3. MSP-121-specific B 
cells were quantified as the total number per section, the number in a given area or the 
estimated amount in the whole spleen. Irrespective of the representation of data, the peak 
number of MSP-121-specific B cells was between two- and tenfold lower than the number 
o f CGG-specific B cells seen 10 days after immunisation. In CGG immunisation, there is 
only one antigen eliciting an immune response, whereas the B cell response will be 
directed against different parasitic antigens during malaria infection. In addition, a large 
pool of plasma cells which is not Plasmodium-s^QQifiQ is generated in malaria infection 
(Langhome gf a l, 1985; Rosenberg, 1978). The proportion of the B cell response which 
can be dedicated to any given antigen is homeostatically regulated by competition with B 
cells o f other specificities for survival signals. Since the CGG-specific response develops 
without such competition, a response to a single malarial antigen which is half that size in 
total splenic numbers seems strong.
This contrasts with the evidence listed in Section 4.1.4 which suggested poor 
immunogenicity for MSP-121. Those results dealt mainly with immogenicity for T cells. 
However, M SP-l2i-Specific B cells can also be activated by T cells recognising other 
parts of the MSP-1 molecule, so a poor T cell response to MSP-121 does not 
automatically imply a poor MSP-121-spGcific B cell response. Apart from a 1 -week delay 
in the detectability of MSP-121-specific IgM, the levels of IgG and IgM responses in 
P. c. chabaudi (AS)-infected BALB/c mice are comparable for MSP-121 and other parts of 
the MSP-1 molecule (Quin and Langhome, 2001a), suggesting that the B cell response 
does not exhibit as much variation between different parts of the MSP-1 molecule as the 
T cell response. An immunohistological comparison of the B cell responses to MSP-121 
and one of the N-terminal fragments is essential for answering the question o f the relative
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immunogenicity of MSP-121 for B cells. Particular attention should be paid to spleens 
from the first 2  weeks of infection, when the delayed IgM response to MSP-121 takes 
place. In addition, it would be valuable to compare the B cell response to another malarial 
antigen such as apical membrane antigen (AMA)-l.
The kinetics of the first half of the M SP-l2i-specific response correspond well with the 
kinetics in previously published immunisation studies: The first peak in M SP-I21- 
specific B cells is seen on day 8-9 of infection. Day 8-10 also represents the peak B cell 
response seen in the spleen or draining lymph nodes of NP-CGG-immunised mice 
(Luther e/ a l,  1997; Toellner et a l, 1998) or in the draining lymph nodes after infection 
with mouse mammary tumour virus (Luther et a l, 1997). Immunisation with thymus- 
independent antigens results in an earlier peak at 5 days, because there is no 72-h delay 
for T cell priming (Garcia de Vinuesa et a l,  1999). The timing of the peak in M SP-121- 
specific B cells suggests a predominantly thymus-dependent response which is initiated 
at the beginning of the infection or a thymus-independent response requiring a certain 
threshold of parasite antigen. The immediate induction of a thymus-dependent B cell 
response seems the more probable scenario, since MSP-121 does not contain the kind of 
repetitive epitopes seen in thymus-independent type 2  antigens and thymus-independent 
type 1 antigens require an additional stimulus such as LPS for B cell activation.
The possibility that the GPI anchors might exhibit endotoxin-like activities in malaria 
infection was discussed in Section 3.3 in connection with the unusually large numbers of 
IgD^ plasmablasts in the red pulp. The results in this section show that up to 33% of the 
MSP-121-specific B cells are also IgD^, implying that some o f these plasmablasts form a 
part of the Plasmodium-s^Qcific B cell response. Therefore, the involvement o f a 
thymus-independent portion of the immune response must still be kept under 
consideration. Immunohistological study of earlier time points in the infection might 
reveal an earlier peak of specific B cells.
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Another interesting facet of the kinetics o f the MSP-121-specific B cell response is that 
the first peak takes place before or concurrent with the peak of infection, although the 
antigenic load increases over a period of 9 days and could therefore continue to activate 
naive B cells resulting in a later peak or a plateau. Apparently, the smaller dose of antigen 
at the beginning of infection is sufficient to activate most of the M SP-l2i-specific B cells 
and later activation could be prevented by competition as described earlier.
The second peak of specific B cells at day 30 does not have a parallel in immunisation 
studies. It could be linked to the recrudescence of parasites, which occurs at the same 
time. Alternatively, since this peak contains predominantly IgG^ cells, it is possible that 
germinal centre B cells play a role in the peak. The only germinal centre detected in the 
infected spleens was found at day 2 0  o f infection. It is likely that other MSP-121 germinal 
centres were present but lay outside of the section, since the infected spleens are so large. 
On the present evidence, it is difficult to judge whether the germinal centre response 
against CGG or MSP-121 is stronger, as more CGG^ germinal centres were seen, but these 
were mainly so weakly stained that the staining could be due to immune complexes. On 
the other hand, there was only the one MSP-121-specific germinal centre, but it was large 
and very clearly stained and had 10 more days to develop than the germinal centres 
observed in sections from day 10 after CGG immunisation. Spleens firom day 20 after 
CGG immunisation should be examined to determine for a better comparison. 
Nonetheless, the presence of the germinal centre and the IgG-switched B cells indicate 
that memory generation against MSP-I21 is possible in malaria infection.
Small numbers o f IgG^ antigen-specific B cells are seen on day 7 of infection, increasing 
on day 8 and peaking after a transient drop on day 11. IgG^ B cells appear as early as 2 
days after immunisation (Jacob et a l, 1991a), so the presence o f switched M SP-121- 
specific B cells on day 7 after infection is not unusual. The peak at day 11 also matches 
well with the peak in immunoglobulin heavy chain yl switch transcripts seen on day 10 
after immunisation with NP-CGG (Toellner et a l, 1996) or the peak o f IgG l^ B cells
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seen around day 10 after immunisation with NP-KLH (Smith et a l, 1996). The 
fluctuations before the peak could be due to the problems with the staining method or be 
caused by the splenic disruption at this time.
Overall, several interesting conclusions can be made about the B cell response to MSP-121 
from these data, but the technique used to identify M SP-l2i-specific B cells has a 
number of flaws which need to be addressed before these issues can be studied on more 
detail. One of the problems is the number of cells stained in the MBP control. If  those 
cells are truly B cells which either recognise the MBP component or themselves contain 
carbohydrate residues bound by that portion of the fusion protein, then using a 
recombinant MSP-121 protein which does not contain MBP would eliminate this 
complication. Direct biotinylation of the antigen is sufficient for detection o f CGG- 
specific B cells and would also reduce the cross-reactivity by decreasing the number of 
staining steps. If  the staining seen in the MBP control is due to macrophages rather than 
B cells, which is unlikely as there were hardly any positive cells when no antigen was 
used, then switching from immunohistology to immunofluorescence would avoid the 
problem of incompletely blocked endogenous peroxidases and phosphatases. The colour 
combinations in immunoflourescence would also make it easier to identify double­
positive cells because the difference between yellow and green is clearer than that 
between dark blue and grey-black as well as avoiding confusion with haemozoin granules. 
In summary, although the immunohistological method needs to be refined, this approach 
shows that the MSP-121-specific primary response roughly resembles classical 
immunisation responses in kinetics and isotype switching. The specific response has a 
strong extrafollicular component, but the existence of a germinal centre demonstrates the 
potential for generation of memory B cells and long-lived plasma cells. The persistence of 
MSP-121-specific immunity and the development of specific antibody responses during 
secondary infection will be addressed in Section 6  along with further evidence for the 
persistence of memory B cells and long-lived plasma cells.
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Section 5. Protection against reinfection
5.1 Introduction
The previous two sections have examined the B cell response in a primary response and 
have shown that the potential for long-lived B cell responses exists. Before adressing the 
realisation of this potential in terms of the B cell response during secondary infections, it 
is necessary to establish the degree of protection against reinfection in this malaria model. 
Therefore, this section deals with the protection against parasites upon reinfection with 
the homologous strain after increasing periods of time.
Protection against reinfection has been studied in a variety of ways in rodent malaria 
models, most frequently using a parasite strain which would be lethal to the chosen host 
without intervention. The degree of parasitaemia and mortality o f the initial infection are 
controlled by methods such as drug treatment, cytokine treatment, diet or blood 
transfusions (e.g. (Eling and Jerusalem, 1977; Eling, 1980; Falanga and Pereira da Silva, 
1989; Mohan et a l,  1999)). This gives the host enough time to develop immunity to the 
parasite and makes host survival an unambiguous measure o f protection in challenge 
infections. Protection measured by host survival and decreased peaks o f parasitaemia has 
been shown for example for drug-controlled P. chabaudi (IP-PCl) and P. vinckei 
infections (Cox, 1966; Falanga et a l, 1984). In these studies, mice were reinfected 7 or 30 
days, respectively, after the first infection became undetectable.
There is a very detailed study demonstrating the longevity of protection against lethal P. 
berghei (K173) in outbred Swiss mice over much longer periods (Eling, 1980). Mice were 
treated with subcurative doses of sulfathiazole during the first infection, which kept the 
parasites at subpatent levels while allowing immunity to develop. Mice were challenged 
with the homologous parasite 2 days after the end of dmg treatment. All mice which 
survived the challenge (84% of the initial group) were declared immune and were 
reinfected at later time points. The longer the interval between the primary and
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reinfection episodes, the fewer mice survived, but even after 304-488 days, about 40% of 
the mice survived a challenge infection. This shows that protection in this system is long 
lasting but does decay with time. When non-lethal, self-curing infections - such as P. 
yoelii (17X) in GP mice or P. c. chabaudi (AS) in NIH or CBA/Ca mice - are studied, 
long-lived protection in the form of reduced parasitaemic peaks and diminished duration 
o f parasitaemia can also be seen (Barker, 1971; Jarra and Brown, 1985; Pearson et a l, 
1983) (discussed in more detail in Section 5.3).
These reinfection studies used many different parasite species and strains, mouse strains, 
drug treatments, infection regimens and definitions of protection. In addition, most of 
them will have been performed with uncloned parasite isolates which can contain multiple 
strains o f the parasite. Therefore it is crucial to establish the quality and type of 
protection for the model used in this thesis before asking questions about the longevity of 
B cell responses. If  C57BL/6 mice are infected with P. c. chabaudi (AS) and then 
rechallenged 1-2  months after the primary infection reaches subpatent levels, the 
secondary infection shows a reduced peak and duration (shown e.g. in Taylor et a l,
2001). However, it is unknown how long this partial immunity lasts and whether it is 
maintained by long-lived cells of the immune system, serum antibody or by continued 
effector cell activation by low numbers of persisting parasites.
As discussed above, it has been shown for drug-cured P. berghei infection that protection 
against reinfection (in form of host survival) correlates with parasite persistence (Eling, 
1980). However, when CB6F1 mice were infected with P. c. chabaudi (AS), drug cured in 
the early stages of infection and reinfected 7-8 weeks after parasite elimination, 
parasitaemias are also reduced in the secondary infection (Favila-Castillo et a l, 1999), 
arguing against a role for parasite persistence. It is difficult to compare these studies 
because the models are very different. Nonetheless, the studies demonstrate that parasite
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persistence must be considered when looking at the longevity of protection against 
Plasmodium infection.
Therefore the aims of this chapter are to characterise the P. c. chabaudi model of infection 
in C57BL/6 mice regarding
(i) persistence of parasites
(ii) longevity o f protection in the presence and absence o f parasites 
5.2. Results
5.2.1 Experimental design
The experimental design is outlined in Fig. 5.1. All time points are calculated from the day 
of injection of parasites in the primary infection. To determine how long C57BL/6 mice 
retain P. c. chabaudi parasites, the parasitaemic status o f infected mice was determined 
for up to 9 months after infection, first by thin blood smear and then by subinoculation 
into naïve hosts at monthly intervals. For these experiments, mice were infected with 10  ^
pRBC. After 1-9 months, the mice were bled out under lethal anaesthesia and the blood 
from each mouse was injected into one or two RAG-2-deficient mice. Immunodeficient 
(RAG-2-deficient) mice were used to increase the likelihood of low numbers of 
transferred parasites establishing an infection without interference from the immune 
response if the low initial parasite numbers took a long time to establish a patent 
infection. Thin blood films were taken at intervals of 2-3 days for 2 weeks and the RAG- 
2 -deficient mice were kept under observation for several weeks after that.
A further set of experiments studied the longevity of protection: Two groups of mice 
were infected with 10  ^P. c. chabaudi pRBC while a third age-matched group was kept as 
controls. To distinguish between protective effects based solely on the existence of long- 
lived cells and those due to continued effector cell stimulation by low levels o f replicating 
parasites, parasites were completely eliminated by chloroquine treatment after the 
primary
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Figure 5.1. Experimental design for Section 5.
The top half of the figure shows the three types of infection protocols used in this 
section. The bottom half shows what procedures were performed with these mice after 
waiting for intervals of 2-9 months.
1°: primary infection, 2 °: secondary infection
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infection in one group of mice. Both groups were then infected a second time between 2 
and 9 months later with the same number, species and strain of parasites. At the same 
time, an age-matched naive control group was infected to ensure that none of the observed 
effects were due to an abnormal infection or age-dependent changes in either the immune 
response or susceptibility to parasites.
Thin blood films were taken daily between days 3 and 12 of infection for maximal 
sensitivity during the rise and peak o f parasitaemia and at intervals o f 2-3 days thereafter. 
Protective effects were defined as alterations in parasitaemia in the form of lower 
amplitudes, delayed onset of patency and delayed peaks during the course of infection.
5.2.2 Persistence of parasites
Mice were infected with P. c. chabaudi and the infections were allowed to progress 
normally. After 2-9 months, mice were bled out and the blood was transferred into RAG- 
2-deficient mice. The results are summarised in Table 5.1. Parasites were detectable by 
this method up to 2 months post infection in some but not all o f the mice. From 3 
months onward, no infections developed in the sub-inoculated RAG-2-deficient mice, 
suggesting that no viable parasites were transferred or that their numbers were too small 
to establish an infection. So although parasites persist past the 30-40-day detection limit 
for thin blood films, they are not likely to play an active role in stimulating immune 
responses later than 3 months after infection. Parasite antigen will o f course be displayed 
in immune complexes on follicular dendritic cells as would be the case with any non­
replicating immunogen, but the additional stimuli supplied by a live parasite are absent.
5.2.3 Longevitv of protection
Mice were reinfected after 2.5, 4.5, 6.5, 7 or 9 months. At all time points, protection 
against the parasite could be seen for both reinfected groups, irrespective o f drug 
treatment. Protection manifested itself in the significantly reduced peaks o f parasitaemia 
as compared to the age-matched controls. This reduction is in the range of 100-fold for
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Table 5.1 Persistence of parasites demonstrated by whole blood transfers
Time after 
infection
No. of blood 
donor mice
RAG-2 mice with 
parasites
Persistence of 
parasites
1 month 3 33% YES
2 months 2 50% YES
3 months 2 0% NO
4 months 2 0% NO
5 months 2 0% NO
6 months 3 0% NO
7 months 2 0% NO
8 months 2 0% NO
9 months 2 0% NO
a) The whole blood transfers at 1 to 6  months were performed and evaluated by Emma 
Cadman, NIMR.
b) The blood from each infected mouse was transferred into two RAG-2-deficient mice 
for the 1-6 -month time points and into one mouse for the 7-9 month time points.
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the chloroquine-treated group reinfected after 2.5 months (p=0.0079). whereas the peak 
of parasitaemia is reduced over 10-fold further for the untreated group at this time point 
(p=0.0025). (Fig. 5.2a),. From 4.5 months onwards, these reductions were in the range of 
100-fold for both chloroquine-treated and untreated mice (Figs. 5.2b and c and Fig. 5.3). 
Other measures of protection, namely delayed patency and a delayed peak of 
parasitaemia, were only seen clearly for the untreated 2.5-month-reinfected group. For all 
other reinfected groups, the timing of the peak precedes or matches that of the uninfected 
group, suggesting that infection progresses at the normal rate but is controlled at an earlier 
stage. There is a 1-day delay in patency in the reinfected groups from the 7- and 9-month 
time points, but it is not as definite as the 3-day delay seen for the 2 .5-month untreated 
reinfected group.
Due to circumstances beyond our control, there was an unintentional parasite eradication 
step about 4 and 6  months after the primary infections of the mice showed in Fig. 5.3a 
and b, respectively. All mice had been switched to a new diet, which rapidly terminated 
all current measurable malaria infections. The cause is unknown, but we assume that this 
batch o f food was contaminated with anti-coccidial or antibiotic drugs. Therefore, mice in 
both the chloroquine-treated and the untreated groups were to all intents and purposes 
drug treated late in the infection. This should not have had any effect, as parasites were 
no longer detectable after 3 months after infection (Section 5.2.2) and the reinfections at 7 
and 9 months have comparable results to those at 4.5 and 6.5 months.
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Figure 5.2. Reinfections after 2.5, 4.5 and 6.5 months.
Chloroquine-treated and untreated mice were infected with 10  ^ Plasmodium chabaudi 
chabaudi (AS)-parasitised red blood cells and reinfected 2.5 months (a), 4.5 months (b) or 
6.5 months (c) later while the age-matched controls underwent a primary infection at the 
same time. The parasitaemia was measured by counting in Giemsa-stained thin blood 
films and is displayed logarithmically as the percentage of parasitised red blood cells. 
Geometric means were calculated from five to eight mice for the two reinfected groups 
and from three to five mice in the age-matched control groups. The control mice in panel c 
were not perfectly age matched with the reinfected groups. Error bars represent the 
positive SEM.
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Figure 5.3. Reinfections after 7 and 9 months.
Chloroquine-treated and untreated mice were infected with 10  ^ Plasmodium chabaudi 
chabaudi (AS)-parasitised red blood cells and reinfected 7 months (a) or 9 months (b) 
later while the age-matched controls underwent a primary infection at the same time. The 
parasitaemia was measured by counting in Giemsa-stained thin blood films and is 
displayed logarithmically as the percentage of parasitised red blood cells. Geometric 
means were calculated from three to eight mice per group. Error bars represent the 
positive SEM.
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Figure 5.4. Summary of Section 5.
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5.3 Discussion
The results are summarised in Figure 5.4 and show that a single infection causes 
protective effects against the same strain of parasite for periods up to 9 months. 
Individual observations from other publications match well with these results: 
Reinfection of NIH mice with P. c. chabaudi showed that the peak o f parasitaemia was 
reduced by less than an order of magnitude with a 96-day interval between infections and 
by about 3 orders of magnitude with a 369-day interval (Pearson et a l,  1983). Infection 
of CBA/Ca mice with P. c. chabaudi (AS) also resulted in peaks of parastaemia reduced 
between one and two orders of magnitude upon reinfection after 98 or 332 days (Jarra 
and Brown, 1985). These data confirm the longevity of protective effects and that 
protection may differ in degree depending on the interval after the first infection. 
Differences in the magnitude can be explained by the use o f different mouse strains, 
parasite doses, infection routes and potentially o f animal diet (Gilks et a l,  1989). 
Protection is also seen in at least one other non-lethal species of Plasmodium, as NIH 
mice infected with P. berghei yoelii (now known as P.yoelii yoelii), were also protected 
from reinfection with the same strain (Barker, 1971). When reinfected after 2 months, the 
protection was complete and after 12 and 17 months, peak parasitaemias were reduced 
about fivefold. The lesser reduction in parasitaemia may be due to the greater virulence of 
this species of Plasmodium compared to P. c. chabaudi. It is more difficult to make 
comparisons with the studies on lethal infections mentioned in Section 5.1, as the degree 
of parasitaemia seen in the mice surviving reinfection was normally not reported.
The duration of parasite persistence could also play a role in the different degrees o f 
protection seen between models. Whereas about 50% of mice infected with drug-treated 
P. berghei still had blood-transferable parasites after 126 days and 15% after 186 days
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(Eling, 1980), the experiments described above show that the parasites persist less than 3 
months in the P. c. chabaudi (AS) infection. Although this comparison is quite clear, 
there are limits to the subinoculation method for analysing parasite persistence. Parasites 
may sequester in the tissues and therefore not be accessible to transfer in whole blood. In 
addition, with very low numbers o f parasites, uneven distribution of parasites according 
to Poisson distribution statistics and poor parasite viability in the inoculum may prevent 
transfer of any infectious parasites. Regarding the Poisson distributions, unpublished data 
by Emma Cadman (NIMR, London) shows that when the inoculum size is reduced to 
100 parasites or less, not all mice are infected. Therefore, a more sensitive method, such 
as detection of parasite RNA in tissues or peripheral blood by real-time polymerase chain 
reaction (PGR) is required to definitively determine the duration o f parasite persistence. 
The importance o f subpatent levels of parasites can clearly by seen by comparing the 
drug-treated and untreated groups reinfected after 2.5 months. The untreated group, 
which would have had subpatent parasites up to the time of reinfection (or at least a time 
point later than the 30-day termination induced by chloroquine), experienced an 
additional level of protection, manifesting as a tenfold lower peak of parasitaemia. Once 
all parasites from the primary infection have been eliminated, it does not appear to make 
any difference whether mice had been drug-cured or not, since the courses o f parasitaemia 
were practically identical for treated and untreated mice from 4.5 months onwards. 
Therefore the presence o f parasites must be the deciding factor for the difference between 
the untreated and drug-treated reinfections at 2.5 months.
The mechanisms responsible for controlling infection in the absence of parasites fi"om a 
previous infection are based on long-lived lymphocytes. Long-lived plasma cells produce 
parasite-specific antibodies, which can lead to elimination o f the parasites and can also 
target the parasites for rapid phagocytosis and antigen processing and presentation. Long-
181
lived memory B and T cells with parasite specificity are present in higher frequencies 
than naïve parasite-specific B and T cells. Along with their lower activation threshold and 
high proliferation capacity, this results in faster production o f the lymphocyte numbers 
necessary for controlling the infection. In the mice still harbouring parasites from the 
previous infection, these resting long-lived cells will be supplemented by short-lived 
effector cells, such as Thl, Th2 and short-lived plasma cells, which have been activated 
by the parasites from the primary infection. These cells can respond to the parasites from 
the second inoculum immediately and can aid the long-lived cells by directing the immune 
response and supplying more partners for the B and T cell interactions. Higher levels of 
plasma antibody may also play a role in keeping the secondary parasitaemia lower. 
Although the exact cells involved in reducing the parasitaemia in a secondary infection in 
the presence of pre-existing parasites cannot be identified by the parasitological approach 
used in these experiments, it is very likely that an interaction between activated effector 
cells and long-lived lymphocytes is the central mechanism.
This mouse model is comparable with human malaria in that a single infection is not 
sufficient to generate sterile immunity against reinfection. Beyond that, it is difficult to 
compare the degree o f protection between the mouse and human systems, because 
different parameters are measured in each case. The experiments in this section were 
looking for protection against the parasite whereas human studies tend to evaluate 
protection against disease. As discussed in Section 1, levels of parasitaemia and disease 
often do not correlate. As mice, especially those of the C57BL/6 strain, do not experience 
severe disease symptoms and it is not possible to document the infection and 
parasitaemic history of humans in sufficient detail, a direct comparison is not possible. 
Another important difference is that the mice were infected with the same strain of 
parasite, whereas field studies in humans indicate that new episodes o f symptomatic
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malaria are usually caused by a different strain o f parasite (Bull et a l, 1999; Eisen et a l,
2002). In addition, antigenic variation is thought to play a major role in susceptibility to 
reinfection (Bull et a l, 1998; Marsh et a l,  1989). P. c. chabaudi does undergo antigenic 
variation (del Portillo et a l,  2001; McLean et a l, 1982), but it is still unknown how 
important this is in immune evasion and the antigenic variation is unlikely to play a large 
role in these experiments due to the design of the infection (Section 2.4). An additional 
difference could lie in the duration of exposure to parasite during the acute infection stage. 
Chloroquine treatment o f P. c. chabaudi-mÎQQXQà mice at different time points of infection 
showed that the generation and degree of immunity depend on the duration o f the 
infection (Favila-Castillo et a l,  1999). If  this is the case in human malaria as well, then the 
tendency to treat fever immediately with anti-malarial drugs immediately could prolong 
the time it takes for immunity to develop.
In summary, the experiments from this chapter show clearly that the mouse immune 
system is capable of partial protection against reinfection with P. c. chabaudi (AS), but 
they cannot give any indication of whether B cells are involved in the protective effects. 
The role o f B cells in the immune response in relation to the presence or absence of 
parasites will be addressed in more detail in the following section.
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Section 6 Development of the antibody response 
to merozoite surface protein-1
6.1 Introduction
6.1.1 Prevalences and levels o f MSP-1 m-specific antibodies in human infections
This section shows the development of the IgG response to MSP-121 in relationship to 
the parasitic status of the host. Plasma cell longevity is studied here via the persistence of 
antibodies after a primary infection and the presence of memory B cells is assessed by 
comparing antibody level and affinity development during primary and secondary 
infections.
The structure and proteolytic processing of MSP-1 as well as its relevance in protection 
against malaria infection have been discussed in Section 4. This section will review the 
data pertaining to the development of anti-M SP-l2i-specific antibody responses.
Field studies which measured IgG levels against MSP-119 in humans from malaria- 
endemic areas offer important insights into the quality of this particular antibody 
response. It has been shown for various conditions of endemicity that the prevalence o f 
these antibodies as well as their levels drop after termination o f exposure: In an area of 
seasonal malaria transmission in The Gambia, prevalences o f IgG antibodies to P. 
falciparum  MSP-119 or MSP-142 o f 25-50% have been measured outside of the 
transmission season (Egan et a l, 1995; Riley et a l, 1992). However, even under 
conditions of moderate perennial exposure to malaria, prevalences between 30% and 72% 
were measured in Ghana (Dodoo et a l, 1999; Riley et a l, 2000). The highest prevalences 
of MSP-119-specific antibody, namely 82% and 100%, were measured in two areas of 
perennial transmission in Papua New Guinea (O'Donnell et a l,  2001). It is particularly 
striking that antibodies against MSP-119 were found in 61%-73% of individuals with 
clinical malaria and only in 11-14% of individuals without clinical malaria in any given
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transmission season in a 4-year longitudinal study in an area of unstable malaria 
transmission in the Sudan although 96% of the cohort experienced clinical malaria during 
the observation period (Cavanagh gr <7/., 1998). As discussed previously in Section 1.5.4, 
MSP-1-specific antibody levels can drop rapidly when exposure to the parasite ceases, 
due to the end of the transmission season or departure from the endemic area (Cavanagh 
et a l, 1998; Soares et a l, 1999). However, this fluctuation in antibody levels may only be 
restricted to children (Taylor et a l,  1996).
6.1.2 Evaluation of the presence of long-lived and memorv B cells
This rapid decay of antibody levels suggests that the MSP-119-specific antibody 
response is generated mainly by short-lived plasma cells. As stated in Section 1.4.5, the 
antibody response to MSP-119 has been seen in some cases to be predominantly o f the 
IgGl or JgG3 isotype. The serum half lives of 21-23 days and 8 days, respectively, for 
these isotypes explains why antibody levels (and thereby prevalence) must drop rapidly 
once the antigenic stimulus for the generation of short-lived plasma cells is reduced. 
However, the drops in antibody levels measured in field studies were only trends and it is 
impossible to link antibody levels to exact infection histories. Therefore, a more detailed 
analysis of the development of MSP-121-specific antibody levels in dependence on the 
recency of infection must be performed in the animal model. By setting an endpoint to 
the exposure to live parasites, it is possible to use serum antibody levels as a readout for 
either plasma cell longevity (or continued generation o f short-lived plasma cells via 
antigen complexes on follicular dendritic cells).
The importance of MSP-119 antibodies in protection against clinical malaria was 
discussed in Section 4.1. However, pre-existing antibodies generated by long-lived plasma 
cells may not be enough to control the numbers of parasites released from the liver after 
hepatic schizogony, since MSP-119 is not expressed on accessible parasites before 
initiation of the erythrocytic stage of the parasite’s life cycle. Therefore, it is necessary to
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analyse the memory B cell response as well as the long-lived plasma cell response for 
M SP-121. One way to do this is to compare the magnitude and speed of the primary and 
secondary antibody responses as detailed in Section 1. A further test for B cell memory 
which has been used in establishing rubella or toxoplasma infection history as well as 
determining the efficacy of vaccination with meningitis or Haemophilus influenzae 
polysaccharide conjugates is the measurement of antibody affinities (Bottiger and Jensen, 
1997; Goldblatt et a l,  1999; Goldblatt et a l, 1998; Jenum et a l ,  1997).
6.1.3 Aims
The IgG response to malarial antigens, especially to P. c. chabaudi M SP-I21, is to be 
studied to address the following issues:
(i) Determination of plasma cell longevity for MSP-121 and total parasite antigen
(ii) Assessment of the generation of MSP-121-specific memory B cells
(iii) Evaluation of the role of parasite persistence in the development of M SP-l2i-specific 
long-lived plasma cells and memory B cells
6.2 Results
6.2.1 Experimental design
The basic design for the experiments in this section is outlined in Fig. 6.1. Mice were 
infected with 10  ^P. c. c/zûrèflw<7/'-parasitised red blood cells and then either allowed to self 
cure or were treated with chloroquine 1 month post infection to eliminate parasites. 
Plasma samples were taken at monthly to bimonthly intervals after the primary infection. 
The mice were reinfected 2.5 months, 4.5 months or 6.5 months after the first infection at 
the same time as an age-matched control group underwent a primary infection (as 
described in Section 5.1 and Fig. 5.1). Plasma samples were taken at weekly intervals 
during the primary and secondary infections.
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Figure 6.1 Experimental design for Section 6.
The three groups listed at the top correspond to the groups detailed in Fig. 5.1. Sera taken 
1 month after the primary infection and at roughly bimonthly intervals thereafter were 
used to determine how M SP-l2i-specific IgG levels and affinity develop with increasing 
distance to the infection. Sera taken weekly during secondary infections were used to 
compare the M SP-Grspecific antibody response with that o f a primary infection in age- 
matched controls.
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The plasma samples taken after the primary infection were used to assess the longevity 
of the malaria-specific antibody response by measuring the levels of IgG recognising 
M SP-I21 or a crude malarial extract. The affinity of MSP-121-specific IgG antibodies was 
also determined for these samples. Affinities against the crude malarial extract were not 
measured, because the antigen mix is too heterogeneous. To study whether the secondary 
antibody response to MSP-1 was affected by the interval between primary and 
secondary infection, the levels and affinities of MSP-121-specific IgG were determined in 
reinfections initiated after 2.5,4.5 or 6.5 months.
6 .2 .2  IgG levels against MSP-121 and crude malarial extract after primarv infection 
The relative amounts of IgG specific for either crude malarial extract or P/c/i/a-purified 
recombinant MSP-121 were determined by ELISA, as described in Sections 2.29 and 2.30. 
Crude malarial extract was prepared from P. c. chabaudi parasites according to the 
protocol in Section 2.7 and is a mixture of parasite antigens present at the late 
trophozoite stage, including MSP-1. Plasma was collected from groups o f four to eight 
mice at 1, 2.5, 4.5 or 6.5 months after an untreated primary infection or at 2.5, 4.5 and 6.5 
months after a drug-treated primary infection. At 1 month, there is no differentiation 
between chloroquine-treated and untreated mice, as the drug treatment only begins after 
this time point.
Between 1 and 2.5 months after infection, plasma IgG levels specific for crude malarial 
extract or for MSP-121 drop and the reductions are statistically significant for the 
untreated as well as the chloroquine-treated groups: a drop o f 4.4-fold for crude malarial 
extract (p=0.0079 for both the drug-treated and the untreated groups) and 2.3-fold for 
M SP-I21 (p=0.0048) (Fig. 6 .2 ). From 2.5 months on, the levels are similar in untreated 
and chloroquine-treated mice, suggesting that the drug treatment has little effect on the 
later persistence of MSP-121-specific IgG. The slight changes in IgG levels observed 
between 2.5 and 6.5 months are not statistically significant for either antigen.
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Figure 6.2 IgG levels for crude malarial extract and MSP-121 after primary infection.
IgG levels were measured with specificity for crude malarial extract (top panels) or 
recombinant P/c/z/a-expressed MSP-121 (bottom panels). Samples were taken after an 
untreated primary infection (left side) or a chloroquine-treated primary infection (right 
side). All levels are given in arbitrary units calculated by defining the binding by C57BL/6 
hyperimmune plasma to each antigen as 1 U (see Section 2.30). Each symbol represents 
the IgG level in units from an individual mouse and the lines represent the corresponding 
geometric mean. The upper and lower sets of panels are on different scales. Plasma 
samples were analysed for 19 mice (1 month, bottom panels), 2 mice (4.5 months, 
bottom left panel), 4 mice (6.5 months, bottom left panel) or 5 mice (all other time 
points).
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For crude malarial extract, the highest measured IgG amount (at 1 month past infection) is 
0.11 U and the mean for all sera at this time point is 0.07 U, as compared with an IgG 
level of 1 U for hyperimmune serum for the same antigen. The highest MSP-121-specific 
measurement is 0.87 U with a mean of 0.36 U compared with a value of 1 U for the 
hyperimmune serum standard. It is not possible to compare the relative units between 
antigens, but these results do show that the amount of IgG produced after a single 
infection is closer to the amount detected after multiple infections for the MSP-121 
specificity than for crude malarial extract. This implies that B cells directed against the 
ftill spectrum of malarial antigens respond more strongly to repeated boosting than the 
subpopulation of B cells recognising MSP-121.
6.2.3 Changes in MSP-121-specific antibodv levels during reinfection
Three sets o f mice were infected twice with an interval of either 2.5, 4.5 or 6.5 months 
between the primary and secondary infections. Plasma samples were taken before 
reinfection and at weekly intervals for 4 weeks (see Fig. 6.1) and MSP-121-specific IgG 
levels determined by ELISA. Each infection set consisted o f three groups o f mice as 
described in Section 5: untreated mice infected twice, mice which were infected, 
chloroquine treated and then reinfected and age-matched controls undergoing primary 
infection at the same time as the other groups were given the second infections. All 
plasma samples belonging to the three groups of the same infection series were analysed 
simultaneously to maximise comparability. The geometric means for all three infection 
series are summarised in Fig. 6.3. The IgG levels from individual mice and the 
corresponding geometric means are shown in more detail for the reinfected groups in Fig.
6.4 along with the corresponding parasitaemias, as determined in Section 5.
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Figure 6.3 Comparison of MSP-121-specific IgG levels between the three treatment 
groups.
The geometric means of MSP-121-specific IgG levels are shown for mice reinfected at the 
stated time points after an untreated primary infection (a) or after a chloroquine-treated 
infection (b). These two panels represent a summary of Fig. 6.4a-c and d-f, respectively, 
with the inclusion of a primary infection shown in black for comparison. Panel c shows 
IgG levels in primary infections for the age-matched control mice from these three 
experiments. All levels are given in arbitrary units calculated by defining the binding by 
C57BL/6 hyperimmune serum as 1 U. Lines represent the geometric from three to eight 
mice (four to five being the usual number).
193
(a)
(b)
Averages of MSP-12 1 -specific 
IgG levels during reinfection 
of untreated mice
3
{
(DO)
20 4 03 00 10
reinfection afte r 2 .5  m onths 
reinfection  afte r 4 .5  m onths 
reinfection a fter 6 .5  m onths 
prim ary
Days after infection
Averages of M SP-1 2 1 -specific 
IgG levels during reinfection 
of chloroquine-treated mice
re in fe c tio n  a f te r  2 .5  m o n th s  
re in fe c tio n  a f te r  4 .5  m o n th s  
re in fe c tio n  a f te r  6 .5  m o n th s  
p rim a ry  in fec tio n
Days after infection
(c)
I.OO1
s  0 .7 5
g  0 .5 0 -  
OO)
0 .2 5 4
0 .00-
Primary infections (controls)
10 20  30
Days after infection
40
Figure 6.4 Development of M SP-l2 i-specific IgG levels during reinfection.
The left page of the figure shows the parasitaemias (taken from Section 5) of the courses 
o f infection whose IgG levels are shown on the right-hand page.
The levels o f IgG specific for recombinant P/c/n'a-expressed MSP-121 are shown for mice 
reinfected 2.5 months (a and d), 4.5 months (b and e) or 6.5 months (a and e) after a 
primary infection without (a-c) or with chloroquine treatment (d-f). All levels are given in 
arbitrary units calculated by defining the binding by C57BL/6 hyperimmune serum as 1 
U. Each symbol represents the plasma level from an individual mouse (measured in 
duplicate) and the lines represent the geometric mean of all plasma levels at that time 
point. Panel b has a break in the y axis to accommodate the highest value. Lines represent 
the geometric from four to eight mice (four to five being the usual number).
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The primary and secondary infections differ clearly in the rapidity and magnitude of the 
MSP-12rspecific IgG response (Fig. 6.3). In the age-matched control mice undergoing 
primary infection, IgG levels remained low for the first 3 weeks of infection and then rose 
sharply in the 4* week. The variation in antibody levels at week 4 is not significant 
(p>0.05). In all o f the secondary infections, the M SP-l2i-specific IgG levels rose more 
rapidly than in the primary infection and IgG levels are significantly higher at all 
secondary infection time points (p<0.05) except for week 4 of the 2.5-month drug-treated 
and untreated reinfected groups and for week 4 o f the 6 .5-month reinfected drug-treated 
group (Fig. 6.3a, b and c).
There is a clear difference in the development of the MSP-121 IgG response between 
drug-treated and untreated mice at 2.5 months but not at either o f the later time points 
(Fig. 6.4). The specific IgG levels in the 2.5 month untreated group are significantly lower 
than those in the drug-treated groups at weeks 2 and 3 of infection (p=0.0159 and 0.0079, 
respectively). At 4.5 and 6.5 months there are no statistically significant differences 
between the drug-treated and untreated groups (except for week 1 at 6.5 months with 
/?=0.0159). There are also no statistically significant differences between the 4.5- or 6.5- 
month reinfected groups (apart from the 1 week value) or between the 4.5- or 6.5-month 
drug-treated groups (p>0.05 for all time points). However, the specific IgG levels in the
2.5-month reinfected group are significantly different from those measured at 4.5 and 6.5 
months for the first 3 weeks or weeks 1 and 4, respectively. In summary, IgG levels 
develop similarly in all reinfections except in untreated mice reinfected 2.5 months after 
the primary infection. As discussed in Section 5, this is the only reinfection regimen in 
the study when parasites from the primary infection would still be present. Comparison 
with the parastaemias shown in Fig. 6.4 shows that the 2.5-month untreated group was 
also displays a course of parasitaemia deviating from that observed in the other
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reinfection groups. This suggests that the presence of parasites at the time of reinfection 
affects both the degree of protection and the development of MSP-121-specific IgG.
6.2.4 Determination o f antibodv affinity
The relative affinity of the MSP-1-specific IgG antibodies was measured by chaotropic 
ion-induced dissociation of antibody binding in ELISA (described in Section 2.31) and 
Fig. 6.5 depicts how the data is interpreted. The top image shows an example comparing 
antibody affinities between different days of infection, with the percentage of bound 
antibodies displayed in relationship to the concentration of sodium thiocyanate. It is very 
difficult to interpret the data in this format, so the data was converted into other more 
easily comparable measures. A standard measure in this type o f assay is the affinity 
index, which is the salt concentration required to reduce the amount o f binding antibody 
by 50%. The decadic logarithm of the percentage of bound antibody is plotted against the 
salt concentration. A curve is fitted by linear regression. If  the fitted curve has a 
correlation coefficient (R^) greater than 0 .8 , the affinity index is measured as shown in 
Fig. 6.5.
Although the affinity index is a useful and comparable way o f summarising information 
from chaotopic ion elution assays, it is not a satisfactory measure on its own. M any 
unrelated changes may happen in a polyclonal mixture of antibodies and a given affinity 
index can represent numerous different combinations of antibody affinities, especially as 
changes within the high-affinity populations do not affect the affinity index. Therefore, 
affinity distribution profiles were generated according to a method modified from 
(Ferreira and Katzin, 1995) as delineated in Fig. 6.5. The distribution profiles show how 
much antibody is dissociated by each 0.5-molar increase in salt concentration and thereby 
allow shifts in low or high affinity antibody populations to be recognised.
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Figure 6.5 Calculation of the affinity index and affinity distribution.
The top image is a typical graph of the arithmetically meaned antibody affinities at 
different time points of an infection.
The left-hand branch shows how these values are used to calculate the average affinity 
index (AI), which is the molar concentration of sodium thiocyanate required to reduce the 
OD representing bound antibody to 50%. The affinity curves from duplicate 
measurements of each plasma sample were linearised by plotting the decadic logarithm 
against the molar chaotropic ion concentration. The affinity index (AI) is the 
concentration of sodium thiocyanate corresponding to 1.70, the decadic logarithm of 50. 
Only curves with a correlation coefficient (R^ ) greater than 0.8 were used to calculate the 
average affinity index for each time point. The arithmetic mean of the affinity indices was 
plotted with error bars representing the SEM.
The affinity distribution was calculated by defining the amount of antibody bound in the 
absence of sodium thiocyanate as 1 0 0% and determining the percentage of that amount 
bound at each salt concentration by OD measurement. The percentage of antibody 
dissociated by each 0.5-M increase in salt concentration was calculated, with the value > 
3 M representing the antibody still bound at the highest salt concentration. These values 
were plotted in the affinity distribution graph with each bar representing the arithmetic 
mean from all sera at that time point and salt concentration and error bars representing the 
SEM.
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6.2.5 Affinity indices after primarv infections
The affinity of MSP-121-specific IgG was measured in the sera whose levels were 
determined in Section 6.2.2 (Fig. 6 .6 ). The mean affinity index between 1 and 6.5 months 
after a primary infection was 1.33 M in the untreated group and 1.29 M in the 
chloroquine-treated mice and the indices did not change significantly (p>0.05) during this 
interval. Furthermore, the difference between the affinity indices of chloroquine-treated 
and untreated groups had no statistical significance either (p>0.05). At all times, the 
affinity index was lower than that measured in hyperimmune plasma, whose arithmetic 
mean in the three experiments was 2.21 M. This difference was statistically significant 
until 4.5 months after infection (p< 0.007), but at 6.5 months the difference between the 
primary infected and hyperimmune affinity indices was no longer significant (p= 0.063).
6.2.6 Affinity distribution after primarv infection
The affinity distribution after primary infection (Fig. 6.7a and b) was determined from 
the same set of measurements as the affinity indices calculated in the previous section. In 
all o f the graphs, the increase of salt concentration from 1.5 M to 2 M causes little 
antibody dissociation, suggesting that this concentration step represents a kind of 
boundary between the low and high affinity categories of antibody. (This effect is also 
seen in many of the affinity distributions shown in Figs. 6.9-6.11). For all o f the plasma 
samples taken after primary infection, the amount of antibodies falling into these low and 
high affinity categories is roughly equal, whereas the balance is shifted towards the high 
affinity group in hyperimmune plasma. All sera contain a population of antibodies which 
does not dissociate even at the highest thiocyanate concentration (labelled > 3.0 M in the 
figures). This population represents about 30% of the total MSP-121-specific antibodies 
in hyperimmune plasma but only 10-25% in the plasma samples taken after primary 
infection. Together with the affinity index calculations, this demonstrates clear affinity 
differences between singly and multiply infected mice.
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Figure 6.6 Development of the affinity index after primary infection.
The average affinity indices are shown at different time points after a primary infection 
without or with chloroquine treatment. No chloroquine-treated samples were taken 1 
month after infection, because the drug treatment occurs then. The average affinity indices 
determined for hyperimmune plasma in the three individual experiments are included as 
orange lines. Each bar represents the arithmetic mean from duplicates of four or five mice 
and error bars show the SEM.
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Figure 6.7 Changes in affinity distribution after primary infection.
The affinity distribution of MSP-121-specific IgG is shown for several time points after a 
primary infection without (a) or with drug treatment (b). Each bar represents the 
arithmetic mean from duplicates o f four or five mice and error bars show the SEM.
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The following changes in affinities are shared by the sera taken from untreated (Fig. 6.7a) 
and drug-treated mice (Fig. 6.7b) between 2.5 and 6.5 months after infection: The clearest 
individual change in affinities can be seen between 2.5 and 4.5 months when the lowest 
affinity group shrinks by over 15% in the untreated mice and 35% in the drug-treated 
mice. This set of antibodies appears to dissociate first one and then two concentrations 
steps higher at 4.5 and 6.5 months, respectively. An overall shift towards higher affinity 
can be observed within both the low and high affinity categories with increasing distance 
from the primary infection. At 6.5 months, this culminates in a pattern o f two sets of 
rising affinities interrupted by the 2.0-M value, a pattern also seen in hyperimmune 
plasma. These shifts clearly demonstrate affinity maturation of MSP-121-specific 
antibodies after a primary infection although none was detected by studying the affinity 
index.
There is hardly any difference in the affinity distribution patterns of the respective 
untreated and drug-treated groups at 4.5 and 6.5 months after infection (Fig. 6.7a and b). 
At 2.5 months, the proportion of antibodies in the lowest affinity step is noticeably 
higher in the drug-treated than in the untreated group, but the negative value for 1.0 M 
salt concentration in the drug-treated group indicates that this measurement is at least 
partially distorted. This distortion could be attributed to variations in the degree of 
influence o f drug treatment in individual plasma samples. However, together with the 
affinity indices calculated in Section 6.2.5, the affinity distributions do not support a 
strong role for parasite persistence in the shaping of serum antibody affinities.
6.2.7 Affmitv indices during reinfection
The affinity indices were determined from sera taken at weekly intervals during 
reinfection after 2.5, 4.5 or 6.5 months. The untreated and drug-treated reinfected mice 
were compared with age-matched mice undergoing primary infection (Fig. 6 .8 ). Affinity 
indices are not shown at some time points because the curve fits were too poor for 
measuring these values.
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Figure 6.8 Changes in the affinity index during reinfection.
The average affinity indices are shown during reinfection 2.5 (a), 4.5 (b) or 6.5 months (c) 
after a primary infection without (red) or with chloroquine treatment (blue). The average 
affinity index determined for hyperimmune serum in each experiment is included as an 
orange line. The affinity indices during a primary infection of age-matched controls are 
shown in black. All lines represent arithmetic means from three to five mice and the error 
bars show the SEM.
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No serum samples were tested for day 7 of the primary infection shown in panel a and 
the affinity index could not be calculated for day 7 of the primary infection shown in 
panel b.
The affinity indices in the primary infections (black lines in Fig. 6 .8 ) are consistently 
lower than the affinity index of hyperimmune plasma, generally by a factor of about 
twofold. This difference is statistically significant for the primary infections shown in 
Figs. 6 .8b and c (p=0.0007-0.0198), but was only significant at 3 weeks in Fig. 6 .8a 
(/?<0.05).The affinity index does not change much during the course o f a primary 
infection, apart from the 2 -week time point in the control for the 2 .5-month reinfection 
(Fig. 6 .8a). Since there is no rise at this time point in the other two primary infections 
(Fig. 6 .8b and c), the most probable explanation is experimental error.
For all o f the secondary infections, the affinity indices of the untreated and drug-treated 
groups are very closely matched for the first 2 weeks. In the 2.5- and 6 .5-month 
reinfections, the affinity index in the untreated group continues to the rise, whereas the 
affinity index in the drug-treated group peaks at 2 weeks and then drops again (Figs. 6 .8a 
c). However, the differences betweeen the affinity indices o f the drug-treated and the 
untreated groups are not statistically significant for either the 2.5 or the 6 .5 -month 
reinfections (p=0.8413 or 0.1143, respectively). In addition, in the 4.5-month reinfection, 
the affinity indices of the untreated and drug-treated groups remain well matched through 
to the 4^  ^week, making it questionable whether the affinity index in secondary infection is 
affected by parasite persistence.
The average affinity indices of all reinfected groups except for the 2.5-month drug-treated 
rise over the course of 4 weeks. In the 6.5-month reinfection, which already commences 
with a higher affinity index than the other two reinfections, the level o f hyperimmune 
plasma is already exceeded in the 2"  ^week of infection. However, the difference betweem 
the affinity index of the 6 .5-month reinfection samples and o f hyperimmune plasma is 
not significant (p=0.0798). In general, the data described in this section shows mainly
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trends rather than statistically significant differences. Even the difference bet'ween the 
affinity indices o f the primary and secondary infections is only significant for a few time 
points. As can been seen by the size of the standard error, there is considerable variation 
in the affinity index between individual mice, which is not surprising in a polyclonal 
antibody response. However, in order to ascertain whether any of the observed trends are 
relevant, it would be necessary to repeat these experiments using larger groups of 
samples, more replicates per sample or both.
6.2.8 Affmitv distributions during reinfection
The changes in affinity distribution are shown during reinfection after 2.5 months (Fig. 
6.9), 4.5 months (Fig. 6.10) or 6.5 months (Fig. 6.11) for untreated mice (a), drug-treated 
mice (b) or primary infection in age-matched controls (c). The affinity distribution of 
hyperimmune serum is included in each figure as a comparison. At the bottom of each 
page, the corresponding course of parasitaemia from Section 5 is shown for reference.
In all three groups of untreated reinfected mice, the population of antibodies requiring 
more than 3.0 M salt concentration for dissociation becomes the most prominent group 
within the first 1-2 weeks (Figs. 6.9a, 6.10a and 6.11a). At 2.5 months (Fig. 6.9a), the 
affinity distributions look almost identical for days 0 and 7 o f reinfection and the shift 
into the > 3.0 M affinity category is not seen until day 14. At 4.5 and 6.5 months, (Figs. 
6.10a and 6.1 la) where the peak parasitiaemia is 10-fold higher and occurs 3 days earlier, 
the change in the distribution pattern and the increase in the highest affinity category can 
be observed 1 week earlier. The highest affinity category increases most at 6.5 months, 
where it contains about half of the M SP-l2i-specific antibodies on day 20 of reinfection, 
a higher proportion than that found in hyperimmune plasma. In fact, the size o f the >3.0 
M population in hyperimmune plasma is surpassed in all reinfected groups except the
2.5-month drug-treated mice. It is interesting that the affinity patterns o f all four o f the 
groups reinfected at 4.5 and 6.5 months develop similarly, despite different initial 
distributions at day 0  o f reinfection.
212
Figure 6.9 Changes in affinity distribution during reinfection after 2.5 months.
The affinity distribution of MSP-121-specific IgG is shown for plasma samples taken at 
weekly intervals during reinfection 2.5 months after a primary infection without (a) or 
with drug treatment (b). The affinity distributions during a primary infection of age- 
matched controls are shown for comparison (c) .Each bar represents the arithmetic mean 
from duplicates of four to five mice and error bars show the SEM.
At the bottom of each page, the parasitaemia for this course of infection is shown (taken 
from Fig. 3.2).
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Figure 6.10 Changes in affinity distribution during reinfection after 4.5 months.
The affinity distribution of M SP-121-specific IgG is shown shown for plasma samples 
taken at weekly intervals during reinfection 4.5 months after a primary infection without 
(a) or with drug treatment (b). The affinity distributions during a primary infection of 
age-matched controls are shown for comparison (c). Each bar represents the arithmetic 
mean from duplicates o f four to five mice and error bars show the SEM.
At the bottom of each page, the parasitaemia for this course of infection is shown (taken 
from Fig. 3.2).
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Figure 6.11 Changes in affinity distribution during reinfection after 6.5 months.
The affinity distribution of M SP-l2rspecific IgG is shown shown for plasma samples 
taken at weekly intervals during reinfection 6.5 months after a primary infection without 
(a) or with drug treatment (b). The affinity distributions during a primary infection o f 
age-matched controls are shown for comparison (c). Each bar represents the arithmetic 
mean from duplicates of three to five mice and error bars show the SEM.
At the bottom of each page, the parasitaemia for this course of infection is shown (taken 
from Fig. 3.2).
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The 4.5 and 6.5-month time points of the drug-treated groups (Figs. 6.10b and 6.11b) 
display similar characteristics as their untreated counterparts (Figs. 6.10a and 6.11a), 
namely an increase of the highest affinity category visible from day 7 of infection and a 
higher degree of affinity maturation at 6.5 months than at 4.5 months. In contrast, the 2.5 
month drug-treated group (Fig. 6.9b) differs from its untreated counterpart (Fig. 6.9a) as 
well as from the later reinfections of drug-treated mice (Figs. 6.10b and 6.11b). At days 7 
and 14, the antibody population which is not dissociated by the 3.0 M thiocyanate 
concentration reaches 20 and 25%, respectively, without becoming the predominant 
population. At days 20 and 28 of reinfection, the population shrinks again to less than 
20%. The pattern shows a fairly even distribution of affinities with the second-lowest 
affinity group (1.0 M) favoured slightly over the lowest affinity category when 
comparing with the other time points in drug-treated mice. Since the course of 
parasitaemia is almost identical between the three drug-treated groups, this indicates that 
elimination of parasites 1 month after primary infection affects the affinity distribution in 
temporally close reinfections but not in remote ones.
Surprisingly, there is considerable variation between the control primary infections (Figs. 
6.9c, 6.10c and 6.11c). This can partially be attributed to limitations o f the thiocyanate 
dissociation assay at low IgG levels. This can be seen in the affinity distributions 
calculated for the control plasma samples for the 4.5 month reinfection (Fig. 6.10c) which 
were eightfold more dilute than the other control samples. The inaccuracy o f these 
measurements was reflected by the fact that the correlation coefficients (R^) o f the linear 
regression curves for day 7 were all too low for the affinity index calculations (Section 
6.2.7) and also resulted in the two negative values in the day 7 affinity distribution graph 
in Fig. 6.10c. As the day-7 distribution in Fig. 6.10a is unreliable and those values are 
missing in Fig. 6.9a, it is not worth comparing the affinity distribution in the primary 
infections before day 14.
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The day-14 distribution during the 2.5-month reinfection (Fig. 6.9a) should also be 
ignored and needs to be repeated, as some error must have occurred in that measurement. 
The distribution neither matches the other two affinity distributions at day 14 nor does it 
fit into the further affinity development during the 2.5-month reinfection. In addition, the 
affinity index calculated for this time point was also in contradiction with the rest of the 
primary infection values. Apart from that, all o f the affinity distributions for the primary 
infections are weighted towards the low affinity categories. A slight shift to the right can 
be seen in the 3^  ^ or 4* week in Figs. 6.10c and 6.11c, but this is limited to the low 
affinity categories The >3.0 M category of antibodies remains between 10 and 25%, 
which is much lower than in the secondary infections. However, the affinity distribution 
assays should be repeated for the primary infections at a higher plasma concentration to 
confirm these results.
In summary, antibody affinity does mature slightly during primary and more strongly 
during secondary infection, with the size of the highest affinity population increasing 
with the interval after the primary infection. Drug treatment with chloroquine impairs the 
affinity development at 2.5 months but not at the later time points.
6.3 Discussion
The results from this section are summarised in Fig. 6.12. Briefly, the persistence of 
MSP-121-specific IgG after primary infection even in the absence of live parasites 
indicates that long-lived plasma cells are generated during infection with P. c. chabaudi 
(AS). The clear differentiation o f both antibody levels and affinities into primary and 
secondary antibody response patterns shows that M SP-l2rSpecific memory B cells are 
generated as well. The discussion will focus on the quality of these responses in 
comparison with other infections and immunisations and the influence of drug treatment.
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Figure 6.12 Summary of the results from Section 6.
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The first part o f the discussion will deal with the antibody levels against MSP-121 and 
crude malarial extract after a single infection. Long-lived plasma cells are responsible for 
maintaining serum antibody levels in the absence of continued antigenic stimulation or 
infection. Therefore, the persistence of antibody after the end of the Plasmodium 
infection showed that long-lived plasma cells existed with specificity for both MSP-121 
and antigens present in the crude malarial extract. New plasma cells could be generated by 
activation of B cells recognising antigen presented on the follicular dendritic cells. 
However, it seems unlikely that this process would result in the observed steady level of 
serum antibody without the presence of long-lived plasma cells, since follicular dendritic 
cells gradually enfold the antigenic complexes they present and this would reduce the 
availability of antigen for stimulation of new short-lived plasma cells. Nonetheless, the 
definite proof for long-lived plasma cells - direct detection in the bone marrow - must still 
be performed.
The elimination of parasites did not affect the amount by which antibody levels against 
MSP-121 and crude malarial extract dropped between 1 and 2.5 months after infection. 
This fits in with the theory that long-lived plasma cells are generated early in the germinal 
centre response (Smith et a l, 1997; Tarlinton and Smith, 2000) so that all long-lived 
plasma cells would already have been generated by the time the mice were treated with 
chloroquine, making the size of the pool independent of parasite persistence later than 1 
month. The peak MSP-121-specific antibody levels at 1 month can be mainly attributed 
to short-lived plasma cells, whereas the antibody detected at 2.5 months would be 
produced by the long-lived population.
The drop in IgG levels observed for MSP-121 and crude malarial extract is larger than that 
observed in other immunisation and infection systems. After immunisation with the NP 
hapten, IgG levels drop only 1.5-fold between 20 and 80 days after immunisation
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(Takahashi et a l, 1998). The drop in Plasmdodium-sçQQiüc antibody levels differs even 
more strongly from that observed in B-lymphotrophic gammaherpesvirus infection. The 
virus causes life-long latent infections of B cells and macrophages and in this rodent 
model, virus-specific IgG levels remained constant from the peak o f infection until at least 
day 90 (Sangster e t a l,  2000), a time frame in which the P. c. chabaudi-mÎQCtQd mice also 
harbour parasites. The differing influence o f parasite persistence could be due to the 
choice of host cells, with cells of the immune system stimulating a better response than 
the malaria parasites which spend the majority o f their time in the immune-privileged 
environment of the red blood cell. Alternatively, differences in the numbers of persisting 
pathogens in the two infections could be important. It would be necessary to determine 
whether the strong extrafollicular plasma cell response, which is mainly short lived, seen 
in malaria also exists in other diseases to determine the reason for these differences.
The next issue is the development o f MSP-121-specific antibody levels during infection. 
The M SP-l2i-specific IgG levels during the primary and secondary infections with 
P. c. chabaudi exhibit a differentiation into a slow primary response with low antibody 
levels and a faster secondary response with higher peak levels. The slow rise o f antibody 
levels during primary infection has also been observed in P. c. chabaudi infection of 
BALB/c mice (with the peak 5 weeks after infection) (Quin and Langhome, 
2 0 0 la).However, comparison with other infection and immunisation models shows that 
the change in M SP-l2i-specific IgG levels differs from other primary antibody responses. 
NP-specific IgG levels peak 8-12 days after immunisation and MMTV-specific IgG 
levels reach their highest levels 5 days after infection (Luther et a l,  1997; Takahashi et a l, 
1998). In B-lymphotrophic gammaherpesvirus and Neisseria meningitidis primary 
infections, IgG levels begin to rise sharply from day 8 o f infection and reach maximal 
levels at day 20-25 or day 10, respectively (Colino and Outschoom, 1998; Sangster et a l,
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2000). These results are in contrast with the slow development of MSP-121-specific IgG 
in the primary response, where levels only begin to rise between 3 and 4 weeks after 
infection and peak at or after the 1-month time point.
IgG responses in secondary infection can be compared with the mouse infection model o f 
Neisseria meningitidis where mice were infected with bacteria expressing a modified 
capsular polysaccharide, which acts as a thymus-dependent antigen (Colino and 
Outschoom, 1998). Bacteraemia was usually controlled within 8 h and mice were 
reinfected after 3 weeks. IgG levels against the polysaccharide peak 10 days after 
reinfection, reaching levels about ten times higher than the peak in primary infection. In 
the P. c. chabaudi secondary infection, the peak in MSP-121-specific IgG levels is not 
quite fivefold higher than in the primary infection. This increase is smaller than the one in 
N. meningitidis infection, but it is on the same order of magnitude. However, as in the 
primary infection, the MSP-121-specific IgG levels take longer to peak during the 
secondary infection, with a delay of 0.5 to 2.5 weeks compared to the N. meningitidis 
model.
There are several possible explanations for the slow rise in M SP-l2i-specific IgG levels. 
One explanation could be low levels of antigen. As the merozoite surface is coated with 
MSP-1 and the parasite can infect up to 30% of circulating erythrocytes at the peak o f 
infection, this explanation does not sound very plausible. Another possible reason for the 
low IgG measurements is that a large proportion of the plasma cell output binds to 
antigen within the mouse and is therefore not accessible for detection by ELISA. This 
would be especially relevant during the primary infection, when large amounts o f 
parasitic antigen are available to absorb specific antibodies. However, two observations 
make this an unlikely explanation for slow level development. First, parasite numbers 
have dropped strongly by days 14 and 21 of primary infection, but the MSP-121-specific
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IgG levels do not begin to rise noticeably until after day 21. Second, in the secondary 
infections at 2.5 months, the IgG levels are lower in untreated than in the drug-treated 
groups, although the parasitaemia is tenfold lower in the former. This argues against 
antibody absorption as a major obscuring factor in the measurements.
There is evidence for poor immunogenicity of MSP-121 which could explain the slow 
increase in antibody levels. Comparison within the MSP-1 molecule shows that the B cell 
response to MSP-121 is no worse than that against other portions o f the molecule. In 
BALB/c mice infected with P. c. chabaudi, IgG levels against the N-terminal portions of 
the MSP-1 molecule also develop slowly over 4-5 weeks (Quin and Langhome, 2001a). 
However, this just shows that the antibody response to the entire MSP-1 molecule is 
slow compared to other immunisations or infections. It is likely that low levels or slow 
development of T cell help are partially responsible, as it has been shown that antigenic 
processing of MSP-121 for presentation to T cells is slow and that T cell help to the 
molecule is slow to develop (Quin and Langhome, 2001a; Quin et a l,  2001b). Analysis of 
IgG levels after immunisation with different concentrations of MSP-121 would reveal how 
much of the slow rise in IgG levels can be attributed to the poor immunogenicity o f the 
molecule itself.
Finally, it is possible that the slow MSP-12rspecific IgG response is part o f a general 
phenomenon of immune suppression in malaria. There is some evidence that immune 
suppression occurs during malaria infection in both mice and humans (Greenwood et a l, 
1972; Weidanz and Rank, 1975). This immune suppression affects both the primary and 
secondary responses to non-malarial antigens such as bovine semm albumin (McBride 
and Micklem, 1977; Strambachova-McBride and Micklem, 1979). Recently, several 
studies have been published showing that the immunosuppression may be occurring at 
the stage o f dendritic cells (Ocana-Morgner et a l, 2003; Urban et a l, 1999; Urban and
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Roberts, 2003). The immunisation with MSP-121 mentioned above would also help to 
answer the question of the degree to which general immunosuppression is involved in the 
slow MSP-121-specific IgG response. Furthermore, the experiments where the immune 
response to a non-malarial antigen is studied during malaria infection should be repeated 
in order to analyse the results in the context of the additional knowledge on B cell 
development which has been gathered during the last 25 years.
One of the most interesting results from this section is the effect o f the presence or 
absence of parasites on the development o f IgG levels during reinfection. The impaired 
development of M SP-l2i-specific IgG levels at 2.5 months in untreated mice (as 
compared to the corresponding drug-treated mice and later time points) can be explained 
in two ways. First, the generation of memory B cells could be reduced in the presence of 
parasites. Second, the lower parasitaemia in the untreated mice results in a diminished 
antigenic stimulus, which could elicit a lower M SP-l2i-specific B cell response. To 
determine whether parasite number may explain the lower response, a further infection 
experiment should be carried out, where a secondary infection at 2.5 months is initiated 
with 10 ,^ 10  ^ or 10  ^ parasitised red blood cells in untreated mice and 10 "^ or 1 0  ^
parasitised red blood cells in drug-treated mice. These studies were in progress at the time 
of writing. Hopefully, these different doses will result in at least one combination where 
the untreated and drug-treated groups have comparable peaks of parasitaemia in the 
secondary infection. Determination of MSP-121-specifîc IgG levels in these groups will 
reveal whether the specific IgG level depends on the amount o f antigen in the secondary 
infection or the persistence of parasites from the primary infection. Another ongoing 
experiment is the measurement of IgG levels specific for crude malarial extract or MSP- 
I33 in the plasma samples from the drug-treated and untreated mice reinfected at 2.5 
months. This experiment is essential to determine whether the influence o f persistent
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parasites on the development of IgG levels during secondary infection extends to other 
malarial antigens or is unique to MSP-121.
The next part of the discussion will deal with the method of affinity measurement, 
summarise the results and their implications and then make comparisons with affinity 
measurements in other systems and finally draw conclusions for disease management. 
Chaotropic ion dissociation in the ELISA has been established as a method for 
determining avidities o f polyclonal antibodies for some time (Pullen et a l, 1986). Using 
panels of monoclonal antibodies, it has been shown that results are comparable to those 
obtained by the equilibrium dialysis and biospecific interaction analysis (BIA) methods 
(Macdonald et a l, 1988; McCloskey et a l, 1997). There have been two reports of 
artefacts in the thiocyanate elution method (Gray and Shaw, 1993; Hall and Heckel, 
1988) and it therefore appears that some combinations of antibodies and antigens are not 
suited for thiocyanate elution analysis. However, the type o f curve skewing observed by 
Gray and Shaw does not appear with the samples studied in this chapter and no 
problems have been reported for polyclonal antibody mixtures. Therefore, the 
thiocyanate elution method should give accurate representations of the relative affinity of 
MSP-1-specific antibodies. This method does not allow the determination of the 
Michaelis-Menten dissociation constant Kd, but that could be determined by measuring 
real-time binding of selected plasma samples by biospecific interaction analysis.
Affinity maturation can be observed with increasing intervals after primary infection by 
assessing the affinity distribution, but not from the affinity indices. This affinity 
maturation appears to be independent o f drug treatment and can presumably be attributed 
to selection processes among long-lived plasma cells (Smith et a l, 1997; Tarlinton and 
Smith, 2000). As will be discussed in terms of the affinity index, affinity maturation after 
infection is seen in several other systems as well. From 2.5 to 6.5 months after primary
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infection, antibody levels against MSP-121 are similar, so that the relative population 
sizes o f the different affinity categories also represent the absolute sizes of those 
populations. Comparison of primary and secondary infections shows that the affinities 
change differently for these situations. The shifts during the primary infection are subtle 
and only visible by affinity distribution, occurring mainly in the low affinity populations. 
This is consistent with the majority of the serum antibody stemming from short-lived 
plasma cells of the extrafollicular foci which do not undergo affinity maturation. In the 
secondary infections, affinity maturation is much more pronounced with a large 
proportion of the antibodies attaining the highest affinity category. This effect can be 
attributed to restimulation of memory B cells, as it is rapid and follows the same pattern 
for all o f the reinfections except the chioroquine-treated 2 .5-month reinfection -even 
though the affinity distribution patterns at day 0  differ for the different reinfection time 
points. This is a clear indication that the serum antibody seen before reinfection stems 
from a different source than the majority o f the antibody produced during reinfection (i.e. 
long-lived plasma cells versus memory B cells). Newly activated B cells also contribute to 
serum antibody during secondary infection as can be seen by the continued presence of 
low affinity antibody. The contribution of these cells is likely to be quite high, as the 
levels o f MSP-121-specific antibodies change strongly during reinfection, leading to altered 
sizes as well as the proportions of the affinity categories.
In the long run, drug treatment has no effect on how antibody affinities develop during 
reinfection. There are no major differences between the untreated and drug-treated groups 
at 4.5 and 6.5 months post infection. However, there is a clear difference during the 2.5 - 
month reinfection when chloroquine treatment determines whether low numbers of 
parasites are still present at the beginning of reinfection. Antibody affinity develops less 
stongly in the chioroquine-treated mice. This result stands in contrast to the higher
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M SP-121-specific IgG levels observed in the drug-treated group. This represents an 
unexpected duality in the response of memory B cells to the presence or absence of 
parasites at a reinfection time point of 2.5 months; parasite persistence appears to 
interfere with memory B cell generation or reactivation while resulting in increased 
affinity of these cells. Further experiments must be performed to clarify this issue and the 
easiest option would be to measure the antibody affinities in the plasma samples from the 
mice reinfected with different doses of parasite (described above).
Affinity indices have been measured by the thiocyanate elution method in a number of 
immunisation and infection systems. Immunisation of toddlers with conjugate vaccines 
used to improve the antibody response to poorly immunogenic capsular polysaccharides 
from Haemophilus influenzae type b resulted in maximal mean affinity indices o f 0.55 or 
0.104 M, even after boosting (Goldblatt et a l,  1999; Goldblatt et a l,  1998). Mouse 
monoclonal antibodies generated after immunisation with nitrophenyl haptens had 
affinity indices ranging from 0.45 to over 8 M (Macdonald et a l,  1988; McCloskey g/ a l,  
1997). Immunisation of two seronegative women with attenuated rubella virus led to 
maximal affinity indices of 4.5 M (Pullen et a l, 1986). After periodontitis (infections at 
the tooth root), maximal affinity indices of 1.38 M and 0.67 M were measured for the 
two responsible pathogens (Mooney et a l,  1995). Chronic infection of up to 11 years 
resulted in constant affinity indices of around 3 M and 2 M for two o f the antigens of 
Pseudomonas aeruginosa (Ciofu et a l, 1995)
Therefore, the affinity index value of around 1.5 M seen after primary infection seems to 
represent a normal degree of antibody affinity. In a rabbit immunisation study with a 
peptide containing four of the RESA (ring-infected erythrocyte surface antigen) tandem 
repeats, the maximal affinity index of 1.7 M was achieved with Freund’s complete 
adjuvant and a 0.5 M affinity index was generated by peptide-transfected vaccinia virus
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(Lqsn et a l, 1988). Thus, the affinity index for M SP-121 in infection is almost as high as 
that generated against another malarial protein by immunisation under optimal conditions. 
Affinity indices against whole parasitised red blood cell extract in humans ranged from 
0.04-0.45 M during acute Plasmodium falciparum  infection and from 0.01-0.75 in 
convalescent patients protected from reinfection for 63 days after drug treatment 
(Ferreira and Katzin, 1995). However, these results cannot be compared with the 
response to M SP-121, as each antigen found in the malarial extract will have its own 
pattern of antibody affinity resulting in too many variables.
It has been shown in NP-immunised mice that affinity maturation o f serum antibodies 
continues after germinal centres become undetectable, with a steady increase of antibody 
affinity up to day 119 post immunisation (Takahashi et a l,  1998). This was measured by 
comparing the ratio of antibodies against a carrier protein with two degrees of 
haptenation: one which would be recognised by all antibodies of that specificity (NP26) 
and one which could only be recognised by high affinity antibodies (NP5). In contrast, the 
affinity index of MSP-fyi-specific antibodies was shown to remain constant after the 
termination of the acute infection. Comparison with the affinity indices measured in 
several other immunisation systems reveals a mixed picture. Toddlers and young children 
vaccinated with polysaccharide conjugate vaccines show increases 10 - 10 0% in antibody 
avidity in the interval between 1 and 6-7 months after the last immunisation (Borrow et 
a l, 2001; Borrow et a l,  2002; Goldblatt et a l,  1998; Richmond et a l ,  2001). However, a 
comparable polysaccharide vaccination in adults did not lead to avidity maturation 
(Goldblatt et a l,  2002).
Affinity measurements made during or after infections with other pathogens also give 
mixed results: Samples taken from cystic fibrosis patients with chronic Pseudomonas 
aeruginosa infections o f up to 11 years duration showed no development o f antibody
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avidity in this time period (Ciofu et a l, 1999). On the other hand, the avidity o f rubella- 
specific antibodies increased up to sixfold over a period of 15 weeks after infection 
(Bottiger and Jensen, 1997). The avidity o f pathogen-specific antibodies can increase up 
to 14-fold between 4 and 30 weeks after Toxoplasma gondii infection. Some caution must 
be retained in making these comparisons, as the affinities in the last two examples were 
determined using a variation of the thiocyanate elution method or antibody dissociation 
with urea in infection system. The affinity index has also been measured in a set of P. 
falciparum-infQctQd, patients, once right after drug treatment and again 63 days later (with 
patients protected from mosquito exposure during that time period) (Ferreira and Katzin, 
1995). In 11 out of 20 patients, the index rose (with increases of 50-350%) in 7 o f those 
patients and fell in 9 patients.
Taken together, this shows that affinity index measurements often do not give a 
sufficiently clear picture of what is happening in a polyclonal response. However, the 
affinity distributions of plasma samples taken after primary infection do show that 
affinity maturation is taking place, even when this is not revealed by the affinity index. 
This discrepancy is caused by the fact that the affinity index does not register shifts 
between neighbouring affinity categories and is not affected by changes in the high 
affinity categories. The affinity maturation after primary infection can be attributed to 
two causes. One is the selection of higher affinity plasma cells in the bone marrow 
(Takahashi et a l, 1998). Another possibility is generation of additional plasma cells from 
B cells which have to compete with high affinity serum antibody to bind to malarial 
antigen presented on follicular dendritic cells. It is not possible to distinguish between 
these options with a strictly serological approach and therefore, more detailed analysis of 
the MSP-fyrspecific B cells themselves is required.
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There is little data in human malaria infections with which to compare these results. The 
affinity measurements by Falanga et al. examined antibody directed against whole parasite 
antigen whereas the M SP-121 studies lack information on the infection history. 
Nevertheless, some conclusions can be drawn for human malaria. If long-lived plasma 
cells and memory B cells with specificity for an epitope of proven protectivity are 
generated in malaria infection, why does this not lead to sterile immunity upon reinfection 
in humans? One possibility is that drug treatment is begun too early for full-scale 
development of the immune response. It has been shown in mice that a minimum time of 
parasite exposure before drug treatment is necessary for protection against reinfection 
with a lethal parasite strain to develop (Favila-Castillo et a l, 1999). The slow 
development of the MSP-121-specific antibody response suggests that the length of 
exposure to primary infection may be relevant for the development of long-lived plasma 
cells or memory B cells In addition, the results showed that the presence of parasites at 
the time point of reinfection could impair the B cell memory response. This could be a 
deciding factor in highly endemic areas, where both multiple and chronic infections are 
common. If these observations are confirmed, it would mean that patients must be drug 
treated before vaccination to avoid interference with the memory B cell response.
Further analysis of the precise mechanisms of long-lived plasma cell and memory B cell 
development would be greatly aided by the aid o f a mouse carrying a rearranged 
immunoglobulin transgene specific for a malarial antigen. This gene would have to be 
“knocked in” to the immunoglobulin location so that all normal steps o f B cell 
development can take place. It would then be possible to observe affinity maturation, 
isotype switching and memory generation in greater detail.
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7 Summary
The results have been discussed individually in Sections 3-6 and further experiments have 
been suggested. This section summarises how the separate sections fit together and considers 
some of the implications for future work. Sections 3 and 4 revealed that both the follicular 
and the extrafollicular pathway are represented in the general as well the specific B cell 
responses to Plasmodium antigens during primary infection, showing that the potential exists 
for long- and short-lived B cell responses. The existence of long-lived immune responses 
(although not necessarily in the B cell compartment) was demonstrated by the reinfection 
studies in Section 5. These data also showed that the presence o f parasites at the time of 
reinfection may result in synergistic cooperation between activated effector cells and long- 
lived cells of the immune system. Section 6  showed that the presence of parasites at the time 
point of reinfection affects the B cell response differentially. Persistence of parasites beyond 
day 30 o f infection appears to have no effect on long-lived plasma cell development and 
maintenance. However, persisting parasites may slow down the memory B cell response 
while simultaneously leading to an increase o f memory B cell affinity.
One remarkable aspect o f these results is the parallel occurrence of reduced anti-MSP-121- 
specific IgG levels during the 2.5-month reinfection of untreated mice and reduced 
parasitaemias. Along with the slow kinetics o f the M SP-hi-specific IgG response as 
compared to other infections and immunizations, this raises the possibiliy that M SP-121- 
specific antibodies and perhaps the anti-malarial antibody response per se may not be as 
important for protection against malaria as generally assumed. It has been shown that an 
effective immune response can be mounted against AMA-1 without strong antibody 
involvement [Xu et a l ,  2000] and these data could be interpreted in a similar light. 
However, although mice lacking B cells are able to counter an infection with Plasmodium, 
they are not immune to reinfection, indicating that antibody is important for the development
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of immunological memory. Furthermore, it is unclear what quantity o f M SP-1-specific 
antibody would be required to mediate protection. Studies with vesicular stomatitis virus 
infection have shown increases of antibody levels and affinities beyond a certain level do not 
further increase the level of protection [Bachmann et a l ,  1997] and it is unknown at what 
level such a threshold might exist for the MSP-1-specific immune response.
Another consideration when studying antibody responses to MSP-1 is that the antibodies 
detected by ELISA may contain non-protective blocking antibodies (discussed in Section 
4.1.2) as well as protective processing-inhibitory antibodies. The existence of these types of 
MSP-121-specific antibodies has not yet been shown for mice, but the possibility of an MSP- 
121-specific pool of mixed protectivity must be kept in mind. Therefore, it is crucial to 
examine the B cell responses to further Plasmodium  antigens and determine whether other 
malarial antibody responses develop according to the same pattern as the M SP-hi-specific 
antibody response.
The combination of cell-based examination methods during primary infection and 
serological analyses during primary and secondary infection in these experiments has been 
very useful in analysing B cell development during malaria infection. However, further 
analyses must be performed at the antigen-specific level to avoid studying the nonspecific 
polyclonal response elicited by malaria infection which is probably not part of the long-lived 
B cell response. Generating a knock-in mouse with an MSP-121-specifîc rearranged 
immunoglobulin heavy chain, as suggested in Section 6.3, would avoid the problem of how 
to detect the low numbers of M SP-hi-specific B cells. Ideally, the rearranged gene would 
also include a reporter gene such as green fluorescent protein under the same promoter. This 
would allow direct detection by immunohistology or flow cytometry. The existence o f a 
large pool o f B cells with identical receptors would also make it possible to follow the 
development o f B cells in the germinal centers and allow tracking o f migration patterns
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afterwards by single cell analysis o f somatic hyperm utation in the rearranged 
immunoglobulin genes.
A final consideration in this project is that all infections were performed solely with the 
erythrocytic stage of the parasite. Evidence is accumulating that Plasmodium-mfQctQd 
erythrocytes can affect the maturation of dendritic cells [Ocana-Morgner et a l ,  2003, Urban 
et a l ,  1999, Urban and Roberts, 2003] and thereby in turn influence immune response 
against the hepatic stages o f the parasite. It is therefore conceivable that sporozoites or 
hepatic merozoites could influence the immune response against the erythrocytic stages of 
the parasite as well. Therefore, if  further studies confirm that the presence o f parasites from 
a previous infection affect the memory B cell response, it would be important to examine the 
situation in infections initiated by sporozoite inoculation.
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